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? ? ? ? ? Abstract
Rodent-specific BC1 RNA and primate-specific BC200 RNA, here referred to collectively as “BC 
RNAs”, are small non-protein coding RNAs transcribed by RNA polymerase III and generated by 
retroposition of tRNAAla and 7SL RNA, respectively. Despite their different evolutionary origins, both RNAs 
share many features, thus they are considered to be functional analogues. Both RNAs are preferentially 
expressed in neurons and are transported efficiently to the dendrites. They are also involved in translational 
regulation. However, their precise cellular functions have yet to be discovered. In the cell they are bound to 
proteins and form ribonucleoprotein (RNP) complexes. To date, over a dozen proteins are reported to bind to 
these RNAs, but most of them are highly debated and controversial. To determine the precise functions of 
the BC RNAs, it is essential to purify and characterize their RNPs. Many biochemical purification methods 
were previously used in an attempt to purify the BC RNP complexes, but most of them were not successful 
in isolating pure or entire complexes. Thus, we developed an RNA tag-based affinity purification procedure, 
whereby both BC RNAs were tagged with MS2 RNA motifs in combination with the MS2 coat protein fused 
to the tandem affinity purification (TAP ) tag to purify the endogenously assembled BC RNP complexes 
using an affinity matrix. The TAP tag is a two-step affinity purification method, whereby contaminants can 
be eliminated during the purification, and provides a higher purification compared to other conventional 
biochemical purifications. Preliminary ex vivo experiments were carried out in NIH 3T3 cells; however, as 
these are not neuro-specific cells, such studies might have missed the neurospecific protein partners. In 
addition to purification, the MS2 RNA tag can also be used to study transport. Thus, I established two 
different transgenic mouse models, BC1MS2B+MS2TAP and BC200MS2+MS2TAP, to study the 
purification and transport of both BC RNAs from mouse brain. Initial purification and transport studies 
provided a hope that both objectives may be achieved in the in vivo situation.  
The second part of my thesis took advantage of the fact that both BC1 RNA and BC200 RNA are 
related to Short INterspersed Elements (SINEs). BC1 RNA is a master gene for the rodent-specific ID 
repetitive elements yielding SINEs. SINEs are abundant in all rodent genomes and have been used as 
powerful tools for examining rodent evolution. In this study, SINE elements were used as effective markers 
for reconstructing the phylogeny of rodents. Computerized databases from Mus musculus and Rattus
norvegicus, published human genomic sequences, and preliminary trace sequences from Dipodomys ordii, 
Cavia porcellus, and Spermophilus tridecemlineatus were used to screen for phylogenetically informative 
SINE insertions [human and lagomorph (Oryctolagus cunlculus) sequences were used as outgroups]. Using 
different computational strategies for selecting phylogenetically informative loci, we were able to resolve 
some of the unsettled questions in the rodent phylogenetic tree. Twenty-two independent diagnostic SINE 
markers were found in 17 different loci. In addition to those already known, we found five new SINE 
markers that confirm the monophyly of rodents. The most important findings were two diagnostic SINE 
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markers that group Sciuridae and Aplodontidae in the Squirrel-related clade, two markers that group 
Caviomorpha and Phiomorpha species together within the Ctenohystrica clade and four new markers that 
group members of the superfamily Geomyoidea. The remaining nine markers confirmed previously known 
groupings within the three main rodent clades.  
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The mouse genome sequence revealed that less than 2% of genome codes for proteins, while 37.5% 
of the genome is composed of repetitive elements (Waterston et al., 2002, Venter et al., 2001). Among them 
B1, B2, B4 and ID elements are the most abundant repetitive elements, which amount to more than 1 million 
copies representing 7.8% of the genome. Retroposition is the mechanism responsible for amplification of 
these elements. Retroposed elements belong to the Short INterspersed Elements (SINEs) family. SINEs are 
derived from small RNA templates with an internal RNA polymerase III promoter, especially 7SL RNA or 
tRNAs (Okada, 1991, Ohshima and Okada, 1994). SINE repeats, representing the major class of non-
autonomous retroposons, are usually about 75-600 nucleotides long. SINEs are probably best defined as short 
DNA sequences arising from reverse-transcribed RNA molecules, originally transcribed mostly by RNA 
polymerase III (Singer, 1990). Most of the SINEs are transcriptionally not active, but some SINEs are 
actively transcribed and participate in retroposition are termed master genes (Deininger et al., 1992). Alu and 
B1 elements are derived from 7SL RNA [a component of signal recognition particle, SRP RNA], while ID 
and B2 elements are derived from tRNA genes. SINEs can be used to resolve the phylogenetic relationships 
among rodents, this will be discussed in the second part of my thesis.  
BC1 RNA is a master gene for generating SINEs namely ID elements. BC200 is a transcribed 
monomeric Alu element derived from 7SL RNA. Both are small non-protein coding RNAs (npcRNAs) 
(Brosius, 1999, Wang et al., 2002) transcribed by RNA polymerase III, (Martignetti and Brosius, 1993a) 
complexed with proteins that form ribonucleoprotein particles [RNPs] in the cell (Chen et al., 1997a, 
Kremerskothen et al., 1998b, Muddashetty et al., 2002). Rodent-specific BC1 RNA/RNP and primate-
specific BC200 RNA/ RNP, here referred to collectively as “BC RNAs/RNPs”. Unlike the majority of small 
stable RNAs, these cytoplasmic RNAs are almost exclusively expressed in neurons of brain and 
developmentally regulated. In neurons, both the RNAs/ RNPs are efficiently transported into distal parts of 
dendrites (Tiedge et al., 1993, Tiedge et al., 1991) and their expression during development coincides with 
synapse formation and is involved in synaptic activity. The unique expression pattern, both temporally and 
spatially and their ability to inhibit translation in vitro and ex vivo [transfected cells] makes them very 
interesting molecules to study (Kondrashov et al., 2005, Wang et al., 2005, Wang et al., 2002). Both RNAs 
share similar domain organization, the tRNA-related ID region for BC1 RNA, and the 5' repetitive domain, 
representing the Alu domain in BC200 RNA, a central A-rich region and a unique region at the 3' end 
(Martignetti and Brosius, 1993a). In order to fully understand and experimentally test the role of both BC 
RNAs in neuronal dendrites, it is important to identify all the proteins that are associated with their respective 
RNPs. Studies of RNP components [RNA-protein interactions] are far from technically simple. Many 
proteins bind to cellular RNAs, usually in a dynamic way that reflects changes in cellular metabolism and 
regulation or function. These proteins bind and remain bound with varying affinities that can be influenced 
by other constituents of the RNP complex. To date, there are several in vitro and in vivo methods available to 
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study RNA-protein interactions. In vitro techniques have been instrumental for the precise characterization of 
RNA and protein interaction sites. Early studies on RNA-protein interactions employed filter binding assays 
or electrophoretic mobility shift assays, in which a known RNA-binding protein was incubated under 
equilibrium conditions with the radio labeled RNA harboring a potential binding sequence. Methods such as 
UV cross-linking (Dreyfuss et al., 1984), have been effective in identifying the interacting components as 
well as in precisely pinpointing the site of RNA-protein interactions in vitro. Recently RNA affinity tags 
(Srisawat and Engelke, 2001) were found to be useful for studying RNPs. Although in vitro methods are 
valuable in understanding the structure/function relationship of RNP complexes, they are prone to artifacts 
and may fail to reflect physiological interactions, which can be addressed only by in vivo systems. 
To date, over a dozen proteins are reported to be the components of BC1 or BC200 RNP 
(Kondrashov et al., 2005). Most of them are in vitro or interpretational artifacts except poly (A)-binding 
protein (PABP) for both BC RNAs (Muddashetty et al., 2002, West et al., 2002) and SRP9/14 for BC200 
RNA (Skryabin et al., 1998, Bovia et al., 1997). Thus, we have developed an RNA tag-based affinity 
purification procedure, to our knowledge, this is an advanced affinity purification strategy of endogenously 
assembled either BC1 or BC200 RNPs from the mouse brain extract. We believe this method may be useful 
to overcome the aforementioned general biochemical purification problems, where intact and complete 
purification of BC RNPs were not possible. 
In our method bacteriophage MS2 translational repressor or RNA motif, (Horn et al., 2004, 
Johansson et al., 1998, van den Worm et al., 1998) were tagged to the BC RNAs to study the RNA-protein 
interactions and the transport of these BC RNAs. The 19 nt stem loop MS2 motif (stem-loop operator) has a 
high in vitro affinity to MS2 coat protein. The MS2 coat protein had been fused to the Tandem Affinity 
Purification [TAP] tag (Rigaut et al., 1999), where the BC MS2/MS2TAP RNP complexes will be 
immobilized on an affinity matrix for a two step affinity purification. In this MS2/MS2 coat protein (MS2 
RNA motif and its MS2 coat protein) complex have been conceived as a handle for the purification of BC 
RNP complexes and the whole complex represents (reflects) an RNA tag based affinity purification (Hogg 
and Collins, 2007). 
1.0 Origin and evolutionary significance of BC RNAs 
In general, retroposition is an ancient process that has been instrumental in the transformation of an 
exclusively RNA/RNP world into the modern world with three major macromolecules DNA-, RNA-, Protein 
(Brosius and Tiedge, 1995). The process of retroposition is mediated by the enzyme reverse transcriptase, 
which converts RNA to DNA. The event is rather random whereby any cellular RNAs can serve as a 
template for reverse transcription and the resulting cDNA copies are integrated into the genome more or less 
at any position. 
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Neuronal BC1 RNA has been generated by retroposition of tRNAAla (DeChiara and Brosius, 1987). 
The cDNA copy of tRNAAla integrated fortuitously into a locus [chromosome 7 between Fgf3 and Itgal 
(Oraov) in a common ancestor of all rodents] (Taylor et al., 1997) where flanking promoter elements were 
available in conjuction with internal promoter elements (box A+B'). (Martignetti and Brosius, 1993b) The 5' 
end of BC1 RNA has ~80% sequence similarity with tRNAAla, however this domain does not fold like a 
cloverleaf structure of tRNA but rather forms a stable stem/loop (Fig 1.0.) (Rozhdestvensky et al., 2001). The
remainder of BC1 RNA consists of the central A-rich region and the unique region.The BC1 gene is present 
in all rodent species examined so far. BC1 RNA possesses very specific, specialized expression patterns in 
the brain. Furthermore, the expression of BC1 RNA is restricted to the mammalian order Rodentia. Its 
sequence in distantly related rodent genomes is highly conserved compared to its flanking regions and it is 
the first known RNA polymerase III transcript expressed almost exclusively in nerve cells, where it is 
efficiently transported up to the distal parts of dendrites (Tiedge et al., 1991). Another important finding is 
that BC1 RNA also serves as master gene for ID1 SINE elements (Kim et al., 1994). Other ID elements, 
including ID2-4 presumably are retroposed from a few transcribed ID-related RNAs (Kim et al., 1994, Shen 
et al., 1997). 
Fig 1.0 Origin of BC1 RNA 
gene the pre-tRNAAla is the 
precursor of BC1 RNA gene. 
Base changes leading from its 
putative tRNAAla precursor are 
indicated by circles to 
facilitate comparison. BC1 
RNA gene serves as master 
gene for ID repetitive 
elements. The figure was 
adapted from (Rozhdestvensky 
et al., 2001).
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BC200 RNA, which is present in anthropoid primates, located on human chromosome 2p16 (Basile 
et al., 1998), but the human genome sequence [build 36.3] places it on 2p21 between TACSTD1 (tumor-
associated calcium signal transducer 1)/MIRN559 and CALM2 [calmodulin 2]/LSL [leptin, serum level] has 
been exapted from a monomeric Alu element. The progenitor of this Alu family of SINEs began with a 7SL 
RNA which is derived from a deletion of 141 nucleotides in the 7SL RNA gene starting from position 98, 
followed by a few point mutations in the “B-box” of the RNA polymerase III promoter. The resulting master 
gene given rise to a SINE called the fossil Alu monomer [FAM] (Quentin, 1992). It amplified to a number of 
copies that are still detectable in the human genome. The FAM most probably given rise to another SINE, the 
free left Alu monomer [FLAM (PB1)] by the deletion of another 42 base pairs starting from the position 84 
(Kriegs et al., 2007). The FLAM probably is the common ancestor for the BC200 RNA gene in primates, via 
intermediate ancestral elements to the 4.5SH gene as well as to the B1 SINEs in rodents. The FLAM fused to 
another FAM-derived element, the free right Alu monomer [FRAM] that given rise to the Alu family of 
SINEs (Fig 1.1) .The insertion of the FLAM copy that given rise to BC200 gene must have occurred after the 
divergence of the anthropoid lineage from the prosimian lineage (Kuryshev et al., 2001). Like its analogue 
BC1 RNA, BC200 RNA is evolutionarily conserved and thus under selective pressure, characteristic for 
functionally active genes. The gene is conserved in all anthropoids including Old World monkeys, New 
World monkeys and Hominoids (Skryabin et al., 1998). However this gene is absent in representatives of the 
prosimian lineages [galagos, lemurs and tarsiers]. Interestingly, the orthologus loci in G. moholi and E. 
coronatus harbor a dimeric Alu element nearly exactly at the same position of the BC200 gene. G22 RNA is 
almost twice the size of BC200 RNA has a similar sub-cellular localization like in BC200 RNA. Further 
experimental evidence revealed that G22 RNA also forms RNP complex by interacting with proteins, 
SRP9/14 and PABP (Khanam et al., 2007b) like BC200 RNA. BC200 RNA and G22 RNA represents the 
rare offsprings of repetitive DNA families that is transcriptionally and retropositionally active (Khanam et al., 
2007b, Kuryshev et al., 2001, Ludwig et al., 2005, Skryabin et al., 1998, Watson and Sutcliffe, 1987) and 
may be associated with higher cognitive functions in the nervous system. The BC200 RNA gene itself given 
rise to several [~200] retropseudogenes, but also pseudogenes generated by segmental duplication, examples 
are BC200? and BC200? (Martignetti and Brosius, 1993a). BC200 RNA gene is relatively young, the 
estimated age is about 35-55 million years. 
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Fig 1.1 Origin of BC200 RNA gene The 7SL RNA is a progenitor for the origin of proto-Alu gene and the 
neuronal BC200 RNA gene was exapted from a monomeric Alu element. The central S-domain (black) is 
deleted from the 7SL RNA gave rise to a fossil Alu monomer [FAM]. FAM given rise to FRAM part of Alu 
SINEs (blue). The red 42 bp long portion of the BC200 gene is a unique sequence derived from the locus of 
integration and not from the 7SL RNA gene. Both BC200 gene and the first dimeric Alu element arose 
through independent retroposition.  
1.1 Structural features of BC RNAs 
The 152 nt long rat BC1 RNA sequence can be subdivided into three major domains (Fig 1.2). The 5' 
ID domain of 75 nucleotides [nt] which forms a stable stem-loop, this domain harbors a dendritic targeting, a 
cis-acting element that is responsible for dendritic transport (Muslimov et al., 2006, Muslimov et al., 2002) 
and a stretch of 22 nt of adenosine residues followed by a unique 3' terminal stem loop structure of about 55 
nt. The chemical and enzymatic probing showed that, this domain underwent a structural transition into an 
extended rod-like stem-loop structure, which is substantially different from the original tRNA cloverleaf 
structure (Rozhdestvensky et al., 2001). Nucleotide changes in BC1 RNA that are responsible for this 
structural transition are predominantly located in the sequences corresponding to the acceptor and anti-codon 
stems of authentic tRNAAla, which participate now in formation of the 5' stem structure (Rozhdestvensky et 
al., 2001). 
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Like rat BC1 RNA, 200 nt long human BC200 RNA can be subdivided into three major domains 
(Skryabin et al., 1998) (Fig 1.2). The 5' domain consists of ~120 nt similar to monomeric Alu repetitive 
elements, originated from 7SL RNA, the RNA component of the signal recognition particle (Ullu et al., 1982, 
Ullu and Tschudi, 1984). The central 41 nt of adenosine [A-rich] domain and a 3' terminal segment of 42 nt is 
unique for BC200 RNA. 
Fig 1.2 Schematic representation of secondary structures of BC1 RNA and BC200 RNA 
1.2 Dendritic localization and subcellular distribution of BC RNAs 
Despite their different evolutionary origins, both RNAs have many features in common and they are 
considered to be functional analogues. These RNAs are exclusively expressed in the nervous system and are 
developmentally regulated. In situ hybridization studies on BC RNAs revealed the sub-cellular distribution. 
Both RNAs are expressed in the retina of ganglion cell layer, innermost part of the inner nuclear layer and 
inner plexiform layer. Little or no specific labeling was observed over the outer nuclear layer and the outer 
plexiform layer cells (Tiedge et al., 1991). In the hippocampus CA1, CA2 has moderate signal and CA3 had 
intense signal for both BC RNAs. In dentate gyrus, no signal was observed for BC1 RNA and a weak signal 
observed in case of BC200 RNA. In the hippocampus, both BC RNAs are highly expressed in the pyramidal 
cells in Ammon’s horn and in the hilar region.  
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The olfactory bulb and neo-cortex containing all layers (II – IV except layer I) showed extensive staining. In 
the cerebellum BC1 RNA labeling was low to moderate (Tiedge et al., 1991). White matter areas throughout 
the brain showed little or no labeling, indicating the absence of BC1 RNA in axons and glial cells.  
Two important conclusions were drawn from the studies on BC RNAs [BC1 and BC200] in 
comparison to GAP-43 mRNA in situ hybridization in the adult rat brain and the human brain [respectively]. 
First the hippocampal neurons that express BC RNAs also contain GAP-43 mRNA indicating that BC RNAs 
and GAP-43 mRNA are co-expressed by the same type of neuronal cells (Lin et al., 2001, Tiedge et al., 
1993). Second BC RNAs are located in postsynaptic domains, while GAP-43 mRNA has been observed in 
presynaptic domains. It has been shown that BC1 RNA is a prominent component of isolated dendritic spines 
and synaptodendrosomes (Chicurel et al., 1993, Rao and Steward, 1993). Therefore BC RNAs colocalization 
in postsynaptic microdomain further supports speculation on postsynaptic RNA metabolism and regulation of 
mRNA translation. 
1.3 Functional Significance and Synaptic Plasticity 
BC RNAs localized to dendritic processes of neurons may play an important role in physiological 
activity and synaptic plasticity responsible for learning and spatial memory. BC RNAs operate as modulators 
of dendritic RNA functions, like transport of other dendritic components (Tiedge and Brosius, 1996, Tiedge 
et al., 1993, Tiedge et al., 1991) and dendritic translational regulation (Brosius and Tiedge, 1995, Wang et al., 
2005, Wang et al., 2002), Brosius, 1996). Both were speculated earlier – in 2003, the first possibility could be 
ruled out (Skryabin et al., 2003). Both RNAs are under selective pressure to be expressed in brain and testes 
of rodents and anthropoid primates respectively. This reflects that these RNAs must have a functional role, 
but that function must be a subtle rather than essential. Because neither of the RNAs are present in all 
mammalian orders. This was confirmed, when the gene encoding BC1 RNA was deleted, and no noticeable 
phenotype was detected and the mice did not reveal any neurological abnormalities. The BC1 deficient mice 
had shown normal brain morphology and the other dendritic mRNA transport and localization was not 
changed. Nevertheless, BC1 deficient mice exhibited behavioral changes in terms of reduced exploration and 
increased anxiety (Skryabin et al., 2003). 
From the studies of BC1 deficient mice, we learned dendritic transport of other RNAs, such as 
mRNAs is not affected. The other possible speculation about these RNAs is that they must involve in 
translational regulation. This is supported by finding poly(A)-binding protein [PABP], the protein partner of 
both BC RNAs. This might indicate that BC1 RNA inhibits translation in vitro also in ex vivo [transfected 
cells]. These important findings came from our laboratory (Kondrashov et al., 2005, Muddashetty et al., 
2002). Wang et al have confirmed, and further demonstrated that BC1 RNA inhibited translational initiation 
by blocking the formation of 48S initiation complexes (Wang et al., 2005, Wang et al., 2002). They also 
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demonstrate that BC1 RNA-mediated inhibition occurred by a competition between mRNA and BC1 RNA 
for binding of eukaryotic initiation factor 4 [eIF4] and PABP (Wang et al., 2002). 
1.4 BC RNAs – Expression and deregulation in tumours 
In general, BC RNAs are selectively expressed in neurons of brain, also in germ cells such as 
spermatogonia, oocytes and in cultured immortal cell lines of non-neural origins (Muslimov et al., 2002, 
Tiedge et al., 1993). But there were reports that BC1 RNA and BC200 RNA apparently were expressed in 
murine and human tumours respectively (Chen et al., 1997a, Chen et al., 1997b). Distinctively, BC200 RNA 
was expressed in certain cancerous cells such as breast, cervix, oesophagus, lung, ovary and tongue but not in 
the corresponding normal tissues (Iacoangeli et al., 2004). The detection of BC200 RNA expression in human 
tumours demonstrated that BC200 RNA is deregulated in those tumours. Recently Tiedge’s laboratory 
reported, that BC200 RNA is differentially regulated in aging and in Alzheimer’s disease (Mus et al., 2007).
1.5 Preceding work on BC RNPs 
Role of BC RNAs and associated proteins 
The size of the BC1 RNP complex is about 8.8S [naked RNA 6.1S] (Cheng et al., 1996) and the size 
of BC200 RNP complex 11.4S [naked RNA 7.6S] (Cheng et al., 1997) shows that BC RNAs are bound to 
proteins. In any RNA-protein complex, not all interactions are identical, some of the proteins bind to the 
RNA directly, where as other proteins bind to the RNA indirectly via other proteins or transiently. It is very 
important to establish the composition of these RNP complexes, to identify the proteins bind to these RNAs 
to determine their fate and functional role. 
To date, over a dozen proteins have been reported to be part of BC1 RNP complex. Nevertheless, 
most of them must be in vitro or interpretational artificats. The best example, La (Kremerskothen et al., 
1998a) has been published from our laboratory and later we found it is not a part of BC1 or BC200 RNP. 
Another prominent example is FMRP, which is highly debated and controversial (Napoli et al., 2008, Zalfa et 
al., 2003), and has been disproven in five laboratories independently (Iacoangeli et al., 2008b, Iacoangeli et 
al., 2008a). 
Poly(A)-binding protein [PABP] 
Out of so many candidate proteins of BC1 RNP, poly(A)-binding protein [PABP] is the only bona 
fide protein for both BC RNPs. PABP is a unique translation initiation factor that binds to the mRNA 3' 
poly(A)-tail and involved in regulation of translation. Because BC RNAs have a stretch of poly (A)-rich 
sequence 54 nt and 41 nt respectively for BC1 and BC200 RNA, we assumed that PABP can be part of these 
RNP complexes. Several lines of evidences implicates this protein as binding partner for both BC RNAs, like 
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immunoprecipitation, gel shift assays, localization etc (Khanam et al., 2006, Muddashetty et al., 2002, Mullin 
et al., 2004, West et al., 2002). 
SRP 9/14 (signal recognition particle) 
Many Alu containing transcripts such as SRP RNA, BC200 RNA, and B1 transcript share a similar 
secondary structure as well as conserved sequences, which can potentially interact with the SRP9/14 kDa 
proteins (Bovia and Strub, 1996, Bui and Strub, 1999, Hasler and Strub, 2006, Kremerskothen et al., 1998b, 
Tiedge et al., 1993). SRP9/14 proteins form a stable heterodimer in the signal recognition particle and binds 
with high affinities to 7SL RNA and BC200 RNA. These proteins are bound to the Alu domain of BC200 
RNA. This has been confirmed by different lines of evidences like filter binding assays, immunoprecipitation 
etc. In addition to the SRP9/14 proteins bound to the BC200 RNA, PABP is another protein that binds to the 
BC200 RNA (Khanam et al., 2006, Muddashetty et al., 2002, Mullin et al., 2004, West et al., 2002). 
1.6 Isolation of BC RNPs 
The general biochemical methods including gel filtration, sucrose gradients, purifications like DEAE, 
Mono-Q, superdex-G200, heparin resins [matrix] could not purify BC1 or BC200 RNP complexes to near 
homogeneity (Muddashetty, R., thesis). Therefore, we sought to develop RNA tag based affinity purification, 
where BC RNAs are tagged to the MS2 stem loop motif, and the corresponding MS2 coat protein fused to 
TAP tag co-expressed for purification. The TAP (Fig 1.3.) is a two-step affinity purification method, 
developed by Bertrand Seraphin (Rigaut et al., 1999). TAP tag consists of two IgG binding [ProtA] domains, 
and a calmodulin-binding peptide [CBP] separated by a tobacco etch virus [TEV] cleavage site. The CBP tag 
allows for efficient selection and specific release from the affinity resin under mild conditions. In contrast, 
ProtA can only be released from the matrix-bound IgG under denaturing conditions at low pH. Therefore, 
TEV protease recognition sequence has been inserted between CBP tag and ProtA tag. The TEV protease 
enzyme specifically cleaves the ProtA tag from CBP tag under mild conditions, so the complex can be eluted 
under native conditions. 
MS2 tag was chosen for two reasons. First, it could be used for transport studies. The second main 
purpose is to purify the BC RNP complexes to homogeneity and to identify the proteins bound to these 
complexes. MS2 tag was preferred in comparison to other tags for two reasons. First, MS2 stem [MS2 RNA 
motif] structure is quite stable and the corresponding MS2 coat protein protects the MS2 stem from 
processing compared to other tags, which do not have a protein to protect the tagged RNA from processing. 
Another reason is MS2 RNA motif, a naturally available tag and this is the most selective and efficient in 
binding to MS2 coat protein. 
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Fig 1.3 Over view of RNA-tag based tandem affinity purification 
BC RNAs [BC1 RNA-blue rectangle and BC200 RNA-purple rectangle] tagged with the MS2 RNA structure 
[green rectangle] bound to the MS2 coat protein [green oval] complex [other domains shown in purple and 
magenta]. In the first affinity purification the protein A [ProtA - magenta] portion of the TAP fusion 
polypeptide is bound to the IgG matrix. After the first wash, the bound complex is treated with TEV [tobacco 
etch virus - red] protease for cleaving the ProtA portion from the remainder of the TAP polypeptide. In the 
second affinity purification step, the TEV cleaved complex is bound to calmodulin matrix via the CBP tag 
[calmodulin binding peptide - purple] of the TAP polypeptide. The complex bound to the CBP matrix is 
washed with buffer to remove additional contaminants. Finally, the BC RNP complexes are eluted from the 
matrix.
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1.7 SINEs (Short INterspersed Elements) as tools in Rodent phylogeny 
Up to now, I have given a description of two interesting neuronal dendritic npcRNAs, BC1 RNA and 
BC200 RNAs, both of which exhibit relationships to SINE elements. Now I will describe the application of 
SINEs in rodent phylogeny. SINEs are usually very short elements such as ID elements in rodents of about 
75 nt long, while some are rather long such as DAS-III SINEs (about 600 nt) (Churakov and Novikov, 2000). 
SINEs may be amplified to a copy number well beyond >105 total copies per genome. The presence/absence 
patterns of SINE elements have proven as invaluable tools for reconstructing virtually homoplasy-free 
phylogenetic trees (Schmitz et al., 2001, Schmitz et al., 2005, Shedlock and Okada, 2000, Shedlock et al., 
2004). The presence of a retroposed element at an orthologous position in related taxon indicates that they are 
inherited from a common ancestor, while its absence in a taxon indicates they are distant. In general 
retroposed elements possess several features, they are very unlikely to occur twice independently at 
orthologous genomic positions. To take advantage of orthologous SINEs as phylogenetic markers in a given 
group, there must be some SINEs that were actively transposed before the divergence points of speciation. 
Mouse and rat genome sequence revealed the activity of SINEs during their evolution, B4 probably extinct 
before the mouse-rat speciation, while B1, B2 and ID are still actively transposed (Gibbs et al., 2004). 
However, a large number of retroposed SINEs in rodents accomplish in selecting SINEs as reliable markers 
for inferring evolutionary history of rodents.  
The order Rodentia represents almost half of all living mammalian species [2277 species], classified 
into 30-33 families (Hartenberger, 1998, Reyes et al., 2000) is the most diverse order among placental 
mammals. The relationships among rodents have been highly debated. Based on morphological and 
paleontological data, rodents have a single origin and were traditionally divided into either Hystricognathi 
and Sciurognathi (Tullberg, 1899) or Myomorpha, Sciuromorpha and Hystricomorpha (Brandt, 1855) 
suborders. Early molecular studies on rodent evolution suggested a paraphyletic grouping of rodents 
(D'Erchia et al., 1996, Graur et al., 1991, Reyes et al., 1998). Rodent paraphyly has been disproven (Cao et 
al., 1994, Farwick et al., 2006, Huchon et al., 2007, Martignetti and Brosius, 1993b). Recent molecular 
analyses suggest that Rodentia are monophyletic and divided into seven, well supported groups: (1) 
Myodonta [rats, mice, jerboas]; (2) Anomaluromorpha [scaly-tailed flying squirrels, springhares]; (3) 
Castoridae [beavers]; (4) Geomyoidea [pocket gophers, pocket mice]; (5) Ctenohystrica [gundi, porcupines, 
guinea-pigs]; (6) Sciuroidea [mountain beavers, squirrels, woodchucks]; and (7) Gliridae [dormice]. But 
these seven groups are divided into three major clades, a “mouse-related clade” (1 to 4), “ctenohystrica” (5), 
and a “squirrel-related clade” [6, 7] (Adkins et al., 2001, DeBry, 2003, Huchon et al., 2002, Murphy et al., 
2001). Molecular analysis using the nuclear-encoded gene IRBP (DeBry and Sagel, 2001) supports the 
classical hypothesis that groups Castoridae with Sciuroidea and not the grouping of Castoridae with 
Geomyoidea, Anomaluroidea and Myodonta, as suggested by other molecular data. Recent studies using fast-
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evolving nucleotides in mitochondrial, exon and intron DNA fragments supports the grouping of 
Anomaluromorpha, Myomorpha as sister clade to Castorimorpha and other grouping comprises 
Sciuromorpha and Hystricomorpha together (Montgelard et al., 2008). Even molecular analyses were often 
contradictory, because of different rates of molecular clocks in different taxa/lineages or different selection 
pressure on the same gene or protein in different taxa/lineages leads to ambiguous conclusions.  
To resolve the ambiguous relationships within the rodent phylogeny, we have selected retroposed 
elements (Schmitz et al., 2001, Shedlock and Okada, 2000). Even though LINE & LTR presence/absence 
pattern provided a homoplasy-free phylogeny reconstruction of the placental mammalian tree (Kriegs et al., 
2006), still two possible sources of homoplasy have been reported in SINE presence/absence evaluation (I)
exact excision (II) independent orthologous insertion (van de Lagemaat et al., 2005). The probability of exact 
excision of SINE element is very low and it would be insignificant as compared to incomplete lineage 
sorting, an obvious problem for any marker systems. Another possible homoplasy situation is independent 
insertion at the same genomic loci observed in gene conversion, a rare event. Salem et al., (Salem et al., 
2003) found only three cases of gene conversion and only one of them involved full gene conversion, among 
133 hominoid Alu-insertions. Analysis of SINE retroposed elements promises a nearly homoplasy-free 
reconstruction of the rodent phylogenetic tree. 
1.8 SINEs in Rodents 
Rodents have experienced intense mobile element activity of 7SL RNA, tRNA and 5S rRNA derived 
SINEs. SINE elements are usually about 75-600 nt long and are defined as short DNA sequences amplified in 
the genome via an RNA intermediate, transcribed mostly by RNA polymerase III (Singer, 1982). SINEs are 
widely distributed in the mammalian genome amount to 33% - 45% (Lander et al., 2001, Waterston et al., 
2002). They are thought to be dependent on LINE elements and were classified as nonautonomous. Most of 
the SINEs except human Alu, rodent B1-related and Ped-1 elements are derived from tRNA genes (Daniels 
and Deininger, 1985, Ohshima and Okada, 2005, Gogolevsky et al., 2008). Rarely SINE RNAs are exapted to 
serve cellular functions such as Alu derived BC200 RNA and tRNA derived BC1 RNA (Martignetti and 
Brosius, 1993b). In mammals more than 30 different SINE families have been identified so far, and each of 
them categorized within distinct taxonomic superorders, orders, families (Kramerov and Vassetzky, 2005). 
Approximately 33% of the mouse genome consists of rodent-specific repeats (Waterston et al., 2002). The 
sequencing and comparative analysis of mouse genome revealed 564,000 B1 elements; 348,000 B2 elements; 
391,000 B4 elements and 79,000 ID-related elements (Waterston et al., 2002). Moreover, different SINE 
families were distributed in various rodent lineages at different periods. For example, B1-related SINEs are 
common to all 30 rodent families (Vassetzky et al., 2003). The first described tRNA derived SINE is B2, 
about 190 nt in length (Krayev et al., 1982) and, present in four rodent families: Muridae [mice and rats], 
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Cricitidae [hamsters, voles, and gerbils], Spalacidae [mole rats], and Rhizomyidae [bamboo rats] (Serdobova 
and Kramerov, 1998). ID SINEs are presumably present in all rodents. ID elements originated from tRNA-
like regions. A monomeric 200 nt SINE referred to as DIP element was found in two rodent families, jerboas 
[Dipodidae] and birch mice [Zapodidae] (Serdobova and Kramerov, 1998). 4.5SH RNA is present in six 
rodent families: Muridae, Cricetidae, Spalacidae, Rhizomyidae, Dipodidae and Zapodidae (Gogolevskaya et 
al., 2005). In addition, dimeric SINEs composed of ID and B1 moiety can be very abundant, for instance, B4 
in rat and mouse (Lee et al., 1998, Waterston et al., 2002) or B1-dID in squirrels [Sciuridae] and dormice 
[Gliridae] (Borodulina and Kramerov, 2001, Kramerov, 1999, Kramerov and Vassetzky, 2001, Rogozin et 
al., 2000). The aforementioned composite SINEs have a different order of the monomers, ID-B1 in B4 and 
vice versa in B1-dID. Based on SINE information mentioned above, we have used the presence/absence 
patterns of SINE elements as phylogenetic markers in Rodentia. 
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1.9 Previous work on Rodents 
In our lab Farwick et al., has developed an automatic computational strategy to efficiently identify 
retroposed SINE presence/absence loci with highly conserved flanking regions to resolve the phylogenetic 
relationships among rodents. From that study, they found 16 informative loci with 31 diagnostic SINE 
markers (Farwick et al., 2006, Huchon et al., 2007). Some of the deepest branches were not fully assigned, 
further information is needed to resolve the rodent phylogenic clades, which include “Mouse-related clade”, 
“Ctenohystrica”, and “Squirrel-related clade”. Furthermore, we expanded our species sampling compared to 
the previous studies. We further developed new SINE searching strategies, to find more informative loci to 
cover all three major clades. Available trace database on NCBI GenBank from the representative species in 
each clade [mouse, rat, kangaroo rat, guinea pig, spermophilus and rabbit as out-group] encouraged us to 
develop alternative strategies to solve the rodent phylogeny. 
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Objectives of the study 
1 The main objective of this study is to generate a transgenic mouse system to purify the BC1 and BC200 
RNP complexes in brain and to identify the proteins bound to the complexes using RNA affinity tags. 
To achieve this goal, two different transgenic mouse lines should be established, which harbors the 
BC1MS2 RNA expressing gene in combination with the MS2TAP protein-expressing gene for affinity 
purification of the BC1 RNP complex and the BC200MS2 RNA expressing gene in combination with 
the MS2TAP protein-expressing gene.  
 The established transgenic mouse line should be homozygous with respect to both transgenes 
[BC1MS2Tg/Tg+MS2TAPTg/Tg_BC1 RNA-/-] in the endogenous BC1 RNA-depleted homozygous 
transgenic mouse. In addition BC200MS2Tg/Tg+MS2TAPTg/Tg transgenic mouse line should be 
homozygous to with respect to both transgenes. 
2 A second important objective of the study is to examine the dendritic transport of the MS2 tagged  
 BC RNAs in vivo.
3 The third main objective of the study is to solve rodent phylogenetic relationships applying retroposed 
SINE elements including BC1 RNA related ID repetitive elements. 
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2.0 Generation of transgenic mice for RNP purification and to examine
dendritic transport 
2.1 Construction and generation of BC1MS2 and BC200MS2 (MS2 protein binding 
sites at 3' end) transgenic mice 
For construction of the vector for expressing rat BC1MS2 and human BC200MS2 (MS2 located 
at the very 3' end of the RNA but proximal to the RNA polymerase III terminator), fragments harboring 
the RNA genes were cloned into pCR TOPOII cloning vector [Invitrogen]. The two MS2 stems were 
introduced at the very 3' end of the both RNA genes by PCR mutagenesis as outlined below. PCR based 
mutagenesis was performed using the following oligonucleotides for the BC1MS2 RNA gene. 
[Lowercase letters indicate MS2 stems and italicized lower case letters indicate restriction endonuclease 
recognition sites, uppercase letters correspond to the oligonucleotides used to amplify the BC1MS2 and 
BC200MS2 RNA gene fragments.] A spacer (underlined) with the sequence GCAATACCACTATAGAA 
was added between the two stems to avoid possible sterical hinderance of protein binding to BC1MS2 and 
BC200MS2. 
BC1 forv (5'-AGTCATCgagctcTCATTTTCAAAGAGAC-3')  
BC1 unirev (5'-GTCTTTTTTAAGGTTGTGTGTGCCAGTT-3')  
BC1uniMS2(5'-AACCTTAAAAAAgacatgaggatcacccatgtctGCAATACCACTATAGAAgacatgaggatcacc 
catgtctTTT-3')
BC1 rev (5'-GTCGGACAGGCCCCTTTcctaggATGTTCT-3'). 
The rat BC1 RNA gene was used as a template for generating BC1MS2 RNA gene. In the first 
step, PCR amplification was performed using BC1 forv - BC1 unirev oligonucleotide pair, amplified the 
upstream of BC1 RNA locus until the very 3' end of the BC1 RNA gene (i.e. before UUU [3U’s]). In 
another amplification step, using BC1 uniMS2-BC1 rev oligonucleotides, the downstream part of the BC1 
RNA locus was amplified including the two MS2 stems at the 3' end of the BC1 RNA gene in place of 
UUU, UUU and the following were inserted after the two MS2 stems for termination of the BC1MS2 
transcript followed by wild type locus sequence (TCATTTTCAAA). In the second PCR amplification 
step, both the above mentioned PCR fragments were mixed, and the entire 1.5 kb fragment including the 
two MS2 stems was amplified using the BC1 forv and BC1 rev oligonucleotide pair (Fig 2.0 A). Thus, 
two MS2 RNA motifs were introduced at the very 3' end of BC1 RNA (proximal to the unique region). 
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Figure 2.0 Scheme of the cloning strategy for fusing two MS2 stems [green color, with a short spacer 
between the two stems in dark green] at the very 3' end of the BC1 RNA gene [blue color] and BC200 
RNA gene [purple color]. MS2 stems were placed closer to the ID domain (BC1MS2A) and closer to 
the 3' stem (BC1MS2B) followed by RNA polymerase III transcription termination signals as occurring 
in the wild type loci. The flanking regions that include control regions for transcription are shown in 
gray. Arrows denote PCR amplification schemes and primers (for details, see text). 
To amplify the BC200MS2 fragment following oligonucleotides were used. BC200 forv (5'-
ACGATGgaattcTAAGACAGTGTCATAGA-3') and  
BC200 uniMS2 (5'-CCCTTAAAAAAgacatgaggatcacccatgtctGCAATACCACTATAGAAgacatgaggatc 
acccatgtctTTTC-3') BC200 unirev (5'-ATCCTCATGTCTTTTTTAAGGGG-3') BC200rev (5'-
GACTTTCTTTGActtaagCTAT-3'). For BC200MS2 RNA gene, the human BC200 RNA gene was used 
as a template for amplification. In the first step, PCR was performed using BC200 forv- BC200 unirev 
oligonucleotide pair, amplified the upstream of BC200 RNA locus until the very 3' end of the BC200 
RNA gene (i.e. before UUU [3U’s]). In another PCR amplification step using BC200 uniMS2 - BC200 
unirev oligonucleotide pairs, downstream part of the BC200 gene locus was amplified including the two 
MS2 stems at the 3' end of the BC200 RNA gene in place of UUU and the UUU and the following were 
inserted after the two MS2 stems for termination of the BC200MS2 transcript followed by the wild type 
locus sequences (TCATATT). In the second PCR amplification, both the PCR products were mixed and 
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reamplified the entire 3.9 kb fragment including the two MS2 stems using the BC200 forv and BC200 rev 
oligonucleotides (Fig 2.0 B). Thus, two MS2 RNA motifs were introduced at the very 3' end of BC200 
RNA (proximal to the unique region). Both the mutagenized BC1MS2 and BC200MS2 RNA gene 
fragments were cloned into pCR TOPOII vector. BC1MS2 transgenic mice were generated by inserting 
the 1.5 kb SacI - BamHI fragment released from pCR TOPOII BC1MS2. To generating BC200MS2 
transgenic mice the 3.9 kb fragment of EcoRI - EcoRI was released from pCR TOPOII BC200MS2. 
2.2 Construction and generation of MS2TAP protein transgenic mice
For generating MS2TAP protein expressing mice, the MS2TAP fragment was cloned into the 
pNECKu vector (Blichenberg et al., 1999), a generous gift from Dr. Stephan Kindler, University of 
Hamburg (Blichenberg et al., 1999). The vector features the chicken ?-actin promoter and the transcript 
has a ~1 kb intron in the 5' UTR (also derived from the chicken ?-actin gene). The protein coding 
sequence of MS2TAP replaced the EGFP ORF of pNECKu between the EcoRV/XbaI restriction sites. 
HA and FLAG peptide sequences were fused to the N-terminus of MS2TAP coding sequence for 
detecting the protein expressed in cell lines or in mice by Western blots. The MS2TAP fragment was 
generated using a PCR based approach with appropriate restriction sites to clone into the pNECKu vector. 
Amplification of the MS2TAP fragment was achieved as follows. The fragment encoding the MS2 coat 
protein was obtained from plasmid pG14-MS2-GFP (Kaganman, 2008) (kindly provided by Rodert H. 
Singer, Albert Einstein College of Medicine, Bronx, New York) by PCR using the following 
oligonucleotide pairs : (5'-GGTCGCATgatatcGACACCATGGTGGACTACAAAGAC-3') and (5'-
CAGCGAATTAATTCCAGCACAC-3') was in frame MS2TAP protein. The ATG start codon is 
embedded within a Kozak consensus sequence (Kozak, 1987) (underlined) and, harbored HA and FLAG 
tag peptides at the N-terminus of the MS2 coat protein. The fragment encoding the TAP protein was 
obtained from pTAP (kindly provided by Bertrand Seraphin, EMBL, Heidelberg, Germany) by PCR 
amplification using the following oligonucleotide pairs:  
(5'-TTAACCTTTgcggccgcTCTAGTAACAGCAGCAAGTGTGCTGGAATTAATTCGCTGTCTAGGA 
GGATCCATGGAAAAGAGAAGA-3'), (5'-GGTCGCATtctagaCAAGCTTCAGGTTGACTTCCCC-3'). 
The italicized lower case letters were EcoRV, NotI and XbaI restriction enzyme sites respectively. The 
MS2 coat protein fragment was obtained by PCR amplification was restriction digested with EcoRV and 
NotI and TAP protein fragment was PCR amplified and restriction digested with NotI and XbaI. After 
restriction digestion, both the fragments were ligated to obtain the MS2TAP protein and cloned in 
pNECKu vector, which was previously digested with EcoRV and XbaI restriction endonucleases. The 
obtained plasmid was designated as pNEMS2TAP. The DNA insert was released with PvuI - NruI to 
generate transgenic mice. 
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2.3 Cloning of the combined (double gene) construct and generation of transgenic mice - 
BC1MS2+MS2TAP
Constructs that harbor both BC1MS2 RNA and MS2TAP protein-expressing cassettes were 
cloned into a single plasmid. The cloning scheme for the construct was as follows.  
The BC1MS2 fragment (SacI - ApaI) contained 423 bp upstream of the BC1MS2 RNA gene and 
about 200 bp downstream of the RNA polymerase III terminator of the RNA gene was PCR amplified 
from pCR TOPOII BC1MS2 (described above) and cloned into pBluescript II KS+. The MS2TAP 
fragment was released using PvuI - NruI from pNEMS2TAP plasmid (described above) and subcloned 
into pBS, which harbored BC1MS2 (with the MS2 domains located at the very 3' end of BC1 RNA). 
Insertion of the MS2TAP fragment was done by blunt end cloning resulting in two different orientations 
with respect to the plasmid backbone. The MS2TAP fragment inserted into pBS-BC1MS2 in the same 
transcriptional orientation as BC1MS2 [i.e. head to tail], resulting in plasmid as 11 dirTAP. The plasmid 
with MS2TAP inserted in the opposite orientation with respect to BC1MS2 [head to head] resulting in 
plasmid 3 revTAP (Fig 3.2). The inserts carrying the RNA and protein coding genes were released with 
SfiI and AscI to generate the respective transgenic mice. 
2.4 Construction and generation of BC1MS2A and BC1MS2B RNA (MS2 stems 
internal to the BC1 RNA) transgenic mice 
As the MS2 stems at the very 3' end of BC1 RNA were post transcriptionally removed in most 
molecules in the in vivo mouse system, constructs, which harbor the MS2 stems were placed near the 
central Adenosine-rich domain of BC1 RNA. One was placed proximal to the ID stem of BC1 RNA 
(Rozhdestvensky et al., 2001) designated as - BC1MS2A, and the other was placed proximal to the 3' 
stem of BC1 RNA designated as BC1MS2B. Both constructs were cloned into pDrive cloning vector 
[Qiagen, Hilden]. The following oligonucleotides were used for PCR amplifications to generate the 
BC1MS2A and BC1MS2B DNA fragments. The lower case letters indicates the MS2 stem. A spacer with 
the sequence GCAATACCACTATAGAA was added between the two stems for proper folding.  
BC1d1 (5'-CTCTCATTTTCAAAGAGCACCAT-3')  
BC1d2 (5'-AAAAAAGACAAAATAACAAAAAGACCA-3')  
BC1r1 (5'-GATCCAAAGGGGCCTGTCCGA-3')  
BC1r2 (5'-TTTTTTCGGAGCTGAGGACC-3')  
BC1d2MS2A (5'-GGTCCTCAGCTCCGAAAAAAAgacatgaggatcacccatgtctGCAATACCACTATAGAA
gacatgaggatcacccatgtct(A)22GACAAAATAACAAAAAGACCA-3')  
BC1d2MS2B (5'-GTCCTCAGCTCCGA(A)22AgacatgaggatcacccatgtctGCAATACCACTATAGAAgacat 
gaggatcacccatgtctAAAAAAGACAAAATAACAAA-3'). 
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For generating the BC1MS2A RNA constructs, the rat BC1 RNA gene fragment (1.4 kb SacI-
BamHI) was used as a template for PCR reaction. PCR amplifications were performed as two steps 
reaction. In the first the BC1d1/BC1r2 oligonucleotides, were used to amplify the upstream part of BC1 
locus. The BC1d2/BC1r1 oligonucleotides, were used to amplify the downstream part of BC1 locus. In 
the second step of the PCR both PCR product from the first step were combined with the oligonucleotide 
BC1d2 MS2A containing two MS2 stems, and re-amplified the entire BC1 locus including two MS2 
stems using BC1d1 and BC1r1 oligonucleotides (Fig 2.1 A).
Figure 2.1 Scheme of the cloning strategy for insertion of two MS2 stems [green] with a spacer 
between two stems [dark green] into the BC1 RNA gene [blue]. The flanking regions that include 
control regions for transcription are shown in gray. Arrows denote PCR amplification schemes and 
primers. MS2 stems were placed closer to the ID domain (BC1MS2A) and closer to the 3' stem 
(BC1MS2B) followed by RNA polymerase III transcription termination signals as occurring in the wild 
type loci. Arrows denote PCR amplification schemes and primers (for details, see text). 
The BC1MS2B RNA construct generated analogously. In the first round, the BC1d1/BC1r2 
(upstream part) and BC1d2/BC1r1 oligonucleotides (downstream part of BC1 locus), were used to 
amplify the corresponding regions. In the second step, both PCR product were combined with the 
oligonucleotide BC1d2 MS2B containing two MS2 stems, and re-amplified the entire BC1 locus 
including two MS2 stems using BC1d1 and BC1r1 oligonucleotides (Fig 2.1 B).
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BC1MS2A and BC1MS2B transgenic mice were generated by inserting a 1.5 kb DNA fragment 
released with EcoRI from pDrive BC1MS2A/B plasmids. 
All cloned sequences including mutagenesis in this study were confirmed by sequence analysis, 
before generating transgenic mice. In brief, for generating transgenic mice, the DNA fragments were 
diluted up to 2 ng/µl and injected into the pronuclei of FVB mice according to the protocol (Hogan et 
al., 1986) and subsequently transferred into the uteri of the 2.5 - day pseudopregnant CD-1 foster mice. 
2.5 Generation of BC1MS2B+MS2TAP transgenic mice in BC1 RNA-/- background 
In order not to competing with endogenous BC1 RNA for binding proteins, BC1MS2B RNA 
expressing transgenic mice were crossed with BC1 RNA deficient mice [BC1 RNA-/-]. The resulting 
transgenic mice were designated BC1MS2B in BC1 RNA-/-. Similarly MS2TAP protein expressing mice 
were crossed into BC1 RNA deficient mice [BC1 RNA-/-], designated as MS2TAP in BC1 RNA-/-. Finally 
both BC1MS2B in BC1 RNA-/- and MS2TAP in BC1 RNA-/- were crossed to yield mice, that express both 
BC1MS2B RNA and MS2TAP protein in a background depleted of endogenous BC1 RNA. The resulting 
mouse strain was labeled BC1MS2B+MS2TAP_BC1 RNA-/-. The heterozygous [BC1MS2BTg/-
+MS2TAPTg/- in BC1 RNA+/-] mice were interbred for about 4-5 generations monitoring their status with 
the goal of obtaining homozygosity BC1MS2BTg/Tg+MS2TAPTg/Tg in the BC1 RNA-/- background. The 
resulted mice were screened for BC1MS2BTg/Tg+MS2TAPTg/Tg in BC1 RNA-/- were homozygous to both 
transgenes and expressed no endogenous wild type BC1 RNA. This was confirmed by Southern blotting, 
Real Time PCR analysis and by test crossing with non-transgenic mice [wild type], where all offspring 
was positive (heterozygous) for both transgenes. Thus, we obtained a stable homozygous mouse line with 
the desired traits. 
2.6 Generation of BC200MS2+MS2TAP transgenic mice 
BC200MS2 RNA expressing mice were crossed with MS2TAP protein expressing mice, to obtain 
transgenic mice, which harbor both BC200MS2 and MS2TAP expressing genes. The resulting transgenic 
mouse line was designated as BC200MS2+MS2TAP and were interbred for about 4 - 5 generations to 
obtain homozygous to both transgenes. 
2.7 Generation of BC200 RNA transgenic mice 
Transgenic mice expressing wild type BC200 RNA were previously generated in our laboratory 
and used as a control. They contained the 3.2 kb EcoRI – HindIII DNA fragment from the human BC200 
RNA locus [–2271 bp upstream and 766 bp downstream of the BC200 coding region] (Khanam et al., 
2007b). 
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2.8 Generation of BC1 KO (BC1 RNA-/-) mice 
BC1 RNA gene depleted (knockout) mice were available in our laboratory by targeted gene 
deletion as described before (Skryabin et al., 2003) and used as negative control and for crossing with 
transgenic mice that express BC1MS2B RNA and MS2TAP protein, in order to eliminate competition for 
expression and /or for binding proteins. 
2.9 Construction of pMKS plasmid for stable transfection
The goal for constructing this mammalian vector that allow co-expression of novel npcRNA- 
candidates fused with an MS2 stem sequence and of an MS2TAP protein that specifically binds to the 
MS2 motif to establish a general system to test subcellular-localization of any npcRNAs by transfecting 
mammalian cells and using immunocytochemistry with an antibody against the MS2 fusion protein or by 
in situ hybridization. This general method could be used in transgenic mice but also in high throughput, 
employing transfected-cell array technology. This construct also provides the means for in vitro 
transcription of any npcRNA together with 3' terminal MS2 RNA tag. RNAs are transcribed by CMV 
promoter, an RNA polymerase II promoter and was terminated by CMV terminator. 
The plasmid was constructed as follows. In a first step the previuosly present SalI and NotI
restriction sites, in pNEMS2TAP were eliminated so they could be used at the insertion sites for npcRNA 
coding regions. PCR based [Quick Change Site-Directed Mutagenesis kit from Stratagene, La Jolla, CA] 
site directed mutagenesis was carried out to mutate the SalI and NotI sites using the following 
oligonucleotides:  
FSalI mut (5'-CTCAGTTCGTTCTCgtagatAATGGCGGAACTG-3') 
R SalI mut (5'-CAGTTCCGCCATTatctacGAGAACGAACTGAG-3') 
FNotI mut (5'-CTCCGGCATCTACgcagccgcTCTAGTAAC-3') 
RNotI mut (5'-GTTACTAGAgcggctgcGTAGATGCCGGAG-3'). 
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Figure 2.2 Construct pMKS harbors MS2TAP protein expressing the cassette from pNEMS2TAP, 
features the chicken ?-actin promoter [yellow] was used to drive transcription of the MS2TAP fusion 
protein. The ?-actin promoter is followed by the 5' UTR [gray] which, inturn is interrupted by a ~1 kb 
intron [striped area], also both derived from the chicken ?-actin locus. The MS2TAP fusion polypeptide 
has the following components: orange, FLAG and HA peptide as antigenic determinants, green, MS2 coat 
protein; purple, calmodulin binding peptide [CBP]; red, tobacco etch virus [TEV] protease site; magenta, 
protein A domain [Prot A]. The protein coding sequence is followed by polyadenylation signals from 
SV40 [turquoise]. The vector also harbors two MS2 RNA stem motifs [small green box] driven by the 
CMV promoter [yellow] preceded by SalI and NotI restriction sites that allow cloning novel npcRNAs, 
followed by a CMV transcription terminator [red]. The vector features the neomycin resistance gene 
cassette [ocher] flanked by the Pgk promoter [gray] and the bovine growth hormone [BGH] poly(A) 
addition signal for stable transfection in mammalian cells. 
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In the second step, the two MS2 stems transcribed by the CMV promoter and terminated by the 
CMV terminator were PCR amplified. The SalI and NotI restriction sites were introduced proximal to the 
MS2 stems to clone inserts for example npcRNA-derived cDNA libraries. Both CMV promoter and CMV 
terminator were amplified from pCDNA 3.1. The PCR fragment was cloned into PL452 from Pentao Liu 
to include a Pgk Neo cassette. The plasmid was digested with Asp18 - BamHI, and the fragment 
containing CMV promoter including the two MS2 stems, CMV terminator and Pgk Neo cassette was sub-
cloned into pNEMS2TAP vector. 
The following oligonucleotides were used to amplify the CMV promoter and CMV terminator with two 
MS2 stems. 
fCMVpr : (5'-ATATTAAAGGTACCAAGGCGCGCCTGTAGCGGCACGATATACGCGTTGACAT-3') 
rCMV pr : (5'-GGCCACCCGGGCCAAAAATGTACATTTagacatgggtgatcctcatgtc 
TTCTATAGTGGTATTGCagacatgggtgatcctcatgtcTTTTTTGCGGCCGCTCGAGTCTAGAGTCGACGT
TTAAACGCTAGCCAGCTTGGGTCTC-3')  
fCMV ter: (5'-TGTACATTTTTGGCCCGGGTGGCCCCCTTTAGTGAGGGTTAATTCCTCGACTGT 
GCCTTCTAGTTGCCAG-3') 
rCMV ter: (5'-ATTATATAGAATTCCCCAGCATGCCTGCTATTGTCTTCCCA-3'). 
The cloned plasmid was confirmed by sequence analysis. 
Note: Lower case letters indicates the MS2 stem between the two stems spacer was added. 
2.10 DNA transfection 
NIH 3T3 cells were grown on 10 cm plates with Dulbecco’s modified eagle medium [Gibco 
BRL]. Plates with ~60-70% cell density were chosen for transient transfection [lipofection] with DNA. 
Before transfection, cells were changed into Opti-MEM [Gibco BRL] medium. Liposomes were prepared 
by separately adding 5 and 10 µg of DNA (~1 µg/µl) and 15 ?l of DAC-30 cationic lipid reagent 
[Eurogentec, Seraing, Belgium] to 2.5 ml of Opti-MEM, gently mixed, and incubated at room temperature 
for 20 min. This liposome mixture was then added to the cells. After incubation for 3 hours, the medium 
was changed to Dulbecco’s modified eagle medium and cells grown for an additional 8-12 hours. Cells 
were washed twice with 1x PBS (phosphate-buffered saline) and harvested by centrifugation at 2,000 x g 
for 5 min. Cytoplasmic extracts were generated by lysing the cells in non-denaturing hypotonic buffer [10 
mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, one tablet/50 ml protease 
inhibitor mix “complete”, Boehringer Mannheim], and by subsequently adding NP-40 to a final 
concentration of 0.05%]. This extract was used for Western blotting. For Northern blotting, total RNA 
was extracted by using TRIzol reagent [Gibco BRL] according to the manufacturer’s instructions. 
27
Materials and Methods 
?
2.11 PCR analysis of transgenic mice 
DNA from 3-week-old mouse-tails was extracted as described by (Laird et al., 1991). 
Approximately 500 ng of genomic DNA was taken for PCR analysis. The following oligonucleotides 
were used to screen transgenic mice. 
For analyzing BC1MS2 transgenic mice [BC1MS2 - 3' end, BC1MS2A and BC1MS2B] the 
oligonucleotide pair BC1 ScD (5'-TACCATCTGATACTTGACTGTGT-3') and BC1 ScR (5'-
GGGTGATCCTCATGTCTTCTAT-3') were used. 
For BC200MS2 transgenic mice analysis the oligonucleotides BC200 ScD (5'-
TGCGAACTTCTTACAGTTTAGG-3') and BC200 ScR (5'-AACCTTCCATAATGAAGGC-3') were 
used.
For MS2TAP transgenic mice analysis the following oligonucleotides fMS2 (5'-
TTAACCTTTGCGGCCGCTCTAGTAACAGCAGCAAGT-3') and rTAP (5'-
GGTCGCATTCTAGACAAGCTTCAGGTTGACTTCCCC-3') were used. 
PCR was performed in a solution containing 50 mM Tris HCl pH 9.5, 20 mM (NH4)2SO4, 1 mM 
dithiothreitol, 1.5 mM MgCl2, 0.005% NP-40, 200 µM deoxynucleoside triphosphates, and 0.5 µM of 
each primer; annealing was performed at 94 °C for 4 min, and 35 cycles of 93 °C for 45 s, 55 °C for 30 s, 
72 °C for 1 min, and with a final 5 min extension at 72 °C. The resulting PCR products were fractionated 
by 1% agarose gel electrophoresis. 
2.12 DNA tail biopsy and Southern blot analysis 
Approximately 5 µg of genomic DNA from mouse tails was digested with PstI, EcoRI or BamHI
fractionated on 0.8% agarose gels, and transferred to GeneScreen nylon membranes [NEN DuPont] by 
positive pressure. Membranes were hybridized with a 32P-labeled probe specific for the inserted genes, 
and washed twice with 0.5 x SSPE - 0.5% sodium dodecyl sulfate, [1 x SSPE consists of 0.18 M NaCl, 10 
mM NaHPO4, and 1 mM EDTA pH 7.7] at 65 ?C for 15 min each, and exposed to MS film [Kodak] at -
80 °C overnight. 
2.13 Preparation of tissue extracts
Extracts were prepared from adult mouse brain [excluding cerebellum as this part usually is low 
BC1 RNA expression]. Brain tissue was homogenized in 10 volumes of extraction buffer [20 mM Tris-
HCl, pH 7.5, 100 mM KCl, 5 mM MgCl2, 10% sucrose, 1 mM DTT, 0.25% NP40 and one tablet/50 ml 
protease inhibitor mix “complete”, Boehringer Mannheim]. The extract was centrifuged at 1,750 x g for 
11 min at 4 ?C. The supernatant was collected (S1) and centrifuged at 15,000 x g for 1 hour at 4 ?C. The 
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resulting supernatant (S2) was stored at -80 ºC or further ultra centrifuged at 60,000 x g for 2 hours at 4 
?C. The resulting supernatant (S100) was stored at -80 ºC. 
The following mice were used for preparing the brain extracts: 
Wild type extracts were prepared from NMRI/HWD outbred mice. BC1 KO (BC1 RNA -/-)
BC1MS2 (MS2 at the very 3' end of BC1 RNA), 11 dirTAP, 3 revTAP, BC200MS2TAP (MS2 at the 
very 3' end of BC200 RNA), BC1MS2A (MS2 stems proximal to the ID region of BC1 RNA), 
BC1MS2B (MS2 stems proximal to the 3' stem of BC1 RNA) MS2TAP, BC1MS2B_MS2TAP extract 
were prepared from the corresponding transgenic mice. 
All extracts were used for isolating RNA/RNP of BC1 or BC200 with MS2 tag or for identifying the 
MS2TAP protein. 
2.14 RNA blot analysis 
Total RNA was extracted from different mouse tissues using TRIzol reagent [Gibco BRL] 
according to the manufacturer’s instructions. RNA was separated on 6% polyacrylamide/7 M urea gels 
and electro-transferred to positively charged nylon membranes [Ambion]. After UV-cross linking, 
membranes were hybridized at 58 °C overnight in 1M sodium phosphate buffer pH 6.2, containing 7% 
SDS and 32P labeled oligonucleotide probes. After hybridization, membranes were washed twice with 
0.2M sodium phosphate buffer pH 6.2, containing 1% SDS for 20 min each at 58 °C and exposed to MS 
film [Kodak] at -80 °C overnight to several days [2-8 days]. In case of LNA oligonucleotide probes, 
membranes were washed three times with 0.1M sodium phosphate pH 6.2 and 0.5% SDS for 30 min each 
at 65 °C and exposed to MS film [Kodak] at -80 °C overnight to several days [2-8 days]. 
(a) 5' end labeling of oligonucleotides
Oligonucleotides either DNA or LNA were radiolabeled, using T4 polynucleotide kinase [PNK], 
which adds a phosphate group to the 5' end of the oligonucleotide. Kinase reactions were carried out in a 
15 µl volume, containing 20 pM of oligonucleotide, 1 x PNK buffer [New England Biolab], 10 U of PNK 
[New England Biolab] and 20 µCi of ?32P ATP and volume was adjusted with water. The reaction was 
carried out at 37 °C for 1 hour and was stopped by adding 1µl 0.5M EDTA. Entire reaction mixture was 
directly added to the prehybridization solution. 
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Table 1 
DNA oligo designation oligonucleotide sequence 
BC1MT (27 mer) 5'-GGTTGTGTGTGCCAGTTAACCTTGTTT-3' 
MS2 (35 mer) 5'-CCTCATGTCTTGTAGACATGGGTGATCCTCATGTC-3' 
BC207 (36 mer) 5'-CTTGTTGCTTTGAGGGAAGTTACGCTTATTTGGTAC-3' 
7SL (36 mer) 5'-CGAGGTCACCATATTGATGCCGAACTTAGTGGGTAC-3' 
LNA oligo designation oligonucleotide sequence 
BC1_uni_ LNA (21 mer) 5'-GTGtGCcAGtTAcCTtGTtTT-3' 
MS2_LNA (23 mer) 5'-ATGgGTgATcCTcATgTCTtCTA-3' 
BC200_LNA(21 mer) 5'-GGgGGtTGtTGcTTtGAgGGA-3' 
RBC1(17 mer) 5'-TTTtTTCgGAGcTGAgG-3' 
MBC1(17 mer) 5'-TTTtTCCaGAGcTGAgG-3' 
*Note: lower case letters indicate LNA (Locked Nucleic Acid) positions. 
2.15 Native gel electrophoresis 
The native ribonucleoprotein (RNP) complexes from the S2 brain extract were separated on a 
composite gel containing 4% acrylamide/bisacrylamide [80:1, w/w] and 0.4% (w/v) agarose as described 
by (Lamond et al., 1994). Following electrophoresis, the RNPs and RNAs were electroblotted onto Nylon 
membrane [Ambion]. RNA was immobilized by UV cross-linking, the membrane was then hybridized 
with 32P-labeled BC1MT, BC207, or MS2 DNA oligonucleotide probes. Hybridization was performed in 
1 M sodium phosphate buffer [pH 6.5] containing 7% [w/v] SDS at 58 °C. Two washes of 20 min each 
was carried out at 58 °C in 0.2 M sodium phosphate buffer [pH 6.5] containing 1% SDS. Then the blot 
was exposed to X-ray films [Kodak MS] or screened by phosphoimager. 
2.16 Localization studies and dendritic transport of tagged BC RNAs 
(a) Immunocytochemistry on coronal sections of wild type, BC1 KO? (BC1 RNA-/-)
BC200, BC1MS2B+MS2TAP in BC1 RNA-/- and BC200MS2+MS2TAP transgenic 
mouse  brain 
BC1MS2B+MS2TAP in the BC1 RNA-/- back ground, BC200MS2+MS2TAP transgenic mice, 
and as a control FVB [wild type], BC200 transgenic mice for BC1 and BC200 RNA respectively and as a 
negative control BC1 RNA deficient mice were used. Mice aged around six to ten weeks- were sacrificed 
using dry ice and transcardially perfused with freshly prepared 4% (w/v) paraformaldehyde in phosphate-
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buffered saline, pH 7.2. The brains were removed carefully and fixed overnight at 4 ?C in 4% (w/v) 
paraformaldehyde. Brain coronal sections of 30 ?m thickness through the ascending arc of the 
hippocampus were cut on a vibrating microtome [Leica] and to facilitate handling they were further fixed 
in PFA for 3-7 days at 4 ºC. The free-floating sections were washed with 1 x PBS [3 x 5 min each] 
followed by permeabilisation for 10 min each in 10, 20, 40, 20 and 10 % (v/v) ethanol. Following 
blocking for 60 min [10% (v/v) normal goat serum (NGS), 0.2% (w/v) bovine serum albumin (BSA) in 
PBS] the sections were incubated overnight at 4 ?C with primary antibody [rabbit polyclonal antibodies 
against PABP, HA and MS2] at 1:500 or 1:1000 dilution in 1% NGS, 0.2% BSA in PBS. The unbound 
antibody was removed by washing [3 x 5 min each] with PBS. This was followed by secondary antibody 
incubation at RT with biotinylated sheep anti-rabbit IgG for 1 hour [(1:1000), Sigma] and washing with 1 
x PBS (3 x 5 min each). All washing steps were carried out at room temperature. Next, the sections were 
incubated with pre-formed ABC (Avidin : Biotinylated enzyme Complex) complex [ABC Elite Kit, 
Vector Laboratories, Inc., Burlingame, USA]. The ABC complex should be prepared 1 hour prior to 
incubation. The peroxidase reaction was done by incubating the sections for 10 min in 3,3'-diamino-
benzidine (DAB) and hydrogen peroxide [Sigma Fast, Sigma] with nickel ammonium sulfate 
enhancement [0.03% (w/v)]. After mounting and cover slipping, the stained sections were photographed 
with a NIKON E600 microscope using a Cool SNAP digital camera [Photometrics] and Open Lab 3.0 
software [Improvision, Coventry UK]. 
2.17 DIG-labeled in situ Hybridization 
(a) Generation of DIG (Digoxigenin) labeled probes. 
The 5' part of BC1 RNA shares sequence similarity with ID repetitive elements (Tiedge et al., 
1991). In order to prevent hybridization to other RNAs that contain ID elements e.g., 3'UTRs of mRNA, 
we used probes that correspond to the unique 3' part of BC1 RNA generated from plasmid pMK1, which 
harbors 60 nt of the 3' unique part of BC1, cloned between KpnI and SacI restriction sites of pBluescript 
II KS+. A corresponding BC200 RNA probe was generated from plasmid pKK536-6, which harbors 71 nt 
(position 119-189) from the 3' unique portion of the BC200 gene cloned between the KpnI and SacI
restriction sites of pBluescript II KS+. Both plasmids were linearized with either SacI or KpnI restriction 
endonucleases. DIG-labeled RNA probes were in vitro transcribed using T3 or T7 polymerases for sense 
(S) or antisense (AS) RNA probes, respectively, using the DIG RNA Labeling Kit (Roche Molecular 
Biochemicals) according to the manufacturer’s instructions. The Dig-labeled RNAs were quantified in 
reference to the standards provided in the kit, as described by the manufacturer.
BC1MS2B+MS2TAP inBC1 RNA-/- transgenic mice, BC200+MS2TAP transgenic mice, wild 
type mice, BC200 transgenic mice and BC1 KO (BC1 RNA-/-), all 6-10 weeks of age, were perfused 
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transcardially with 10 mM phosphate-buffered saline (PBS), pH 7.2 followed by freshly prepared 4% 
paraformaldehyde (PFA) in PBS. The brains were carefully removed and fixed overnight at 4 ºC. The 
next morning, coronal sections of 30 µm thickness, through the ascending arc were cut on a vibrating 
microtome [Leica] and, to facilitate handling, they were further fixed in PFA for 3-7 days at 4 ºC. The 
free floating sections were washed with PBS [3 x 5 min each], treated with Proteinase K (1 µg/ml) for 30 
min at 37 ºC, incubated in freshly prepared 0.1 M glycine [2 x 5 min each] and finally rinsed with 2 x 
SSC [2 x 15 min each]. Subsequently the sections were pre-hybridized [50% Formamide, 1.2 M NaCl, 
0.02 M Tris pH 7.5, 2 x Denhardts, 2 mM EDTA, 1 mg/ml denatured salmon sperm DNA, 1 mg/ml total 
yeast tRNA] at 50ºC for minimum 1 hour, in a humid chamber. This was followed by hybridization with 
200 ng/ml of DIG-labeled RNA probe in hybridization buffer [pre-hybridization buffer plus 20% dextran 
sulfate] at 50 ºC overnight, in a humid chamber. The hybridized sections were washed with 2 x SSC (2 x 
5 min each), incubated with RNase A (2 µg/ml) for 30 min at 37 ºC to remove unbound probe, washed 
with 2 x SSC at 50 ºC (3 x 15 min). Final washes were performed under high stringency, with 0.1 x SSC, 
0.1% sodium pyrophosphate (3 x 30 min each). The sections were washed and equilibrated with PBS and 
blocked with blocking buffer [1% blocking reagent, Roche Molecular Biochemicals] for 60 min at RT 
and incubated overnight at 4 ºC with secondary antibody sheep anti-DIG-AP [Roche Molecular 
Biochemicals], 1:500 in blocking buffer. The excess of antibody was removed by washing with 1 x PBS 
(4 x 5 min). Finally the sections were equilibrated with equilibration buffer (0.1 M NaCl, 0.1 M Tris pH 
9.5, 0.05 M MgCl2) [2 x 5 min each], the antibody was detected enzymatically using nitro blue 
tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate as a substrate [Boehringer Manheim]. The sections 
were finally washed, mounted and cover slipped with Vecta Mount [Vector Laboratories, Inc., 
Burlingame, USA]. Hybridization signals were photographed using a Nikon E600 microscope and Open 
Lab Software [Improvision, Coventry UK]. 
2.18 Raising antibodies against MS2 coat protein  
(a) Expression and purification of Recombinant MS2 coat Protein
The gene encoding MS2 coat protein was obtained from plasmid pG14-MS2-GFP (Bertrand et 
al., 1998) [kindly provided by Rodert H. Singer, Albert Einstein College of Medicine, Bronx, New York]. 
An MS2 coat protein gene cassette was generated by PCR amplification using the following 
oligonucleotides.  
pETMS2 forv 5'-CGCGGCAGCcatatgCTAGCCGTTAAATGGCTTCTAACTTTACTCAG-3' and  
pETMS2 rev 5'-GTGCTCGAGTTCAAgcggccgcGTAGATGC-3' with NdeI - NotI restriction recognition 
sites. The PCR fragment was digested with NdeI/NotI and cloned into the pET28b+ vector (Invitrogen). 
Italicized small letters indicate NdeI/NotI restriction recognition sites. 
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Recombinant MS2 coat protein was expressed with an N-terminal histidine tag (Hochuli, 1990) 
for convenience of purification. In order to achieve this, plasmid pET28b+ MS2 was transformed into 
E.coli BL21 (DE3) pLysS cells [Novagen]. A single colony was inoculated in 10 ml of Luria-Bertani 
broth [10 grams of tryptone, 5 grams of yeast extract and 10 grams of sodium chloride in one liter of 
deionized water, with antibiotic kanamycin (100 µg/ml)] overnight. The overnight culture was transferred 
into one liter LB containing kanamycin (100 µg/ml) and chloramphenicol (34 µg/ml) and grown to an 
optical density reached of between 0.4 and 0.6. Transcription was induced with 100 mM IPTG (isopropyl-
?-D-thiogalactopyranoside) and cells were grown for an additional 3 hours, followed by harvesting by 
centrifugation at 5,000 x g for 10 min at 4 °C, resuspension in 15 ml of buffer containing 50 mM HEPES 
[pH 7.5], 250 mM NaCl and 1 mM MgCl2 and once more pelleting at 5,000 x g for 10 min at 4 °C and 
storage at -80 °C.
Expressed protein was affinity purified with a Ni-NTA matrix according to the recommendations 
of the manufacturer [Qiagen, Hilden]. Briefly, the bacterial pellet, which expresses histidine tagged MS2 
recombinant protein was suspended in 10 ml of lysis buffer [20 mM HEPES pH 7.5, 250 mM NaCl, 1 
mM MgCl2, 20 mM imidazole one tablet/50 ml protease inhibitor mix “complete”, Boehringer 
Mannheim]. Cells were sonicated with 2 - 3 pulses (100 W - 20 kHz), and the soluble and insoluble 
fractions were separated by centrifugation at 15,000 rpm (Sorvall) for 1 hour at 4 °C. The resulting 
supernatant was bound to Ni-NTA resin (previously equilibrated with lysis buffer) for about 1 hour at 4 
°C with gentle mixing. The resin [matrix] was washed with 30 ml buffer containing 20 mM HEPES pH 
7.5, 500 mM NaCl , 1 mM MgCl2, 40 mM imidazole and the protein was eluted from the resin with 10 ml 
of elution buffer [20 mM HEPES pH 7.5, 200 mM NaCl, 1 mM MgCl2, 500 mM imidazole]. The protein 
was identified by SDS-PAGE. Contaminant free fractions were pooled, dialyzed against 20 mM HEPES, 
pH 7.5, 100 mM NaCl, 1 mM MgCl2, 50% glycerol and concentrated by dialysis and stored at -80 °C. 
(b) Generation of MS2 antibody 
Purified histidine tagged MS2 coat protein [300 µl, 5 - 10 mg of protein] was mixed with equal 
volume of Freund’s incomplete adjuvant (Sigma-Aldrich). The homogenized mixture (water-in-oil 
emulsion) was injected [subcutaneous/intramuscular] into two New Zealand white rabbits to raise 
antibodies. After 45 days, the sera were collected and designated as JB 43 and JB 44. This serum was 
tested for its immunoreactivity and specificity against MS2 coat protein by immunoblot analysis, as well 
as with brain extracts (S2 fraction) of MS2TAP transgenic mice, BC1MS2B+MS2TAP_in BC1 RNA-/-
background and BC200MS2+MS2TAP transgenic mice, as well as wild type and BC1 RNA-/- knockout 
mice. Antibody was purified using the protein G midi antibody purification kit [Proteaus] for 
immunohistochemistry studies. 
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2.19 Purification of BC RNPs using TAP methodology from [BC1MS2B+MS2TAP and 
BC200MS2+MS2TAP transgenic mouse brain extracts] – an initial attempt
The TAP [Tandem Affinity Purification] protocol (Rigaut et al., 1999) was used with some 
modifications. Mice brain extracts were prepared as described (Materials & Methods, section 1.13) with 
some modifications i.e. buffer [20 mM Tris-HCl, pH 7.5, 100 mM KCl, 3 mM MgCl2, 10 mM ?-
mercaptoethanol, 20 mM NaF, 1.mM phenylmethanesulfonylfluoride (PMSF), 1 mM DTT, 0.25% NP40 
and one tablet protease inhibitor mix “complete”, Boehringer Mannheim/50 ml of buffer]. The extract 
was centrifuged at 1,750 x g for 11 min at 4 ?C. The supernatant was collected (S1) and centrifuged at 
15,000 x g for 1 hour at 4 ?C. The resulting supernatant (S2) was stored at -80 ºC or further centrifuged at 
60,000 x g for 2 hours at 4 ?C. The resulting supernatant (S100) was stored at -80 ºC until further use. The 
centrifuged (S100) supernatant was mixed with 500 µl of IgG Sepharose beads [Amersham Biosciences, 
Piscataway, NJ, USA] and incubated at 4 °C for 4 hours with gentle rocking. The mixture was loaded 
onto a disposable polyprep chromatography column [10 ml bed volume, Bio Rad laboratories, Hercules, 
CA,USA] and washed once with 15 ml buffer B [25 mM Tris-HCl, pH 7.5, 150 mM KCl, 3 mM MgCl2,
10% sucrose, 10 mM ?-mercaptoethanol, 20 mM NaF, 1.mM phenylmethanesulfonylfluoride (PMSF), 1 
mM DTT, 0.25% NP40 and one tablet/50 ml protease inhibitor mix “complete”, Boehringer Mannheim]. 
The column was equilibrated with 5 ml TEV cleavage buffer [25 mM Tris-HCl, pH 7.5, 150 mM KCl, 3 
mM MgCl2, 1mM DTT, 0.5 mM EDTA, 0.1% NP-40 and protease inhibitor mix “complete”, Boehringer 
Mannheim] and the TAP-tagged protein (minus the IgG domain) was released from the resin by digestion 
with 500 U of rTEV protease [Invitrogen] in TEV cleavage buffer containing 1 µM E-64 protease 
inhibitor for 1 hour at 16 ºC and overnight at 4 ºC. The eluate was then bound to the calmodulin (CAM) 
agarose beads [Stratagene, La Jolla, CA, USA] in CAM-binding buffer [CBB; 25 mM Tris-HCl, pH 7.5, 
150 mM KCl, 3 mM MgCl2, 1mM Mg acetate, 1 mM imidazole, 2 mM CaCl2, 10 mM ß-mercaptoethanol, 
0.1% NP-40 and protease inhibitor mix “complete”, Boehringer Mannheim] (Rigaut et al., 1999) and 
eluted with CBB buffer containing 10 mM EGTA. The eluate was TCA precipitated and loaded onto a 
10% polyacrlamide gel for SDS-PAGE. Proteins were visualized either by commassie or by silver 
staining. 
2.20 TEV protease expression and purification 
(a) Expression of histidine tagged TEV protease
The TEV protease expression plasmid [pMHTdelta238] was obtained from the Harvard plasmid 
collection, (Blommel and Fox, 2007). TEV protease was expressed in E.coli BL21 RILP strain 
(Stratagene, La Jolla, CA) with some modifications. Starting inoculums were grown over night at 25 °C in 
10 ml LB containing kanamycin (100 µg/ml), chloramphenicol (34 µg/ml), 0.375% aspartic acid and 25 
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mM sodium phosphate. About 2 ml of overnight culture were transferred to one liter of terrific broth [12 
grams of tryptone, 24 grams of yeast extract and 4 ml of 100% glycerol in 900 ml of deionized water, 
sterilize by autoclaving and adjust volume to one liter with sterilized 100 ml solution of 0.17 M KH2PO4
and 0.72 M K2HPO4 grams of sodium chloride in one liter of deionized water Expression was carried out 
in terrific broth containing kanamycin (100 µg/ml), chroamphenicol (34 µg/ml), 0.8% glycerol with 2 
mM MgSO4 and 0.375% aspartic acid. For induction final concentration of 0.5 mM IPTG was added and 
the induction was carried out for about 10-12 additional hours at 25 °C. The cells were harvested by 
centrifugation at 5,000 x g for 10 min. The pellet was resuspended in 10 ml of a buffer containing 50 mM 
sodium phosphate pH 7.5, 300 mM NaCl and 20% ethylene glycol, and centrifuged again to recover the 
washed cell paste, which was stored at -80 ºC until further use. 
(b) Purification of histidine tagged TEV protease 
The cell paste was resuspended in 10 ml of 20 mM Tris-HCl, pH 8.0, containing 150 mM NaCl, 
and 0.3 mM DTT (dithiothreitol). The cells were lysed using sonication (two times about 2 min pulses, 
100 W – 20 kHz) and centrifuged at 15,000 x g for about 1 hour at 4 ºC. Supernatant was collected, 
passed through the Ni-NTA matrix as described under Materials and Methods section 1.18. Pure protein 
fractions were identified by SDS-PAGE, pooled, dialyzed in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 
mM MgCl2, 50% glycerol and 5 mM DTT, concentrated by dialysis and stored at -80 °C. 
2.21 Silver staining of protein gels 
After electrophoresis, protein gels were kept in fixation solution [40% methanol, 5% acetic acid 
and 55% water] for 30 min at room temperature, and then washed with water for one hour with several 
changes (about 3-4 changes). After sensitisation using 0.02% sodium thio-sulphate solution for 1 min, 
gels were impregnated with 0.1% silver nitrate solution at 4 ºC for 30 min. Gels were developed using 2% 
sodium carbonate solution with 0.04% formaldehyde. The reaction was stopped using 1% acetic acid 
solution.
2.22 Coomassie staining of protein gels 
The protein gels were incubated with coomassie staining solution [1% Coomassie Brilliant Blue 
(CBB) R-250, 45% methanol and 5% acetic acid] for 1-2 hours at room temperature and destained using 
45% methanol and 5% acetic acid solution for several hours at room temperature. 
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2.23 Immunoblotting of protein gels 
After electrophoresis, gels were blotted onto the PVDF membranes [polyvinylidene difluoride] 
(Hybond-P, Pharmacia] using a semi dry transfer system [Bio-Rad]. The blots were blocked using 1x 
TBST [20 mM Tris-HCl pH 7.4, 0.8% NaCl and 0.1% Tween-20) containing 5% non-fat dry milk 
powder, overnight at 4 ºC. The membranes were incubated with primary antibody for 1-2 hours followed 
by 3 x 15 min wash with 1x TBST, followed by HRP conjugated secondary antibody incubation (1:5000) 
for 45 min at room temperature in blocking solution (1 x TBST + 5% non-fat dry milk powder). 
Membranes were washed 3 x 15 min with 1 x TBST. Membranes were developed using the Enhanced 
Chemiluminescence ECL Plus kit [Pharmacia] according to the manufacturer’s instructions and exposed 
to X-ray films from 2 - 10 mins depending on the sensitivity and signal intensity.
2.24 ELAV/Hu [Embryonic Lethal, Abnormal Vision] protein expression and 
 purification 
(a) Expression and purification of histidine tagged ELAV or mouse Hu proteins
cDNAs encoding each mHu family members [mHuB, mHuC and mHuD] were cloned into 
pET28a (+) [Novagen, Madison, WI] such that each coding sequence of Hu proteins was protein was 
preceded by a histidine tag at the N-terminus. After transformation of the construct into E coli BL21
(DE3) pLysS, bacteria were grown in LB broth at 37 °C for 3 hours. Following induction with 1 mM 
isopropyl-?-D-thiogalactopyranoside [IPTG], the cells were grown for an additional 3 hours. Cells were 
harvested by centrifugation at 6,000 x g for 10 min at 4 °C and the cell pellet was stored at -80 °C. Fusion 
protein was purified by nickel chelation chromatography according to the manufacturer’s instructions 
(Qiagen) as described under Materials and Methods, section 1.18 a.  
(b) Purification of histidine tagged Hu proteins 
The cell pellets were re-suspended in small volume of 20 mM sodium phosphate, pH 8.0, 
containing 150 mM NaCl, 0.3 mM DTT [dithiothreitol]. The cells were disrupted by sonication for about 
2 min pulses for two times and the cells were centrifuged at 13,000 rpm for about 1hour at 4 ºC. 
Supernatant was collected and passed through the Ni-NTA resin. The proteins bound to resin was washed 
with 20 mM sodium phosphate buffer, 500 mM NaCl, 20 mM imidazole and 0.3 mM DTT [dithiothreitol] 
to remove contaminants. Finally, recombinant protein was obtained with elution buffer containing 20 mM 
sodium phosphate buffer containing 500 mM NaCl, 500 mM imidazole and 0.3 mM DTT [dithiothreitol]. 
The purified protein fractions were identified by sodium dodecyl sulfate gel electrophoresis, pooled, 
dialyzed, and concentrated. 
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2.25 Immunoprecipitation 
Anti-HuB, anti-HuC and anti-HuD antibodies were immobilized on protein G-Sepharose beads 
[Pharmacia] by gently mixing at 4 ºC overnight, washed three times with buffer [12.5 mM HEPES pH 
7.9, 150 mM NaCl, 2 mM MgCl2, 0.25 % NP-40, 5% glycerol]. Followed by incubation with brain 
extracts (S2) of FVB wild type mice and BC200 [-2271] transgenic mice at room temperature. The 
unbound sample was washed with same buffer, RNA was extracted from the bound complexes using 
TRIzol reagent (Gibco BRL). The RNA was separated on 8% polyacrylamide/7 M urea gels and 
transferred to nylon membranes. 
2.26 Electrophoretic Mobility Shift Assays (EMSA) 
(a) In vitro transcription of BC1 RNA and BC200 RNA 
DNA templates for in vitro transcription of BC1 and BC200 RNAs were generated from pBCX 
607 (Cheng et al., 1996) and pBC200 (Bovia et al., 1997) plasmids, respectively. Plasmid DNA was 
digested with DraI restriction endonuclease that leaves a TTT sequence at the 3' end, yielding genuine 
RNAs that terminate in UUU. Transcription with T7 RNA polymerase was performed in a 100 µl reaction 
volume containing 20 ?l 5 x transcription buffer [MBI Fermentas], 2.0 mM (final concentration) of rGTP, 
rCTP and rATP, each and 0.5 mM rUTP, 100 ?Ci of [?-32P? UTP (Perkin Elmer), 20 units of RNasin 
[Fermentas] and 200 units of T7 RNA polymerase [Fermentas]. After incubation at 37?C for 2 hours and 
30 min, the DNA template was digested by adding 20 units of DNaseI [RNase free, Roche] for 15 min 
and precipitated with EtOH. 32P-labeled RNAs were separated on 8% polyacrylamide/7 M urea 
denaturing gels, and passively eluted into 0.3 M NaOAc buffer pH 5.2, 1.0 mM EDTA, 0.2% phenol at 4 
ºC overnight. Subsequently, RNAs were ethanol precipitated and dissolved in 30 µl H2O.
(b) Gel shift assays. 
Radiolabeled RNAs were heat denatured at 65 ºC for 5 min and placed on ice for 5 min. Gel shift 
assays were performed in 20µl of total reaction volume, with the following buffer: 10 mM Tris-HCl [pH 
7.5], 2.5 mM MgCl2, 100 mM KCl, 15% (v/v) glycerol, 0.5% Triton X-100, 1 ?g of BSA (Sigma-
Aldrich), 1 ?g of total yeast tRNA (Sigma-Aldrich), 20 ?g of heparin and 5 units of ribonuclease inhibitor 
(RNasin, MBI). 10 nM of RNAs were incubated with increasing concentrations of Hu proteins [mHuB, 
mHuC and mHuD] and as a positive control 15 nM of PABP [Poly(A)-Binding Protein]. Reactions were 
incubated for 30 min at 4 ºC or on ice, followed by 10 min at room temperature. Reactions were separated 
on non-denaturing, 6% polyacrylamide/bis-acrylamide (29:1, w/w) gels in 0.5 x TBE [45 mM Tris-borate 
pH 8.3, 1 mM EDTA] at 200 V for 120-180 min depending on RNA length. Gels were dried using 
vacuum and heated slab gel dryer (Bio-Rad) at 80 ºC for 2 hours and exposed to X-ray films. 
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2.27 DNA extraction from different rodents 
DNA was processed by standard protocols (Maniatis et al., 1982) from tissues of the following 
rodent species: Cricetidae: Cricetus cricetus (black-bellied hamster), Ondatra zibethicus (muskrat); 
Muridae: Meriones unguiculatus (Mongolian gerbil); Spalacidae: Nannospalax ehrenbergi (Ehrenberg’s 
mole-rat); Dipodidae: Jaculus jaculus (lesser Egyptian jerboa); Pedetidae: Pedetes capensis (springhare);
Anomaluridae: Anomalurus sp. (scaly tailed squirrel); Castoridae: Castor fiber (Eurasian beaver); 
Heteromyidae: Heteromys gaumeri (Gaumer’s spiny pocket mouse); Ctenodactylidae: Ctenodactylus
gundi (northern gundi); Thryonomyidae: Thryonomys swinderianus (greater cane rat); Echimyidae: 
Proechimys cuvieri (Cuvier’s spiny rat); Myocastoridae: Myocastor coypus (nutria); Octodontidae: 
Octodon degus (degu); Caviidae: Cavia porcellus (domestic guinea pig), Dolichotis patagonum 
(Patagonian mara); Erethizontidae: Coendou prehensilis (Brazilian porcupine); Sciuridae: Sciurus
vulgaris (Eurasian red squirrel), Marmota marmota (European marmot); Gliridae: Glis glis (fat 
dormouse). 
2.28 PCR amplification of informative presence/absence loci 
PCRs were performed for 4 min at 94 °C followed by 35 cycles of 30 s at 94 °C, 30 s at the 
primer-specific annealing temperature and 60 s at 72 °C. The PCRs were finished with 5 min at 72 °C. 
For complicated PCR amplifications, gradient PCRs were used with annealing temp from 45 °C to 65 °C 
for about 30 s to 60 s depending upon the fragment length. For most of the PCR amplifications were 
carried out using my own lab made Taq polymerase. The PCR fragments were purified on agarose gels, 
ligated into the pDrive cloning vector [Qiagen, Hilden] and electroporated into TOP10 cells [Invitrogen, 
Groningen]. Inserts from each of three individual clones were sequenced using the Ampli Taq FS Big Dye 
Terminator Kit [PE Biosystems, Foster City] and standard M13 forward and reverse primers. 
2.29 Computational Strategies to identify the informative loci 
To identify phylogenetically informative presence/absence patterns of retroposed elements, we 
applied five different in silico search strategies, which will be discussed in this chapter.
The high rate of substitution in rodent genomes presents a though challenge in the development of 
special strategies to identify phylogenetically informative presence/absence loci. Highly conserved 
flanking regions are necessary for the successful PCR amplification of orthologus loci in diverged 
species. So previuosly developed CPAL [Conserved Presence/Absense Locus-finder], a fully automated 
computational search program utilizing Bioperl, which was discussed in detail (Farwick et al., 2006). The 
objective of the program is to locate mouse SINEs inserted in introns and to identify conserved regions in 
the flanking exons in order to design universal rodent PCR primers. CPAL is organized in four main 
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processes. 1. An NCBI GenBank search for annotated exon-intron-exon structures in the species of 
choice, in our case Mus musculus. Intron sequences no larger than 1 kb with their flanking exons are 
extracted for further analyses. (2) A local RepeatMasker screen of the selected sequences for interspersed 
repeats, in our case all SINEs known in rodents (3) A StandAloneBlast alignment of the mouse exons 
against sequences of a reference species of choice, in our case all human chromosomes, to reveal loci 
conserved in both mouse and human. (4) A Clustal W (Thompson et al., 1997) alignment of all mouse 
exon-flanked repeat loci against the human reference sequences from point 3. 
FIGURE 2.3 Flow chart of the Conserved 
Presence/Absence Locus finder 
computational strategy. The CPAL Bioperl 
script begins with a GenBank search using 
the query “Mus musculus and exon” and 
excludes mRNAs and cDNAs. All hits are 
scanned for introns not longer than 1 kb, 
flanked by exonic sequences. With a local 
version of the RepeatMasker, CPAL selects 
introns with rodent-specific SINEs (-rod) 
and excludes sequences of low complexity 
(-nolow). A StandAloneBlast search of the 
exonic flanks against all human 
chromosomes reveals loci conserved in 
mouse and human. A CLUSTAL W 
alignment produces a FASTA output file 
with potential presence/absence loci in 
rodent species flanked by highly conserved 
regions facilitating the generation of 
conserved primers for Zoo-PCR in rodents. 
Figure was adapted from (Farwick et al., 
2006).
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Strategies II, III and IV 
 Mouse intronic sequences were downloaded from the Santa Cruz Server (http://genome ucsc.edu/cgi-
bin/hgTables).
After applying script based exclusion of duplicated sequences and the introns larger than 1 kb to facilitate 
PCR amplification, searched for the presence of retroposed SINE elements for rodents (RepeatMasker). 
Mouse introns with rodent specific elements were selected and/or low complexity repeats were excluded. 
The remaining intronic sequences were analyzed for the presence of conserved flanks (Santa Cruz Server) 
and were analyzed by searching against the trace data base of the guinea pig, kangaroo rat and 
spermophilus for the respective strategies II, III and IV at the NCBI server 
(http://ftp.ncbi.nih.gov/pub/TraceDB), and selected 50, 20 and 30 loci to generate PCR primers. 
FIGURE 2.4 Alternative strategies to find 
informative loci. In this strategy 25,000 
intronic sequences of Mus musculus, has 
taken with flanking exons and the intronic 
sequences lack repeats (SINE elements). All 
intronic sequences were blasted against 
Dipodomys ordii (Dor), Cavia porcellus
(Cpo) and Spermophilus tridecemlineatus
(Str). All hits were scanned for introns not 
longer than 1 kb, flanked by exonic 
sequences. With a local version of the 
RepeatMasker, strategies selects introns with 
rodent-specific SINEs (-rod) and excludes 
sequences of low complexity (-nolow). A 
Blast2 sequence alignment produces a file 
with potential presence/absence loci in rodent 
species flanked by highly conserved regions 
facilitating the generation of conserved 
primers for Zoo-PCR in rodents. Finally 
amplified sequences were aligned against 
lagomorphs (used as an our group). 
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For finding informative loci in other representative clades from guinea pig, kangaroo rat and 
spermophilus, where trace data is available in NCBI GenBank for searching informative loci. In these 
strategies, we have taken 25000 mouse intronic sequences of about 1 kb, with highly conserved exons of 
150-200 nt length. We blast these intronic sequences against the trace data of these representative species 
(guinea pig, kangaroo rat and spermophilus). The resulting sequences were checked for repeats in local 
repeat masker where we selected SINEs in rodents. Next step is manual alignment of all available 
representative species [human and rabbit (lagomorphs)] sequences. Design the conserved primers for PCR 
amplification in rodents. 
2.30 Presence/Absence Analysis of SINE retroposed elements 
We applied the RepeatMasker option (-rod) to all our strategies in this study. Thereby focusing only 
on rodent-specific and mammalian wide repeats. Thus, all selected loci represents the presence state should 
contain SINE retroposed elements in the intronic sequence after PCR amplification. Conversely, the absence 
state should have only flanking exons without the retroposed elements therefore appear as smaller PCR 
products. All species contain a transposed element at the orthologous position were considered to have 
derived from a common ancestor. 
For a handful of loci, the PCR patterns were difficult to interpret because of additional independent 
SINE insertions or random indels or deletions in different lineages. The sequencing of all PCR products was 
thus an important criteria to characterize specific presence/absence patterns. 
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Table 2 
marker designation oligonucleotide sequence (5'-3') Tm 
CPAL 25 CAGCCATGGTCCTTTTCACCAG 55 °C 
 CCAGACCCWCCATTRGAGAGTGA  
CPAL 405 GATGGTTCTGCKGCCTATGTTCA/TGCTTGACCATCCTCTAGAC 54 °C 
 GTCCCGTCTTCTARCTGYACTG/ATGTGCCCATACCTAAAAGTAGT  
CPAL 437 GATGAGAAACCTCTTCAGGACA 55 °C 
 AGCACTTCTAGCTGAAGTGACAAGC  
CPAL 1406 YAGGAGCCGACCCYKCTGAG 54 °C 
 AMGCCCTCCTTCACCATCCAGTGTCT  
CPAL 503 AGTGGAARTTCACAGRCTGCTCAG/ 
TAGGGCAGTTGAGATGTGTGAGA 52 °C 
 GCAGGAAGRAGTCTTCACAAGG/AGTGGAGGGTGAGGGGGTAAG 
17 B3A CTAGATACMCCMGAGATGAGRCG 58 °C 
 GTGTGTTTTTCTTTACTCGTTCAGTG 
18 ID4 GGTCAAGACGAGATACATGAACTCTGC 55 °C 
 CCAAGCGGAGAAAGGARGGCA  
19 IDL-Geo AGACTGCCGGGTGTATGGGAG 56 °C 
 TGGCCAGGGCCCGGATCT  
20 PB1-Geo AGGGTGAACGAGAGCTGCA 55 °C 
 GTAGGGATGGAATTCTCAGCTG 
21 PB1-Geo TCTCAGAGACAGAGGAAGTGGC 54 °C 
 GGAGGCTGAGCTATACTCTTGG 
22 PB1-Geo GATCGAAATGGAGATGTACGAAA 51 °C 
 AGGCTTTGCTGGCATGTTAG 
23 IDL-Geo GATTCAGTTTTGCAGCCCTA 54 °C 
 AAGAGTAATTGACGTGTGATATGG  
24 PB1-Geo AATGGGGGTCACTGTCAGAA 55 °C 
 TCGATGTAGCACTGAGCACC 
25 B1F CTGTCAAGACAGCTGTGTCAG 54 °C 
 ATGTCTCCGGATCTGAGAGAT 
26 B1 & B1F GCTGTGGACATATTCGACTTCTG 54 °C 
 GTCCGATGATCCCACAGAAGA 
27 B1 & ID2 AGCGTGGCTGCCAAGAACCT 56 °C 
 CTGGCGCAAGGCATCATTGT  
28 ID4 TGGGAAAGATCTCAGCAATAC 50 °C 
 ATGTATGTTAGCTCCTCAATTTC  
29 B1 AAATTGCCATGTTGCTGTGAT 53 °C 
 CTGTCTTATAGACGCTTCCGTG 
30 ID4 GTTTCATCCCTACATCCCCTT 54 °C 
 TCCATGAAGGCCTCATAGAAAT 
31 ID4 GTTTATGACCAGGTGGAGTTTGA 55 °C 
 ACTGTTCATGATTCGAAGGGACT  
 32 ID2& ID2& ID4 TGAGATTTGTCGGCTGTCTGTTTT 53 °C 
 GTGCAACGATCAGCCAAATTTC  
33 ID-Str CCCCGTGGTGAGCGAGAA 52 °C 
 AACTTTTTGCCACTCTTCCCAG
34 PB1 TTCATTGAAAACTCTTCGTTATGG 51 °C 
 AGAAGAGATGGCCAATTGTGAT 
35 ID4 GATGGTGTGTGTGTCCGTGT 55 °C 
 AGAGGATAAGGAACATTGAAGTAGT 
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RESULTS
Establishing and characterization of the tagged BC RNAs in 
transgenic mice for localization and purification studies
In order to purify the BC RNP complexes and to examine the tagged RNA transport in vivo, we 
have to establish a transgenic mice, which express BC1MS2 RNA and BC200MS2 RNA in combination 
with MS2TAP [MS2 coat protein fused to TAP tag for the affinity purification of BC RNP complexes] 
protein-expressing transgenic mice. Therefore, we have tagged MS2 protein binding sites to the 3' portions 
of the BC RNAs in combination with constructs expressing an MS2 coat fusion protein for binding and as a 
handle for purification.
Results discussed in this section:
(I) How we generated the MS2 tagged BC RNAs in transgenic mice.
(II) MS2 tagged BC RNAs transgenic mouse model for dendritic BC RNAs transport studies.
(III) Transgenic mouse models for BC RNP purification studies and an initial test towards purification.
3.0 Affinity purification as a strategy for purification of BC RNPs.
Protein affinity tags have been used routinely and successfully for either purification or detection of 
the tagged proteins. To study the RNA or RNP [RNA-protein complexes], RNA affinity tags are potentially 
very useful to purify the RNP complexes. For purification or isolation of native in vivo RNP complexes, it is 
useful to have an RNA affinity motif that can be incorporated during the synthesis of the RNA in vivo.
Earlier RNA affinity tags have not been widely used [like protein affinity tags] successfully to 
isolate or to purify the protein subunits of the RNP complexes and for localization or transport studies. 
Recently researchers started using RNA based affinity tags to purify the RNP complexes or to locate the 
tagged RNAs (Hogg and Collins, 2007, Srisawat and Engelke, 2001). These RNA tags can be classified into 
two categories. In the first category, tags that occur naturally were based on RNA - protein interactions 
found in nature. RNA motifs ????????????????????????????????????-phage N anti-terminator protein (N-
peptide) are the prominent examples of this type. In second category, tags were developed based on the 
artificially selected RNA motifs that have small-defined structures and were particularly useful for RNP 
isolation. In this category, in vitro synthesized tags like streptavidin, tobramycin and D8 sephadex were the 
most widely used RNA tags (Bachler et al., 1999, Hartmuth et al., 2004, Srisawat and Engelke, 2001, 
Srisawat et al., 2001). Since our goal is to purify BC RNP complexes to near homogeneity and to study the 
dendritic transport of the tagged RNAs using antibodies in electron microscopy in the future, we had 
developed RNA based affinity tag. By utilizing the MS2TAP tag, we are assuming to purify BC RNP 
complexes in vivo or to identify the proteins bound to these RNPs and to locate the tagged RNAs transport 
for assigning the function to these RNAs.
Results
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Several factors were considered, when we chose the MS2 tag over other RNA tags for purification 
and localization of BC RNPs. MS2 tag is a naturally available tag. It is very selective and efficient in 
binding to MS2 coat protein. Singer et al speculating, that MS2/MS2 coat protein can bind to one 
RNA/RNP at a time compared to PP7 tag (Chao et al., 2008, Kaganman, 2008), which is the utmost 
important thing for selecting MS2 tag. The interaction between MS2 coat protein and its cognate RNA has 
been extensively characterized (Horn et al., 2004, Johansson et al., 1998, van den Worm et al., 1998). 
3.1 Tagging the BC RNAs with MS2 binding sites for localization and 
purification
Several factors like folding, steric hindrance and not losing the tag from BC RNAs via processing 
for purification and localization were considered while tagging MS2 motifs to the BC RNAs. These issues 
were discussed briefly below. 
(I) Folding: It is recommended that the RNA affinity tag should be inserted at either 3' end or 5' end 
of the interested RNAs/RNPs to be purified or to be visualized. So that, the access of tag for purification and 
visualization could be substracted. The folding problem is simply a matter of inserting the tag in such a way 
that both the tag and the RNAs should remain correctly folded. RNA folding algorithms; (Zuker, 2003) 
http://www.bioinfo.rpi.edu/applications/mfold) has been used to predict the folding of these BC RNAs to 
obtain the MS2 tagged RNAs for proper folding. Figure 1.8. depicting the possible folding of BC1 RNA 
with MS2 motif. 
(II) Steric hindrance: This problem arises, when the tag is partially or fully covered the RNA or its 
associated proteins of our interest, thus obstructing access of the tag to the affinity matrix, to avoid any 
hindrance we had placed a spacer between the tag and the RNA. 
(III) Processing: The major problem is keeping the tag on the RNA from being processing for 
purification or localization purpose, that should be tested in order to check for RNA processing in the cell or 
in vivo models like transgenic mouse models. 
3.2 Placing the MS2 protein binding site at the 3' end of BC RNAs 
Bacteriophage MS2 RNA motif is a 19 nt long, whose three-dimensional structure with the 
corresponding MS2 coat protein are well known from the crystal studies (Horn et al., 2004, van den Worm 
et al., 1998). Using mfold program for RNA folding we had inserted two MS2 motifs (stems) to the 3' end 
of the both RNAs (Fig 3.1), and has been cloned in pCR TOPOII vector [invitrogen] under its native BC1 
and BC200 RNA gene promoters respectively. The predicted model in the (Fig 3.0) showing the MS2 tag 
located at the very 3' end of both BC RNAs but proximal to the RNA polymerase III terminator.  
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Note: In case of BC1 RNA, we have cloned rat BC1 gene, in order to distinguish between rat and mouse 
BC1 RNA, expressed in the transgenic mice.  
Fig 3.0 Structures of BC1MS2 RNA (MS2 at 3' end) and BC200MS2 RNA (two MS2 stems located at 
the 3' end). Cloned in pCR TOPOII vector for generating transgenic mice. Both RNAs are transcribed from 
their native promoters. The two MS2 motifs were placed proximal to the RNA polymerase III terminator 
(i.e. ending in UUU in BC1 and BC200 RNA). 
Mfold application showed relatively efficient folding with minimum free energy (?G). From the 
mfold application, we are predicting the MS2 stem of BC RNAs might be free to bind the MS2 coat protein. 
Thus the MS2 tag will allow purification and dendritic transport studies in the transgenic mouse models 
employing antibodies for electron microscopy. 
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Fig 3.1 Secondary structure of BC1 RNA tagged with MS2 stem motifs. Two MS2 motifs separated by 
an unstructured spacer were inserted at the very 3' end of the BC1 RNA. This is followed by a stretch of U-
residues for RNA polymerase III transcription termination. Figure depicting folding of BC1MS2 by mfold 
from Michael Zuker http://www.bioinfo.rpi.edu/applications/mfold.
3.3 TAP tag fused to MS2 coat protein for affinity purification of MS2 tagged 
BC RNPs 
The MS2 coat protein fused to TAP tag [Tandem Affinity Purification] for affinity purification of 
BC RNPs, was cloned into pNE vector (a generous gift from Dr. Stephan Kindler, University of Hamburg) 
under the chicken ?-actin promoter. TAP method involves the fusion of the TAP tag to the MS2 coat protein 
and introduction into the host cell and observes the expression of fusion protein in the mammalian cell lines 
(ex vivo) or in transgenic mouse system (in vivo) [mouse brian extract]. The fusion protein MS2 with TAP 
tag is approximately 357 amino acids long corresponding to 39,329 Da, and at the N-terminus of the 
MS2TAP fusion protein HA and FLAG tag peptides were fused to observe the protein expression by 
Western blot analysis. 
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3.4 Expression of BC1MS2 RNA and MS2TAP fusion protein from combined 
construct in NIH 3T3 cells 
In order to facilitate our work and to avoid generating two different transgenic mice, we had 
generated a construct, which harbors both BC1MS2 and MS2TAP expressing modules in a single plasmid. 
The rat BC1MS2 fragment was PCR amplified from SacI to ApaI from the pCR TOPOII BC1MS2 plasmid 
and subcloned in pBluescript II KS+ vector backbone. The MS2TAP fusion protein is driven by the chicken 
?-actin promoter from pNECKu vector was subcloned in the same vector that harbors BC1MS2 module. 
The MS2TAP insertion was done by blunt end cloning, resulting in two different kinds of orientations with 
respect to the plasmid backbone (Fig 3.2). The MS2TAP fragment inserted into pBS-BC1MS2 was in the 
same transcriptional orientation as BC1MS2 [i.e. head to tail] resulted in plasmid designated, 11 dirTAP. 
The plasmid with MS2TAP inserted in the opposite orientation to the BC1MS2 [head to head], resulted the 
plasmid designated as 3 revTAP (Fig 3.2). Both the plasmids were transiently transfected in NIH 3T3 cells 
and observed for protein and RNA expression (Fig 3.3 & 3.4).
Fig 3.2 Schematic representation of BC1MS2+MS2TAP (not drawn to scale). The MS2TAP fusion 
polypeptide features the MS2 coat protein [green] fused to the TAP module with the following components: 
CBP tag [purple] and protein A tag [magenta] separated by a TEV protease cleavage site [red]. The 
MS2TAP fusion protein is driven by the chicken ?-actin promoter [yellow] including its 5' UTR [gray] 
which, in turn, is interrupted by a ~1 kb intron [striped area] followed by a polyadenylation signal from a 
fragment from SV40 virus containing poly(A) additional signal [turquoise]. The BC1MS2 RNA gene [dark 
blue] has two MS2 stems [dark green] at the very 3' end of the BC1 RNA gene [blue - arrow showed the 
orientation of transcription] is driven by its native promoter with flanking regions [blue]. The MS2TAP 
fragment cloning resulted in two different orientations in the BC1MS2 plasmid backbone. One is in the 
same transcriptional orientation as BC1MS2, the other is in the opposite orientation to BC1MS2, and the 
plasmids were labeled as 11 dirTAP and 3 revTAP respectively. These fragments carrying the RNA and 
protein coding genes were (released with SfiI/AscI restriction endonucleases) used to generate transgenic 
mice. 
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As a first test in order to check expression of the generated constructs, we introduced the construct 
into an ex vivo system before generating transgenic mice (in vivo). We performed transient transfections in 
the mouse embryonic fibroblast cell line [NIH 3T3 cell line] for both the plasmids [3 revTAP and 11 
dirTAP]. After transfections, the whole cell lysates were used for RNA and protein extraction. We observed 
that both plasmids [3 revTAP and 11 dirTAP] showed roughly equal quantity of expression of BC1MS2 
RNA and MS2TAP protein. Northern blot (Fig 3.3) depicting BC1MS2 RNA expression of the expected 
size of ~220 nt in transient transfection in NIH 3T3 cells. As a control in vitro transcribed BC1 RNA was 
loaded and the expected size of BC1 RNA of 152 nt was observed in the blot. 
Fig 3.3 Northern blot showing the expression of BC1MS2 RNA in transient transfections from two 
plasmids in NIH 3T3 cells. Plasmids 3 revTAP and 11 dirTAP were transiently transfected in NIH 3T3 
cells and total RNA was extracted and separated on a 6% polyacrylamide/7 M urea gel, transferred onto a 
nylon membrane and hybridized with a 27 nt long DNA probe complementary to the BC1 RNA unique 
region (Table.1). The tagged RNA exhibited the expected size of 220 nt. The first lane is in vitro transcribed 
BC1 RNA. Lane 3 & 6 were transfected with 3 revTAP [5 µg and 10 µg of total RNA loaded, respectively] 
and lane 4 & 7 were transfected with 11 dirTAP [5 µg and 10 µg of total RNA loaded, respectively]. The 
filter was reprobed for SRP RNA as a control for sample loading (not shown). Total RNA from 
untransfected NIH 3T3 cells (lanes 2 & 5) was used as a negative control. Exposure time for the blot was 
about 3 hours. 
We checked the protein expression in transient transfections for both plasmids [3 revTAP and 11 
dirTAP] in mouse embryonic fibroblast cell line [NIH 3T3 cells]. As the MS2TAP fusion protein exhibits 
an HA epitope at the N-terminus of the fusion protein, we used HA antibody to detect the fusion protein 
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expression. Immunoblot identifies a protein of about 39.3 kDa, as expected from both constructs used in 
transfection (Fig 3.4). We also checked the protein expression using MS2 antibody raised in our lab and the 
experiment showed the same expected size [data has not shown]. 
Fig 3.4 Immunoblot showing the expression of MS2TAP fusion protein in transient transfections of 
NIH 3T3 cells. Plasmids 3 revTAP and 11 dirTAP were transiently transfected in NIH 3T3 cells and the 
total proteins were extracted and separated on 12% polyacrylamide gel electrophoresis containing sodium 
dodecyl sulfate (SDS-PAGE), transferred onto a polyvinylidene difluoride (PVDF) membrane and probed 
with anti-HA antibody, the epitope which is located at the N-terminus of the fusion protein. The signal 
(band) in 3 revTAP and 11 dirTAP indicates that the MS2TAP fusion protein is expressed. Total protein 
from untransfected NIH 3T3 cells were used as a negative control. The lane “Magic marker” shows the 
molecular weight standards with fragment sizes of 120, 90, 60, 50, 40 and 30 kDa. 
3.5 Expression of MS2TAP fusion protein but not BC1MS2 RNA in 
transgenic mice from combined construct 
Transient transfections, indicated that both plasmids exhibited similar expression levels for the 
desired RNA and protein in the ex viivo system. Therefore, we had generated transgenic mice for both the 
constructs (3 revTAP and 11 dirTAP) with the MS2 stems at the very 3' end followed by the RNA 
polymerase III terminator for localization and purification in vivo. Total brain RNA from two transgenic 
mouse founders (3 revTAP mice # 21, #45; and 11 dirTAP mice # 14, # 19; see Appendix Fig 8 A & B)
each was analyzed. Unexpectedly, we have not observed BC1MS2 RNA expression in any of the transgenic 
mouse founders examined (Fig 3.5).
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We have used rat BC1 LNA probe (a nucleotide difference between rat and mouse [C?U and 
A?G] near the ID region) to distinguish between the endogenous BC1 RNA expression and the transgenic 
BC1 RNA expression. We could observe a very small amount of cross hybridization with mouse 
endogenous BC1 RNA but not the larger transgenic BC1MS2 RNA. The reason for failure to detect 
BC1MS2 RNA might be that the MS2 stems at the very 3' end of the BC1 RNA transcript is destabilizing 
the RNA or impedes its transcription. It has been shown, for efficient transcription-termination and 
reinitiating of transcription by RNA polymerase III that the 3'-flanking sequence including the terminator 
mainly consisting of a stretch of U-residues is very important (Dumpelmann et al., 2003). 
Fig 3.5 Northern blot revealing that BC1MS2 RNA was not expressed (MS2 3' end) in transgenic 
mouse brain. Total RNA extracted from mouse brain from 3 revTAP and 11 dirTAP transgenic mice was 
extracted and separated on a. 6% polyacrylamide/7 M urea gel, transferred onto a nylon membrane and 
hybridized with rat LNA oligonucleotide probe (Table.1) complementary to the rat BC1 RNA where it 
differs in two positions from the endogenous mouse BC1 RNA. Rat LNA oligonucleotide probe, 
distinguishes between the transgenic BC1 RNA from the endogenous mouse BC1 RNA. The first lane is in 
vitro transcribed BC1 RNA. As positive and negative controls, rat brain and wild type mouse total RNA was 
loaded, respectively. Total RNA from the transgenic mouse brain of two independent founders (from each 
construct) revealed that the BC1MS2 RNA was not or barely detected from both transgenic mice 3 revTAP 
and 11 dirTAP. The filter was reprobed for SRP RNA as a control for sample loading (not shown). 
Exposure time for the blot was about over night (12 - 14 hours). 
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In order to check the MS2TAP fusion protein expression in transgenic mice, we performed 
immunoblotting. As expected, we detected the fusion protein in 3 revTAP (data not shown) and 11 dirTAP 
transgenic mouse brain extracts (11 dirTAP mouse #21, see Appendix Fig 8 B). Figure 3.6 depicts the 
MS2TAP fusion protein expression of the expected size using MS2 antibody in both transgenic mouse brain 
extracts. 
Fig 3.6 Immunoblot depiciting the expression of MS2TAP fusion protein in transgenic mouse tissue 
extracts. 11 dirTAP transgenic mouse tissue extracts were separated on 12% polyacrylamide gel 
electrophoresis containing sodium dodecyl sulfate (SDS-PAGE), transferred onto a polyvinylidene 
difluoride (PVDF) membrane and probed with anti-MS2 antibody. The signal in brain, testes and liver 
indicates MS2TAP fusion protein expression. The MS2TAP fusion protein showed the expected size of 
about 39.3 kDa. The molecular weight standard with fragment sizes of 120, 90, 60, 50, 40 and 30 kDa is 
indicated at the left margin. 
3.6 Expression of BC200MS2 RNA and MS2TAP fusion protein from 
BC200MS2+MS2TAP transgenic mice 
Parallel to BC1MS2 (MS2 at the very 3' end of BC1 RNA) tansgenic mice, we had generated 
BC200MS2 transgenic mice and investigated the RNA’s expression. In contrast to the untagged BC200 
RNA transgene (Khanam et al., 2007b), we observed a less pronounced expression of BC200MS2 RNA in 
transgenic mouse brain. In order to affinity purify the BC200 RNP from the MS2 tagged BC200MS2, we 
had crossed the BC200MS2 RNA expressing transgenic mice with MS2TAP protein expressing mice. From 
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BC200MS2+MS2TAP transgenic mice, we detected both MS2 tagged BC200 RNA and MS2TAP fusion 
protein expression. Interestingly, in addition to the 270 nt long MS2 tagged BC200 RNA, we observed a 
weaker band in the size of native BC200 RNA. Since normally mice are devoid of BC200 RNA and its 
gene, the smaller band is likely to correspond to an RNA that lost, presumably by processing, the MS2 
domain at the 3' end. Both forms were detected only by using the BC200 unique DNA probe (Table 1) (Fig 
3.7, mice # 11, 13 and 21, see Appendix Fig 8 D). When we hybridized the membrane with the MS2 DNA 
probe (Table 1), we only observed the larger band (data not shown). From this experiment, we concluded 
that the BC200MS2 gene, when introduced into the in vivo system (transgenic mouse), the transcript 
showed a weaker expression and also is partially being processed. 
Fig 3.7 Northern blot showing the expression of BC200MS2 RNA in BC200MS2+MS2TAP transgenic 
mice. Total RNA was extracted from the brain of three independent transgenic mouse founders expressing 
BC200MS2+MS2TAP. The RNAs were separated on a 6% polyacrylamide/7 M urea gel, transferred onto a 
nylon membrane and probed against the BC200 unique DNA oligonucleotide (Table 1) and MS2 DNA 
probe (data not shown). BC200MS2+MS2TAP transgenic mice showed weaker signal of the expected size 
(270 nt) of BC200MS2 RNA compared to the 200 nt long untagged BC200 RNA. In BC200MS2 transgenic 
mouse brain total RNA, we observed two bands one at 270 nt long and a weak one of 200 nt length. About 
10-20% of the BC200MS2 transcript was being processed. BC200MS2 transcript processing was observed 
only, when the membrane was hybridized with the BC200 unique probe. The filter was reprobed for SRP 
RNA as a control for sample loading (not shown). Exposure time for the blot was over night (about 12 
hours). 
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3.7 Expression of BC1MS2 RNA in stable transfection 
To further confirm or to understand the fate that the BC1MS2 RNA not expressed in BC1MS2 
transgenic mice (MS2 at the very 3' end of the BC1 RNA), we had generated a plasmid containing BC1MS2 
with Pgk neo gene to facilitate stable transfection in NIH 3T3 cells. In the stable transfection, we detected a 
weak expression of BC1MS2 RNA and that the transcript was partially processed (Fig 1.15.). Processing is 
not certain, because NIH 3T3 cells have endogenous BC1 RNA expression (McKinnon et al., 1987). From 
these findings with BC1MS2 (MS2 at the very 3' end) in transgenic mice and  stable transfection of 
BC1MS2, we decided on a different strategy, namely to place the MS2 tag internally with respect to BC1 
RNA. 
Fig 3.8 Northern blot showing the expression of BC1MS2 RNA during stable transfection. Total RNA 
was extracted from 10 clones of NIH 3T3 cells stably transfected pMKS-BC1MS2. Plasmid pMKS-
BC1MS2 harbors Pgk neo cassette. Total RNA was extracted and separated on a 6% polyacrylamide/7 M 
urea gel, transferred onto a nylon membrane and hybridized with probe complementary to the BC1 region 
(rat LNA BC1 probe near to ID region, Table 1). The expected size of 220 nt was detected as a weak band. 
The first lane is in vitro transcribed BC1 RNA. Lane 2 was untransfected NIH 3T3 cell total RNA as a 
control. Exposure time for the blot was over night (about 12 hours). 
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3.8 MS2 tag placed internally of BC1 RNA to achieve BC1MS2 RNA 
expression.[MS2 stems proximal to the ID domain (MS2A) and proximal to 3' stem 
(MS2B) of BC1 RNA] 
In order to achieve intact BC1MS2 RNA expression in the transgenic mice, as the MS2 stems at the 
very 3' end of the BC1 RNA likely was posttranscriptionally removed in most molecules in the in vivo
mouse system, we moved the MS2 stems internal to the BC1 RNA gene i.e. immediately 3' to the ID (5' 
stem) or distal to the A22 stretch. Figure (3.9) represents the schemes of the new MS2 tagged BC1 RNAs. 
Both fragments were PCR amplified (described in Materials & Methods – section 1.4.) and cloned into 
pDrive vector (Qiagen, Hilden) and designated as BC1MS2A and BC1MS2B. From both constructs, we 
generated transgenic mice. 
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Fig 3.9 Schematic representation of BC1MS2A and BC1MS2B RNAs. The two MS2 stems motifs (MS2 
protein binding sites) were placed internally of the rat BC1 RNA under their native promoter. In BC1MS2A, 
MS2 stems were placed distal to the 5' stem of BC1 RNA. For BC1MS2B the MS2 stems were located 
proximal to the 3' stem of BC1 RNA. 
We have checked the RNA folding of BC1 RNA with MS2 tags placed internally, by using mfold 
from M. Zuker. http://www.bioinfo.rpi.edu/applications/mfold. The application showed no apparent 
interference with folding of the predicted BC1RNA structures with MS2 stem motifs. From the mfold 
application, we are predicting the MS2 protein binding sites might be accessible in binding the MS2 coat 
protein coexpressed as part of the BC1MS2+MS2TAP complex. We were assuming that the MS2 tag with 
BC1 RNA would express in the transgenic mice to allow for purification and dendritic transport studies in 
the transgenic mouse models (e.g., by employing antibodies in electron microscopy studies). 
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  BC1MS2A      BC1MS2B
Fig 3.10 Secondary structure of BC1 RNA, two MS2 stems placed internal to the BC1 RNA gene in 
mfold. Folding of BC1MS2 using the Michael Zuker program 
http://www.bioinfo.rpi.edu/applications/mfold.?Two MS2 RNA motifs separated by an unstructured spacer 
were placed internal to the rat BC1 RNA, close to the ID stem and the other closer to 3' stem, distal to the 
A22 stretch, designated BC1MS2A and BC1MS2B respectively. 
Transgenic mice were generated using the two constructs BC1MS2A and BC1MS2B.The total RNA 
was analyzed by Northern blot from two independent mouse founders of BC1MS2A transgene and three 
independent mouse founders from BC1MS2B transgene (Fig 3.11). We found little or no expression of 
BC1MS2A RNA in case of BC1MS2A transgenic mice. We found BC1MS2B RNA expression in 
BC1MS2B transgenic mice. The expression of this BC1MS2B RNA was weak in comparison with the 
expression of the wild type BC1 RNA. Among the offspring of three founder mice, one mouse (mouse #16, 
Fig 3.11) showed relatively high levels of BC1MS2B RNA expression. Therefore we expanded that 
transgenic mouse line. 
3.9. Expression of BC1MS2B RNA from BC1MS2B transgenic mice crossed 
with MS2TAP fusion protein expressing mice for purification of BC1 RNP 
Since our goal is to purify the BC1 RNP complex using MS2/MS2 coat protein complex, we had 
crossed BC1MS2B RNA expressing mice with MS2TAP protein expressing mice.We found that BC1MS2B 
RNA expression was further improved (mouse #18, Fig 3.11; see Appendix Fig 9 D). This difference 
between BC1MS2B #16 mouse and BC1MS2B+MS2TAP #18 mice may be due to the possibility that 
protein binding might stabilize the altered BC1 RNA. 
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Fig 3.11 Northern blot showing the expression of BC1MS2A RNA and BC1MS2B RNA in BC1MS2A 
and BC1MS2B transgenic mice. Total RNA was extracted from the offsprings of three independent 
founder mice, expressing BC1MS2B RNA in BC1MS2B transgenic mice and two independent founders 
shows no expression of BC1MS2A RNA in BC1MS2A transgenic mice. The RNAs were separated on a 6% 
polyacrylamide/7 M urea gel, transferred onto a nylon membrane and probed against MS2 DNA 
oligonucleotide (Table 1). BC1MS2B transgenic mice showed only weak expression of expected size [~220 
nt] (mouse #16, #14 & #25). In case of BC1MS2A transgenic mouse brain, we have not detected BC1MS2A 
RNA expression (mouse #10 & # 12) in any of the offsprings from two founder transgenic mice. 
Interestingly, BC1MS2B transgenic mice crossed with MS2TAP transgenic mice revealing increasing 
expression of BC1MS2B RNA (mouse #18). Prior to transfer, the gel was stained with ethidium bromide as 
a control for sample loading (not shown). Exposure time for the blot was about 3 days. 
3.10 Crossing the BC1MS2B+MS2TAP in endogenous BC1 RNA-/- depleted 
background 
When crossing the three independent BC1MS2B transgenic mice with MS2TAP transgenic mice, 
we found three different integration patterns of BC1MS2B fragment in the mouse genome by Southern blot 
analysis, using a probe specific to the 3' flanking region of BC1 RNA (~800 nt). Low copy number 
transgenic mice (mice #54, 67; Fig 3.12; see Appendix Fig 9 D) showed BC1MS2B RNA expression. Multi 
copy number transgenic mice, unable to detect BC1MS2B RNA expression. 
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Fig 3.12 Southern blot patterns of BC1MS2B in 
mouse genome. Southern blot analysis of BamHI-
digested mouse genomic DNAs reveals three 
different types of integration patterns, when crossed 
into BC1 RNA-/- mice and probed with the 3' 
flanking region of BC1 RNA (~800 nt). Band B 
(around ~5 kb), is the endogenous wild type mouse 
DNA fragment (predicted size: 5,048 nt) containing 
the BC1 RNA gene and absent in some mice (# 54, 
67) due to the BC1 RNA-/-. Mice #54 and 67 show 
low copy number transgene integration at the larger 
size range. Mice #35, 36, 52, 56, 57 and 69 show 
multi copy number transgene integration at the larger 
size range.Exposure time for the blot was about 3 
days. 
3.11 Establishing a line of BC1MS2B RNA and MS2TAP protein expressing 
transgenic mice 
In order to eleminate competition of native BC1 RNA expression in BC1MS2B RNA expressing 
transgenic mice, crossed BC1MS2B transgenic mouse (mouse # 16, Fig 3.11, see Appendix Fig 9 C) with 
BC1 RNA-/- mice. Parallel to the BC1MS2B transgenic mice, MS2TAP protein expressing transgenic mice 
were crossed into the BC1 RNA-/- background. The resulting transgenic mice BC1MS2B_BC1 RNA-/- and 
MS2TAP_BC1 RNA-/- were crossed to obtain a transgenic mouse line which harbor BC1MS2B RNA and 
the MS2TAP protein module. To achieve complete elemination of endogenous BC1 RNA in 
BC1MS2B+MS2TAP transgenic mice, we crossed BC1MS2B and MS2TAP transgenic mice to 
homozygosity (BC1 RNA-/-) for about 3-4 generations. This was confirmed by performing Southern blot 
analysis with specific probes against BC1 (BC1 RNA 3' flanking region, data not shown) and MS2TAP (?-
Actin MS2TAP, Fig. 3.14) genes. We also checked for maintenence of BC1MS2B RNA expression by 
Northern blot analysis (Fig. 3.13).
Total RNA from homozygous BC1MS2B+MS2TAP_BC1 RNA-/- and heterozygous 
BC1MS2B+MS2TAP_BC1 RNA+/- transgenic mice was analyzed by Northern blot using BC1 unique DNA 
probe, revealing differences of BC1MS2B RNA expression in the different transgenic mice. In the 
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homozygous BC1MS2B+MS2TAP_BC1 RNA-/- (mice #5 &.#10), we detected only BC1MS2B RNA, 
whereas heterozygous BC1MS2B+MS2TAP_BC1 RNA+/- (mouse #18) showed BC1MS2B RNA along 
with endogenous BC1 RNA.  
Fig 3.13 Northern blot shows the expression of BC1MS2B RNA in BC1MS2B transgenic mouse. Total 
RNA was extracted from two independent founders containing the gene encoding BC1MS2B RNA. RNAs 
were separated on a 6% polyacrylamide/7 M urea gel, transferred onto a nylon membrane and probed 
against BC1 unique oligonucleotide (Table 1). BC1MS2B transgenic mice showed weak expression of the 
expected size (~220 nt) (mouse #5, #10 & #18) of BC1MS2B RNA compared to the wild type mice. Multi-
copy transgene integrated mice showed no expression of the BC1MS2B RNA (mouse #7) where as low 
transgene copy integrated mouse showed the expression of BC1MS2B RNA (mouse #5, #10 & #18). In 
order to avoid the native BC1 RNA competition, BC1MS2B transgenic mice were crossed with BC1KO 
(BC1 RNA-/-) mice until the native BC1 RNA was absent from the transgenic mice. Northern blot also 
revealed the difference between the homozygous BC1 RNA-/- background vs BC1 RNA+/-. Homozygous 
BC1 RNA-/- background transgenic mouse brain showed only BC1MS2B RNA expression (mouse #5 & 
10), in heterozygous BC1 RNA+/- mice, endogenous BC1 RNA expression and transgenic BC1MS2 RNA 
expression was observed (mouse #18). Prior to transfer, the gel was stained with ethidium bromide as a 
control for sample loading (not shown). Exposure time for the blot was about 3 days.  
Another approach in confirming the genotype of the presumptive homozygous to BC1MS2B Tg/Tg 
and MS2TAP.Tg/Tg mice was based on test crossing (statistical genetics). In this approach of test crossing, 
confirmation was accomplished by mating between the presumptive homozygous mice with a non-
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transgenic [wild type (+/+)] partner. If the mouse in question is only a Tg/+ heterozygote, one would expect 
equal numbers of Tg/+ and +/+ (wild type) offspring. If the transgenic mouse was homozygous, all the 
offspring would be heterozygous and could be easily distinguished by PCR analysis and were confirmed by 
Southern blot analysis. 
Fig 3.14 Southern blot demonstrating 
the integration of MS2TAP protein gene 
in BC1MS2B+MS2TAP_BC1 RNA-/-
background. Southern blot analysis of 
BamHI-digested mouse genomic DNAs 
revealed the MS2TAP fragment integration 
into the mouse genome. The probe used for 
identification of MS2TAP was 3' end of ?-
Actin MS2TAP gene (~1.2 kb). The upper 
band around ~3.6 kb correspond to the 
transgenic construct fragment to the 5' 
region and the 0.9 kb correspond to the 3' 
transgenic BamHI- digested DNA 
fragment. Exposure time for the blot was 
overnight (about 12 - 14 hours).
3.12 Affinity purification of BC RNPs from BC1MS2B+MS2TAP in 
endogenous BC1 RNA depleted & BC200MS2+MS2TAP transgenic mice 
Various biochemical methods have been used for purification and isolation of BC RNPs, most of 
them are not successful yet to purify or identify all the proteins bound to these RNP complexes. Therefore, 
we sought to develop a general method for purification of endogenously assembled BC RNPs in vivo and in 
transgenic mouse system. Therefore, we had tagged these RNAs with MS2 motifs and the corresponding 
MS2 coat protein was fused to TAP tag protein. This method represents itself as a RNA tag based affinity 
purification for purification of BC RNP complexes. Affinity purification has been used successfully to purify 
the affinity tagged proteins without disturbing the native structure. Therefore, we assumed affinity tags could 
serve the purpose of BC RNP purification. 
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To our knowledge, the purification of BC1 or BC200 RNPs using RNA tag based affinity 
purification is an advanced affinity purification strategy of endogenously assembled RNPs from the mouse 
brain extract. This generalized method of purification can be easily adapted to other non-protein coding 
RNAs (npcRNAs) to achieve high purification. 
3.13 RNA/RNP integrity is the most important step in RNP affinity purification 
We evaluated the MS2 tagged BC1MS2B+MS2TAP_in BC1 RNA-/- and BC200MS2+MS2TAP 
RNP complex formation in the mouse brain and compared with wild type and BC200 transgenic mouse brain 
extracts. We used DEAE ion-exchange chromatography, where BC1 and BC200 RNP complexes were 
partially purified using DEAE chromatography from wild type and BC200 transgenic mouse brain extracts. 
DEAE purification showed RNA/RNP integrity at 200 – 300 mM KCl concentration, where second round of 
300 mM KCl concentration, the RNP complex was partially dissociated (Muddashetty et al., 2002). 
Therefore, S2 fractions of mouse brain extracts were used for binding to DEAE matrix for partial purification 
of BC MS2 RNP complexes. Same conditions were maintained for binding and washing. Complexes were 
eluted with 200 – 300 mM KCl concentration and checked for RNP integrity, by performing native gel 
eletrophoresis. Fig 3.15 shows transgenic mouse brain extracts (BC1MS2B+MS2TAP_in BC1 RNA-/- and
BC200MS2+MS2TAP) partially purified from DEAE elutes, showed the intact RNP migrates as of wild type 
and BC200 transgenic mouse brain DEAE elutes. 
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Fig 3.15 Autoradiograph of a native gel shows the RNP complex. RNP complex formation from brain 
extracts of wild type mice compared to BC1MS2B+MS2TAP transgene and BC200 transgene compared to 
BC200MS2+MS2TAP transgene where brain extracts were partially purified using DEAE ion–exchange 
resin and eluted with 200 mM and twice with 300 mM KCl concentrations. The RNP complexes were 
separated on a native gel, transferred on to a nylon membrane and probe with unique probes for BC1 or 
BC200 RNAs respectively (Table 1). The complex was stable at low concentrations of salt (200 mM). After 
the second elution with 300 mM KCl concentration, the BC RNP complex is partially dissociated. 
Note: BC1MS2B+MS2TAP and BC200MS2+MS2TAP brain extracts were concentrated to attain a 
comparable signal with wild type and BC200 brain extracts. Exposure time for the blot was over night (about 
12 hours). 
3.14 Initial attempt in purification of BC RNPs using TAP method from 
BC1MS2B+MS2TAP_in BC1 RNA-/- and BC200MS2+MS2TAP transgenic 
mouse brain. 
The RNP integrity is the most important step in purification of any RNP complex, Native gel 
electrophoresis showed intact RNP particles of BC MS2 RNP complexes. Therefore, we attempted to purify 
the BC MS2 RNP complexes using the TAP method. The TAP purification is a two-step affinity purification 
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developed by Bertrand Seraphin (Rigaut et al., 1999), it contains ProtA tag, TEV cleavage recognition site 
and CBP tag. The CBP tag allows for efficient selection and specific release from the affinity resin under 
mild conditions. In contrast, ProtA can be released from the matrix-bound IgG only under denaturing 
conditions at low pH, therefore, TEV protease recognition sequence was inserted, which has been 
specifically cleaving the ProtA from CBP tag under native conditions. 
Fig 3.16 An RNA tag based affinity purification of BC1 and BC200 RNP complexes using TAP method. 
Mouse brain extracts (S100) were used for affinity purification. Proteins present in final TAP purification 
(lanes 4 and 9). First affinity purification of RNP complexes IgG bound resin after wash with IPP buffer. 
(lanes 1 and 5). Before TEV protease cleavage treatment (lanes 2 and 7). After TEV protease cleavage 
treatment (lane 3 and 8). Lane 6 is after TEV cleavage IgG bound resin. 
Using the DEAE eluted fractions, (we exlcuded the second 300 mM KCl elution – as the RNP was 
partially dissociated) (Fig 3.15) of BC RNP complexes from the BC1MS2B+MS2TAP_ in BC1 RNA-/- and 
BC200MS2+MS2TAP brain extracts, we attempted to purify the complexes using TAP methodology. DEAE 
eluted fractions were first incubated with Protein-G sepharose for 2 - 3 hours at 4 °C, washed the Protein-G 
sepharose matrix with IPP buffer (15 ml) [25 mM Tris pH 8.0., 200 mM KCl, 0.1% NP-40, 1 mM DTT, 3 
mM MgCl2 and protease inhibitor]. Followed by TEV protease treatment for 2 hours at room temperature 
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(16-25 °C) and 4 °C over night. Followed by eluting the TEV cleaved protein from the matrix and bind it to 
the CAM sepharose for 2 - 3 hours. CAM matrix was washed with [25 mM Tris pH 8.0., 200 mM KCl, 1 
mM DTT, 3 mM MgCl2, 1 mM Mg acetate, 1 mM imidazole, 2-5 mM CaCl2 and 10 mM ß-mercaptoethanol] 
and finally eluted the RNP complexes with [25 mM Tris pH 8.0., 200 mM KCl, 20 mM EGTA, 3 mM 
MgCl2, 1 mM Mg acetate, 1 mM imidazole, 3 mM CaCl2 and 10 mM ß-mercaptoethanol] and TCA 
precipitated the RNP complexes. . Fractions were run by 12% polyacrylamide gel electrophoresis containing 
sodium dodecyl sulfate (SDS-PAGE). Aspects of the MS2TAP system might be functional as a band in the 
right size range of full-length MS2TAP fusion protein (39. 3 kDa) is observed prior to TEV protease (Fig
3.16). After TEV protease treatment, where TEV protease removes the IgG portion leaving the CBP tag with 
the MS2 domain. The expected molecular size of the remaining portion of the fusion protein after TEV 
treatment is about ~28 kDa, which was observed in our test run of purification. Since the expression levels of 
both RNAs in transgenic mice are relatively low, we need large amounts of mouse brain extracts to obtain 
sufficient amounts of the proteins bound to the BC RNP complexes for sequence analysis. 
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Fig 3.17 Schematic representation of Tandem Affinity Purification (TAP) of BC RNPs 
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3.15 Subcellular-localization of BC MS2 RNAs in BC1MS2B+MS2TAP in BC1 
RNA-/- and BC200MS2+MS2TAP transgenic mice. 
The rodent specific BC1 RNA and the anthropoid specific BC200 RNA are exclusively expressed in 
the nervous system. The distribution of both the RNAs showed a clear dendritic localization in the brain. We 
want to check that the MS2 tagged BC RNAs were transported to dendrites similar to native BC RNAs in 
mouse brain sections. In situ hybridization on coronal sections through the hippocampus of 
BC1MS2B+MS2TAP_in BC1 RNA-/- and BC200MS2+MS2TAP transgenic mice using sense (S) and 
antisense (AS) probes, were designed against the unique regions of BC1 RNA and BC200 RNA, revealed the 
tagged RNA localization was restricted to the cell bodies and were not detected in dendrites. The expression 
pattern in the transgenic mice [BC1MS2B+MS2TAP_in BC1 RNA-/- and BC200MS2+MS2TAP] revealing, 
the MS2 tagged BC RNAs were localized in the CA1, CA2 and CA3 pyramidal cells of the hippocampus. 
Both the BC RNAs were present in somatic cytoplasm of the dendrites. Dendritic localization of these RNAs 
was restricted to cytoplasm but not in the nucleus (Fig 3.18 & 3.19). There could be two reasons for these 
observations: the expression level of the MS2 tagged BC RNAs is too low in transgenic mice to detect them 
in dendrites or tagging these RNAs abolishes transport of these RNAs into dendrites. 
Though the RNA expression levels of these two transgenic mice (BC1MS2B+MS2TAP_in BC1 
RNA-/- and BC200MS2+MS2TAP) were very weak compared to the wild type mice and BC200 transgenic 
mice, we still observed a similar expression pattern of the BC1MS2B and BC200MS2 RNA in the 
corresponding transgenic mice. Both transgenic mice (BC1MS2B+MS2TAP_in BC1 RNA-/- and 
BC200MS2+MS2TAP) on in situ hybridization using unique oligoribonucleotide probe designed against 
BC1 and BC200 RNA revealed that CA1, CA2 and CA3 showed similar localization pattern, compared to the 
BC1 and BC200 RNA. There is little or no expression in the granular cells of the dentate gyrus (DG) was 
observed in BC1MS2B+MS2TAP_BC1 RNA-/- and BC200MS2+MS2TAP, similar to the wild type mice and 
BC200 transgenic mice.  
67
Results 
?
BC1MS2B_TAP_in BC1 RNA-/-_AS_4X Hippo           BC1MS2B_TAP_ in BC1 RNA-/-_S_4X Hippo 
BC1MS2B_TAP_in BC1 RNA-/-_AS_10X CA1          BC1MS2B_TAP_ in BC1 RNA-/-_S_10X CA1 
BC1MS2B_TAP_in BC1 RNA-/-_AS_20X CA2          BC1MS2B_TAP_ in BC1 RNA-/-_S_20X_CA2 
BC1MS2B_TAP_in BC1 RNA-/-_AS_20X CA3          BC1MS2B_TAP_ in BC1 RNA-/-_S_20X_CA3 
Fig 3.18 BC1 RNA in situ hybridization in BC1MS2B+TAP_in endogenous BC1 RNA depleted 
transgenic (BC1 RNA-/-) mice. Non-radioactive in situ hybridization with DIG labeled BC1 unique 
oligoribonucleotide probes on coronal sections of BC1MS2B+MS2TAP transgenic mouse brain. In 
the hippocampus, there is labeling in the cell bodies and dendrites of areas CA1, CA2 and CA3, while 
the dentate gyrus granule cells are not labeled. The higher magnification of CA1, CA2 and CA3 
showed staining only in the proximal regions of dendrites not up to distal parts of the dendrites. The 
BC1 sense probe did not show any signal. 
68
Results 
?
BC200TAP_AS_4X_Hippo         BC200TAP_S_4X_Hippo 
? ? BC200TAP_AS_20X_CA1   ? ??????BC200TAP_S_20X_CA1 
? ? BC200TAP_AS_20X_CA2  ? ? ??????BC200TAP_S_20X_CA2 
? BC200TAP_AS_20X_CA3  ? ? ??????BC200TAP_S_20X_CA3
Fig 3.19 BC200 RNA in situ hybridization in BC200MS2+MS2TAP transgenic mice. Non-
radioactive in situ hybridization with DIG labeled BC200 unique oligoribonucleotide probes on 
coronal sections of BC200MS2+MS2TAP transgenic mouse brain. In the hippocampus, there is 
intense labeling in the cell bodies and dendrites of areas CA1, CA2 and CA3, while the dentate gyrus 
granule cells are not labeled. The higher magnification of CA1, CA2 and CA3 showed staining only 
in the proximal regions of dendrites. The BC200 sense probe did not show any signal. 
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3.16 Subcellular-localization of MS2TAP fusion protein on coronal sections of 
transgenic mouse brain
To determine the localization and expression pattern of the MS2TAP protein in 
BC1MS2B+MS2TAP_in BC1 RNA-/- and BC200MS2+MS2TAP transgenic mice, we performed 
immunocytochemical localization utilizing antibodies against MS2 and HA as MS2 domain and HA peptide 
are part of the MS2TAP fusion protein in transgenic mice. PABP was used as positive control in this 
experiment (Muddashetty et al., 2002). Immunocytochemistry was performed with DAB (diaminobenzidine) 
substrate on the mouse brain coronal sections. MS2, HA-immunoreactivity (MS2-IR and HA-IR) was found 
uniformly distributed in all neuronal cell populations of all brain areas examined, with exception of little 
difference in staining with HA-immunoreactivity, where hippocampus was not stained as much as with MS2 
and PABP. MS2, HA and PABP immunoreactivity was found in somal cytoplasm. Intense immunoreactivity 
was observed in hippocampus of pyrimidal cells and in the cells of the dentate gyrus. Immunoreactivity is 
roughly equal in both transgenic mice (BC1MS2B+MS2TAP_in BC1 RNA-/- and BC200MS2+MS2TAP) 
with MS2 and HA antibodies and with PABP [as positive control]. In the experiment pre-immune sera of 
MS2 antibody and PABP antibody was used as a negative control (data not shown because we did not 
observe any immunoreactivity). 
In wild type mice and BC1MS2B+MS2TAP_in BC1 RNA-/- transgenic mice, PABP and MS2 (both 
antibodies raised in our lab) had shown analogous localization pattern. Intense dendritic staining was 
observed in stratum radiatum of CA3 and significant but less staining in CA1 and CA2. In case of HA 
antibody, very intense staining had been observed in the CA3 region of hippocampus only and only weak or 
no staining in the CA1 and CA2 regions (Fig 3.20). Dentate gyrus also shows intense staining in case of HA 
antibody with significant but less staining with PABP and MS2 antibodies. The reason for the differential 
staining is not known; it is possible that the HA peptide antibody might be more accessible to the CA3 layer 
as compared to PABP and MS2 antibodies.  
In BC200 and BC200MS2+MS2TAP transgenic mouse brain coronal sections with PABP, MS2 and 
HA antibodies have shown similar immunoreactivity (IR) (Fig 3.21) and intense staining with DAB 
(diaminobenzidine) substrate compared to wild type mice and BC1MS2B+MS2TAP_in BC1 RNA-/-
transgenic mice. 
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 wild type_anti-PABP      wild type_anti-PABP 
BC1MS2B_MS2TAP_in BC1 RNA-/-_anti-PABP BC1MS2B_MS2TAP_in BC1 RNA-/-_anti-PABP 
BC1MS2B_MS2TAP_in BC1 RNA-/-_anti-MS2 BC1MS2B_MS2TAP_in BC1 RNA-/-_anti-MS2 
BC1MS2B_MS2TAP_in BC1 RNA-/-_anti-HA BC1MS2B_MS2TAP_in BC1 RNA-/-_anti-HA 
Fig 3.20 Immunocytochemistry of MS2TAP protein in BC1MS2B+MS2TAP_in endogenous 
BC1 RNA depleted (BC1 RNA-/-) transgenic mice and wild type mice. Immunocytochemistry of 
MS2TAP protein localization and expression pattern on coronal sections of wild type mice and 
BC1MS2B+MS2TAP_in BC1 RNA-/- transgenic mice brain sections through the hippocampus region. 
Immunoreactivity (IR) was observed with DAB (diaminobenzidine) substrate in both cytoplasm and 
in dendrites with MS2, HA antibodies and PABP as a positive control. There is intense staining in all 
the regions of hippocampus, CA1, CA2 and CA3 also the cells in the dentate gyrus with MS2, HA 
and PABP antibodies. 
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BC200_anti-PABP  BC200_anti-PABP 
BC200MS2+MS2TAP_anti-PABP   BC200MS2+MS2TAP_anti-PABP 
BC200MS2+MS2TAP_anti-MS2   BC200MS2+MS2TAP_anti-MS2 
BC200MS2+MS2TAP_anti-HA   BC200MS2+MS2TAP_anti-HA 
Fig 3.21 Immunocytochemistry of MS2TAP protein in BC200MS2+MS2TAP and BC200 
transgenic mice. Immunocytochemistry of MS2TAP protein localization and expression pattern on 
coronal BC200 transgenic mouse and BC200MS2+MS2TAPtransgenic mouse brain sections through 
the hippocampus region. Immunoreactivity (IR) was observed with DAB (diaminobenzidine) 
substrate in both cytoplasm and in dendrites with MS2, HA antibodies and PABP as a positive 
control. There is intense staining in all the regions of hippocampus, CA1, CA2 and CA3 also the cells 
in the dentate gyrus with MS2, HA and PABP antibodies. 
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Hu proteins are the potential protein partners of BC RNP complexes 
3.17 Hu proteins are the potential protein partners of BC RNP complexes
In recent years it has become apparent that post transcriptional mechanisms plays an important role 
in controlling a number of neural specific genes. These processes include translation, translational repression, 
transport and stabilization mechanism. ELAV/Hu proteins constitute a family of RNA-binding proteins that 
participate in the post-transcriptional control mechanisms of several neural genes. The Hu genes encode a 
large number of alternatively spliced transcripts to produce a series of related neuron-specific RNA-binding 
proteins named as HuA/R, HuB/HelN1 (Levine et al., 1993), HuC and HuD (Okano and Darnell, 1997). 
These are a family of highly similar RNA-binding proteins that are conserved among vertebrate species and 
share sequence similarity with the Drosophila genes sxl (sex lethal) and elav (embryonic lethal abnormal 
vision). The elav gene is essential for the normal development of the embryonic nervous system. HuB is 
present in neurons and in gonads; HuC and HuD are restricted to neurons. These proteins contain three RNA 
recognition motifs (RRMs) and are known to bind AU- rich elements (AREs) in 3' untranslated regions 
(UTRs) of several mRNAs like GAP-43, c-myc, c-fos and neuroserpin etc (Barreau et al., 2005, Bolognani et 
al., 2004, Chagnovich et al., 1996, Cuadrado et al., 2002, Mobarak et al., 2000, Hinman and Lou, 2008). The 
mouse homolog of HuB (mHuB) has been reported to bind to a GAA-rich sequence (Abe et al., 1996). Hu 
proteins were originally identified as early markers of neuronal differentiation. Recent studies indicate that 
HuD is involved in learning and memory (Hinman and Lou, 2008). Using several complementary 
approaches, we have shown that HuB, HuC and HuD might interact with BC RNAs in vitro. Thus, Hu 
proteins could be some of the potential protein partners of BC RNP complexes. 
3.18 Immunoprecipitation of BC RNAs with antibodies against Hu proteins
In order to determine the interaction of Hu proteins with BC RNP complexes, we have 
immunoprecipitated RNP complexes using Hu antibodies (gift from Dr. C. Durga Rao, Indian Institute of 
Sciences, Bangalore, India). Among the three Hu proteins, HuB had efficiently precipitated BC1 RNA but 
not BC200 RNA, whereas HuC and HuD antibodies had shown very weak precipitation of both the RNAs 
(Fig 3.22). This weak precipitation may be due to the antibody titer or due to weak or no interaction with the 
BC RNAs. As pre-immune serum of HuB, HuC and HuD were not available, which will provide a better 
solution (picture) to imagine that weather the precipitation of BC RNAs found in HuB was due to the 
interaction with the HuB or an artifact. Further experiments were not carried out because, lack of antibodies.  
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Fig 3.23 Immunoprecipitation (IP) of BC RNAs from BC200 transgenic mouse brain (S2 fraction) extracts 
with Hu antibodies. In vitro transcribed BC1 and BC200 RNAs were loaded as a control. Anti-PABP 
antibody was used as a positive control, where both the RNAs are efficiently precipitated. A pre-immune 
serum of PABP was used as a negative control. The extracted RNAs were separated on a 6% 
polyacrylamide/7 M urea gel and hybridized with oligonucleotide complimentary to the unique region of 
BC1 and BC200 RNAs (Table 1).
3.19 Localization and expression of Hu proteins in mouse brain 
To understand the role role of Hu proteins in the brain, we performed immunocytochemical 
localization of Hu proteins using Hu antibodies (HuB, HuC and HuD) on mouse brain coronal sections of 
wild type, BC1MS2B+MS2TAP_in BC1 RNA-/- transgenic mice and BC200 transgenic mice and 
BC200MS2+MS2TAP transgenic mice. HuB, HuC and HuD-immunoreactivity (HuB-IR and HuC-IR and 
HuD-IR) was found uniformly distributed in all neuronal cell populations of all brain areas examined. A very 
intense immunoreactivity was observed in the hippocampus region of all mouse sections with HuB, HuC and 
HuD. HuB-IR, HuC-IR and HuD-IR immunoreactivity was found in cytoplasm. Intense immunoreactivity 
was observed in all regions of hippocampus, CA1, CA2 and CA3 and also the cells in the dentate gyrus. 
Immunoreactivity is approximately equal in all mice brain sections (wild type, BC1MS2B+MS2TAP_in BC1 
RNA-/- and BC200 and BC200MS2+MS2TAP) with HuB, HuC and HuD antibodies. In this experiment pre-
immune sera of HuB, HuC and HuD antibody was not available, hence we used MS2 pre-immune sera, as a 
negative control (data not shown because we did not observe any immunoreactivity). 
As shown in (Fig 3.24 & 3.25) HuB, HuC and HuD had similar localization signal in the cells of 
CA1, CA2 and CA3 region and also in the cells of dentate gyrus. The signal was observed in the cell bodies 
and in the dendrtic fields. This exhibits that the dendritic compartments in the different regions are equipped 
with Hu proteins. 
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Fig: 3.24 Localization of Hu proteins (HuB, HuC and HuD) in wild type and 
BC1MS2B+MS2TAP_in BC1 RNA-/- transgenic mouse brain coronal sections of hippocampus. 
Immunoreactivity (IR) was observed with DAB (diaminobenzidine) substrate in both cytoplasm and 
in dendrites with HuB, HuC and HuD antibodies. There is intense staining in all regions of 
hippocampus, CA1, CA2, CA3 and the cells in dentate gyrus. 
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Fig: 3.25 Localization of Hu proteins (HuB, HuC and HuD) in BC200 and BC200MS2+MS2TAP 
transgenic mouse brain coronal sections of hippocampus. Immunoreactivity (IR) was observed with 
DAB (diaminobenzidine) substrate in both cytoplasm and in dendrites with HuB, HuC and HuD 
antibodies. There is intense staining in all regions of hippocampus, CA1, CA2, CA3 and the cells in  
dentate gyrus. 
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In order to show that Hu proteins might interact directly with BC RNAs and might be part of BC 
RNP complexes, we performed Electrophoretic Mobility Shift Assays (EMSAs) or gel- retardation assays. 
Radio labeled (32P-labeled) BC RNAs (see Materials and Methods – section 2.2 a) were incubated with 
increasing concentration of full-length recombinanat Hu proteins (HuB, HuC and HuD) from 5 nM to 500 
nM and fixed concentrations of radio labeled BC RNAs (0.01 picomole for BC1 RNA and 0.015 picomole 
for BC200 RNA) and run on 6% polyacrylamide gel [native conditions]. Our results show that Hu proteins 
(HuB, HuC and HuD) might interact as Hu proteins are known to bind A-rich regions and AU rich regions. It 
is tempting that Hu proteins might bind to BC RNAs (BC1 RNA and BC200 RNA) that harbor internal A-
rich regions and AU rich regions. Both 32P-labeled BC RNAs bind to the recombinant HuB, HuC and HuD 
proteins with different affinities (K50) was shown (Fig 3.26). HuD has high affinity (approximate K50 ~30 
nM) with both BC RNAs, whereas HuC has intermediate affinity (approximate K50 ~250 nM) and HuB has 
low affinity (approximate K50 ~500 nM) [BC1 RNA showed further low affinity compared to BC200 RNA]. 
Fig 3.26 Electrophoretic mobility shift assays (EMSAs) showing binding of recombinant HuB, HuC, and 
HuD to BC RNAs. Binding experiments were performed using a fixed concentration of 32P labeled RNA 
probe (10 nM) with a range of protein concentrations, indicated in nM. The first lane in each case represents 
the positive control with PABP protein (15 nM) except in BC200 with HuC. The second lane is free RNA 
(without any protein).
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3.20 Hu expression and cross reactivity 
There were reports that Hu genes encode a large number of alternatively spliced transcripts to 
produce a series of related neuron-specific RNA binding proteins, HuA/R, HuB, HuC and HuD. These 
proteins show high sequence similarity and high cross reactivity. We examined the reactivity of Hu 
antibodies with wild type and BC200 transgenic mouse brain extracts (S2 fraction), from Western blot 
analysis that Hu proteins may be part of BC RNP complex (Fig 3.27). In order to determine weather these Hu 
antibodies were cross reacting with poly(A)-binding protein, we performed immunoblotting and confirmed 
that Hu antibodies were cross reacting among each other but not with poly(A)-binding protein (PABP). 
Further experiments are required to confirm that Hu proteins can be the potential protein binding partners of 
BC RNAs. 
Fig 3.27 Western blot analysis of Hu protein expression in mouse brain extracts. Hu proteins (HuB, HuC 
and HuD) expressed in mouse brain extracts (S2 fraction) of wild type and BC200 transgenes. Mouse brain 
extracts (S2) were run on 10% polyacrylamide gel electrophoresis containing sodium dodecyl sulfate (SDS-
PAGE), transferred on to polyvinylidene difluoride (PVDF) and probed with polyclonal Hu antibodies. Wild 
type and BC200 transgenic mouse brain extracts showed the presence of Hu proteins. As Hu proteins are 
splice variants, showing cross reactivity among the recombinant purified Hu proteins but not with the 
recombinant purified PABP. 
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Application of SINEs in rodent phylogeny 
3.21 Conserved Presence/Absence Loci (CPAL) of SINEs 
From the CPAL search out of 232 loci, 14 loci were previously reported (Farwick et al., 2006). We 
have selected two loci out of the remaining 218 loci, as this strategy is focusing only on the mouse-related 
clade. In addition, we further extended the species sampling to the previously published 6 loci (2, 5, 8, 13, 14 
& 16) for PCR amplification and found important information concerning phylogenetic relationships among 
rodents.
3.22 Informative SINE-loci from alternative strategies 
As the CPAL search was based on SINE elements in mouse, we further developed alternative 
strategies to resolve the rodent phylogeny applying the mouse based strategy that includes other clades 
(Ctenohystrica and Squirrel-related clade). 
In this search, we have selected mouse intronic sequences and blasted them against available trace 
sequences of Dipodomys ordii, Cavia porcellus and Spermophilus tridecemlineatus. From these we selected 
7 loci from D.ordii, 7 loci from C.porcellus and 3 loci from S. tridecemlineatus for PCR amplification. From 
the 17 loci, we found 21 phylogentically informative presence/absence markers. 
3.23 SINE elements in the Mouse-related clade 
From the CPAL search, we found a B3A element (marker 17), that group together all Muroidea. ID4 
element (marker 18) was found in all three major clades, compromising the Mouse-related clade, 
Ctenohystrica and the Squirrel-related clades, supporting rodent monophyly (Cao et al., 1994, Farwick et al., 
2006, Huchon et al., 2007, Martignetti and Brosius, 1993b). Previously analyzed markers 2, 5, 8, 13, 14 & 16 
were further extended with newly available rodent species, which were not previously used in our sampling; 
they yielded some additional information. A B1 SINE (marker 2a, Fig 3.28) supports the grouping of 
Muridae, that include Mus musculus, Rattus norvegicus, Gerbillus dasyurus, Psammomys obesus, Meriones 
tristami and Meriones unguiculatus. Two SINEs B3 and a B1-related SINE (marker 8a & 5a, Fig 3.28) also 
supports the grouping Muridae. 
An alternative strategy was developed for Dipodomys (mouse intronic sequences blasted against 
Dipodomys ordii), which yielded very interesting markers, that have not been shown previously. Four SINE 
elements were found, two IDL-Geo and two PB1-Geo, (markers 19 and 23 are IDL-Geo and markers 20 and 
21 are PB1-Geo, Fig 3.28) which is characteristic of the superfamily Geomyoidea, present in Dipodomys 
ordii, Dipodomys californicus, Dipodomys merriami and absent in Heteromys gaumeri, and other rodent 
families in the mouse-related clade. These markers support the classification of Heteromyidae. Three 
retroposed SINEs, two PB1-Geo, and one B1F1 (markers 22, 24 and 25 respectively, Fig 3.28) clustered
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Dipodomys ordii, Dipodomys californicus and Dipodomys merriami and Heteromys gaumeri and were 
absent in other rodents. Thus, these markers support the classification of Geomyoideae, which include 
Geomyidae and Heteromyidae families. 
3.24 SINE elements in Ctenohystrica  
Mouse intronic sequences blasted against Cavia porcellus trace sequences. From the blast, we found 
three orthologous ID4 elements (markers 28, 31 and 32c, Fig 3.28) in all rodents. Thus supporting the 
monophyly of all rodents and the corresponding SINE is absent in lagomorphs selected used as an outgroup. 
Two B1F SINEs (markers 26a and 27a respectively, Fig 3.28) were present in all investigated Ctenohystrica 
except Ctenodactylus gundi, Laonastes aenigmamus and other rodent clades including Mouse-related clade 
and Squirrel-related clade, grouping Caviomorpha and Phiomorpha supporting the grouping of 
Hystricognathi and rejecting the grouping of Laonastes and Hystricognaths. SINE B1 and ID4 (markers 29 
and 30 respectively, Fig 3.28) were found in Cavia porcellus, Dolichotis patagonium and Agouti 
taczanowskii, supporting the grouping of families Caviidae and Agoutidae.Two further integrations, both ID2 
SINEs (markers 27b and 32a, Fig 3.28) grouping Proechimys cuvieri, Myocastor coypus and Capromys 
pillorie and Cavia porcellus, Dolichotis patagonium respectively. 
3.25 SINE elements in the Squirrel-related clade 
In our search, ID-str (marker 33, Fig 3.28) was found in Spermophilus tridecemlineatus and
Aplodontia rufa, but was not found in other rodents. A B1F SINE (marker 34, Fig 3.28) was found in all 
investigated Squirrel-related members, but not in other rodents thus support the monophyly of Squirrel-
related clade. A ID2 SINE found in Spermophilus tridecemlineatus, Marmot marmota and Sclurus vulgaris.
3.26 ID4 SINE and rodent monophyly 
All our search strategies except the Dipodomys ordii biased search, yielded at least one ID4 SINE 
from each search and a total of five ID4 SINE elements, that group all rodents (markers 18, 28, 31, 32 and 
35, Fig 3.28) analyzed. The corresponding loci were empty in lagomorphs, supporting the monophyly of 
rodents.
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Fig 3.28 SINEs retroposed elements as molecular cladistic markers in rodent phylogeny. Roman 
numerals refer to previously discovered multilocus markers (I) Muroidea [B2 SINEs, (Serdobova and 
Kramerov, 1993)], (II) Myodonta [4.5SH RNA, (Gogolevskaya et al., 2005)], (III) Rodents [BC1 RNA, 
(Martignetti and Brosius, 1993b)]. The black circles refer to previously published SINE markers (Farwick et 
al., 2006). SINE retroposed elements found in this study (gray, red and green circles are from strategy I, II 
and III respectively, see Materials and Methods). 
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4.0. Impact of affinity tags on expression of BC RNPs 
RNA-protein (RNP) complexes play fundamental roles in many biological processes. Classical 
example of RNP complex is ribosome, where a number of RNAs and proteins interact with each other in 
complicated manner to carry out an important cellular function, namely protein synthesis. Spliceosome 
complex is another prominent example of RNP complex, where small nuclear RNPs (snRNPs) have an 
essential role in the maturation of pre-mRNA into mRNA. SRP (Signal Recognition Particle) is another 
important complex playing a role in translational elongation arrest and protein secretion. The BC RNPs 
(brain-specific cytoplasmic RNAs/RNPs) namely BC1 and BC200 exclusively expressed in rodents and 
anthropoid primate nervous systems respectively (Cao et al., 2006, DeChiara and Brosius, 1987, Martignetti 
and Brosius, 1993b, Martignetti and Brosius, 1993a). They might function in protein translation in neuronal 
dendrites via translational repression (Kondrashov et al., 2005, Wang et al., 2005). 
To date, close to a dozen proteins have been reported to be components of BC1 RNP complex, most 
of them are in vitro or interpretational artifacts (discussed in the introduction). General biochemical methods 
namely gel filtration, sucrose gradients, Mono-Q and DEAE affinity purification etc (Muddashetty thesis) 
have been used to enrich the BC1/BC200 RNP complexes. None of these methods could succeed in complete 
purification of BC RNPs. Therefore, we have generated the basis for a generic RNA tag based affinity 
purification for these BC RNPs to identify the proteins bound to these complexes. 
Protein affinity tags namely histidine tag, glutathione-S-transferase (GST) tag, FLAG tag etc., are 
fused to the protein of interest for purification and detection (localization) purposes. Unlike protein affinity 
tags, RNA affinity tags were not frequently used to purify the RNP complexes assembled endogenously. But 
recently RNA affinity tags have been started coming into the picture, where RNA-protein interactions like 
MS2/MS2 coat protein, ? phage N anti-terminator protein, PP7 coat protein (Lim and Peabody, 2002, 
Peabody, 1990, Tars et al., 2000) are the most prominent examples of this kind. Based on the MS2 coat 
protein, we generated a TAP tag fusion protein that should bind to MS2 RNA stem tagged BC RNPs for 
purification and localization. 
In general, the tag should be placed at the 3' end or 5' end of the RNA for either purification or 
detection. The folding problem is simply a matter of inserting the tag in such a way that both the tag and 
RNA of interest should fold correctly. Furthermore, the tagged RNA’s expression level should not be too low 
when introduced into the system (in vivo, ex vivo or in vitro). So keeping this information in our mind, we 
had tagged BC1 and BC200 RNAs with two MS2 aptamers at the 3' end and the corresponding MS2 coat 
protein fused to the TAP tag.
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4.1 Characterization of tagged BC RNAs in transgenic mice 
The three main factors (I) folding (II) steric hindrance and (III) keeping the tag (not losing the tag 
from BC RNAs) to the RNAs from processing to study either localization or purification were considered 
while tagging MS2 motifs to the BC RNAs. There are reports that minimum two MS2 stem motifs are 
required to bind efficiently to MS2 coat protein (Ko and Gunderson, 2002). Therefore, in our study two MS2 
stem motifs were used to tag BC RNAs or the MS2 stems were placed internal to BC1 RNA. The folding of 
BC RNAs with MS2 stems are shown in (Fig 3.0 & 3.1). BC1 RNA with two MS2 stems showed no 
apparent interference with folding of the predicted BC1RNA structures with MS2 stem motifs. While mfold 
application showed a different folding of BC200 RNA with two MS2 stem motifs (data not shown). 
The MS2 coat protein is fused to TAP tag (Rigaut et al., 1999) for two step affinity purification. 
Figures 3.0, 3.9 & 4.0. shows the chimeric RNAs (BC1 with two MS2 stems and BC200 with two MS2 
stems) and the MS2 TAP protein complexes (BC1MS2/MS2TAP and BC200MS2/MS2TAP) respectively. 
Fig 4.0 Predicted model showing the BC RNAs tagged to MS2 motifs and the fusion protein MS2TAP 
complexed with BC RNPs. The MS2 RNA motifs [green] internal to BC1 RNA [blue] and at the 3' end of 
BC200 RNA [purple] are shown. MS2 coat protein [green half oval] fused to TAP tag contains CBP tag 
[calmodulin binding peptide - purple] and protein A [ProtA – magenta] separated by TEV protease site 
[tobacco etch virus -red] are shown. The MS2TAP fusion protein bound to the MS2 RNA motif to facilitate 
affinity purification of the respective BC MS2/MS2TAP RNP complexes. Model also exhibit PABP 
(poly(A)-binding protein) bound to both BC RNAs and in addition to SRP9/14 (signal recognition particle) 
bound to BC200 RNA and the other protein partners bound to the BC RNAs at different places is in question 
mark. 
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We have cloned the chimeric RNAs, BC1MS2 and BC200MS2 under the native promoter of the BC1 
and BC200 RNA genes, respectively. The MS2TAP protein cloned under the ?-actin promoter, which was 
previously used in our lab and showed high expression in transgenic mice (Khanam et al., 2007a). For our 
convenience both the RNA expressing and the protein expressing cassettes initially were cloned into a single 
plasmid (discussed in Materials & Methods, section 1.13. and Results 1.5).The combined construct was used 
in NIH 3T3 transfections, both RNA and protein were expressed at relatively high levels (Fig 3.3 & 3.4).
Therefore, we generated transgenic mice for the in vivo purification and the localization. We failed to detect 
BC1MS2 RNA expression in transgenic mouse brain extract in any of the BC1MS2 [MS2 at 3' end] 
transgenic mice generated (Fig 3.5). But MS2TAP protein was expressed in all transgenes analyzed from the 
same transgenic mice (Fig 3.6). This may be due to several reasons (I) processing of BC1MS2 RNA, which 
can not be ruled out, even though we have not observed any processed RNA in our transgenic mice, but from 
the NIH 3T3 stably transfected cells, we observed processing as removal of the MS2 stems from the 3' end 
(Fig 3.8). (II) locus of integration (III) promoter hindrance and transcription termination. These reasons will 
be discussed later. To answer these questions we had generated BC200MS2 transgenic mice. A weak 
expression of full length BC200 RNA with MS2 tag and BC200 RNA without MS2 tag was observed, 
revealing that the MS2 tag was being removed in case of BC200MS2 RNA and that this could have happened 
analogously for BC1MS2. 
In order to achieve the expression of BC1MS2 RNA in transgenic mice, we placed the tag internal to 
BC1 RNA. There are two reasons behind changing the MS2 tag position into the center (I) 3' processing of 
the transcript, has been obsereved in case of BC1MS2 stably transfected NIH 3T3 cells (Fig 3.8), where MS2 
tag has been partially removed from the BC1MS2 transcript and also other parallel evidences like 
BC200MS2 transcript also showed a clear processing event and BC200 U6 tag (unpublished, Khanam, 
thesis), where a U6 RNA tag was removed from the 3' end of BC200 RNA. (II) The RNA polymerase 
recycling and transcription efficiency [MS2 stems placed at 3' portion of BC1 RNA, we were unable to detect 
the BC1MS2 RNA expression] will be hindered, if we externally add any structured sequences (Dumpelmann 
et al., 2003, Goodier and Maraia, 1998). For efficient transcription termination and re-initiation of 
transcription for multiple rounds by proficient recycling of the RNA polymerase (pol III), merely depends on 
the terminator sequence. RNA polymerase III transcripts need three or four U residues surrounded by GC rich 
sequences at the 3' end. The disturbance in these sequences leads to low/no expression due to inefficient 
recycling of the RNA polymerase III polymerase (Dumpelmann et al., 2003, Goodier and Maraia, 1998). 
Another factor may also regulate efficient transcription, the folded structure of the transcript depends on the 
spatial proximity of the 3' and 5' end of the RNAs. Considering all these factors stated above, we have placed 
MS2 tag internally of BC1 RNA at two different locations. By using RNA folding algorithm mfold by M. 
Zucker (Fig 3.1), MS2 tag was placed close to the ID stem designated as BC1MS2A (Fig 3.10). MS2 tag 
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placed further 3' - distal to the A22 sequence, designated BC1MS2B (Fig 3.10). We had generated transgenic 
mice from both the constructs and anticipated BC1MS2A/B RNA expression. 
In BC1MS2A transgenic mice, unexpectedly, BC1MS2A RNA expression was not observed in any 
of the founders. The reasons behind no expression of BC1MS2A RNA in BC1MS2A transgenic mice is not 
clear. Interestingly, we found low levels of expression of BC1MS2B RNA in three individual founders of 
BC1MS2B transgenic mice (Fig 3.11); one of the offsprings from one of the founders showed higher 
BC1MS2B RNA expression. This may be due to the position of integration in the mouse genome. 
4.2 Factors influencing the expression of BC RNAs in MS2 tagged mice
In general, transgene expression is influenced by many factors, some are controlled by the elements 
present in the gene itself that is to be integrated others by the locus of integration or the numbers of integrated 
copies (usually in tandem). In BC1MS2 and BC200MS2, we have used the native promoters, because BC1 
and BC200 transgenes had shown high expression by using their native promoters. From another important 
study (Khanam et al., 2007b, Ludwig et al., 2005) on transcription analysis and the role of promoter, we 
learned that removal of upstream promoter elements lead to transcription repression or tissue non-specificity. 
Therefore we have not shortend the 5' flanking sequences in both constructs. Second reason might be the 
tagged RNAs are not efficiently transcribed [need RNA polymerase III polymerase recycling] (Dumpelmann 
et al., 2003) and may be processed as in case of BC200MS2 transgene. Processing the tag was unable to 
predict and difficult to control, this should be studied differently because this needs understanding of the 
structural elements behind the processing, which is not the aim of this work. 
Transgene expression was also influenced by other important factors, which are host dependent and 
difficult to control. We had observed in case of BC1MS2B transgene, where BC1MS2B RNA expression was 
observed only in some transgenic mice but not all. This drives us to think of locus of integration and position 
of integration. In transgenic mice, integration of the interested gene is random and unable to control the site 
of integration and the copy (copies). There are reports about the multiple copies or high copy number 
integration (Davis and MacDonald, 1988, Garrick et al., 1998, Williams et al., 2008) of transgene in to the 
genomic locus leads to no expression of the desired gene. This had been observed in case BC1MS2B 
transgene with multiple copies (Fig 3.12).
(a) Position-Effect Variegation (PEV) 
Transgenes integrated into the genome randomly, is not possible to control the place of integration, 
and varies from individual to individual. Stably integrated transgenes are prone to low expression due to 
position effects that are caused by the site of chromosomal integration (Weiler and Wakimoto, 1995, Garrick 
et al., 1998). Postion of integration might play a major role in controlling the BC1MS2 RNA expression (we 
had not observed any expression when MS2 was placed at the very 3' end of BC1 RNA), same for 
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BC1MS2A RNA expression (MS2 stems closer to the ID domain) in transgenes. An other serious problem, 
we had encountered in establishing BC1MS2B transgenic mice was the transgenes frequently integrate as 
multiple copies in a concatameric array, leading to no expression (Williams et al., 2008). Position of 
integration might not be ruled out the low expression in both the MS2 tagged BC RNAs. Nevertheless, we 
have observed specific BC1MS2B or BC200MS2 RNA expression only in brain. Incase of MS2TAP 
transgenic mice, we observed protein expression in all offsprings of all founders of the MS2TAP transgenic 
mice. We are assuming that the established transgenic mice (BC1MS2B+MS2TAP_ BC1 RNA-/-) might be a 
low copy number transgene (single copy), result in high fusion protein or RNA expression (Williams et al., 
2008). 
(b) Tissue specificity of BC MS2 transgenic mouse line 
In order to determine the MS2 tagged BC RNAs expression in various tissues in the transgenic 
mouse line, we have performed the Northern blot. The total RNA from different tissues of all transgenic 
mouse founders were analyzed and confirmed, that MS2 tagged BC RNAs expressed only in brain not in any 
other tissues. This supports our previous findings that BC200 and G22 transgenic mouse models also showed 
expression of BC200 RNA or G22 RNA only in brain (Khanam et al., 2007b, Ludwig et al., 2005, Skryabin 
et al., 1998). It has been shown that upstream sequence elements in BC1 and BC200/G22 locus are 
responsible for tissue specific expression (Martignetti and Brosius, 1995). BC1 RNA gene 1.4 kb (SacI-
BamHI) and BC200 RNA gene 3.2 kb (EcoRI-HindIII) fragments contains sufficient information to direct 
tissue specific expression. Hence, we have used the same fragment length, when we cloned BC1MS2 and 
BC200MS2 RNA genes. BC200MS2 RNA expression observed only in brain not in other tissues (Fig 3.7)
from BC200MS2 RNA transgenic mouse and BC1MS2B RNA expression also observed only in brain from 
BC1MS2 RNA transgenic mouse (data not shown). 
(c) Establishing BC1MS2B+MS2TAP_in BC1 RNA-/- and BC200MS2+MS2TAP 
transgenic mouse lines 
Over a period of difficulties, we could finally identify the transgenic mice, which expresses 
BC1MS2B RNA (BC1MS2B transgenic mouse) even though expression levels are much lower compared to 
wild type mice for BC1 RNP complex purification with few mice. In case of BC200MS2+MS2TAP, 
expression levels are also weak compared to BC200 transgene (Khanam et al., 2007b), which made it 
difficult to obtain conclusive results in the first trial runs in purification RNP complexes. For purification of 
these complexes, we need lot of mice to obtain the required results. Thus, we need to establish transgenic 
mice, which is homozygous to BC1MS2B RNA+MS2TAP and BC200MS2+MS2TAP transgene. So that the 
resulting transgenic mice may have high probability of RNA/RNP expression. Moreover making the mouse 
line homozygous to transgenes has several advantages. First, all animals born from homozygous parents will 
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be homozygous to transgenes and those animals need not to be checked for the transgene integration and their 
expression. Second, expression level of the transgene is usually doubled in case of homozygous animals, this 
could be helpful incase of dendritic transport of BC1 and BC200 RNA. In case of BC1MS2B+MS2TAP 
transgenic mice, we crossed with BC1 RNA depleted mice to obtain BC1MS2B+MS2TAP_in BC1 RNA-/-
transgenic mice, where we can use unique oligoribonucleotide probe against BC1 RNA for localization of 
BC1MS2B RNA and also eleminate competition of native BC1 RNA/RNP. 
4.3 RNA localization and dendritic transport 
In general RNA localization contributes to cell polarity and synaptic plasticity. Several RNAs have 
been reported to be localized in dendrites, including microtubule-associated protein (MAP2), (Garner et al., 
1988, Kleiman et al., 1990) the ?-subunit of calcium/calmodulin-dependent protein kinase II (?-CAMKII), 
(Miyashiro et al., 1994) Arc protein, (Lyford et al., 1995) and BC1 RNA and many more. Several factors 
influence the localization of these RNAs namely trans acting and cis acting factors. It has been shown that a 
cis acting targeting element is required for BC1 RNA localization into the dendrites (Muslimov et al., 1997). 
There are many evidences that RNAs are transported up to the distal parts of dendrites, where local 
translation takes place. (polyribosomes are found in synaptodendrosome preparations). It has been reported 
that, BC RNAs complex with proteins to form a ribonucleoprotein particle and transported to dendrites and 
their function is not known. Muslimov et al., (Muslimov et al., 2006, Muslimov et al., 2002) had shown the 
chimeric BC1 RNA (5' BC1 chimeric bcd RNA) has been delivered to the distal dendritic domains by 
microinjecting into sympathetic neurons in culture. They further demonstrated that 74nt 5' BC1 stem-loop is 
sufficient to direct distal dendritic delivery of a normally nondendritic RNA (bcd RNA of Drosophila 
melanogaster). However natural in vivo system contradicting the microinjection studies, where 5' ID or the 
full length BC1 RNA was not able to deliver the EGFP message to the dendrites, when inserted into the 3' 
UTR of the reporter mRNA. However the 3' UTR of ?-CamKII mRNA, which is normally found in neuronal 
dendrites, could efficiently target the reporter mRNA to dendrites in vivo (Khanam et al., 2007a). 
Nevertheless, the mechanism behind these BC RNAs transport in vivo/ ex vitro (microinjected cells) still not 
very clear, even though Muslimov et al., had shown that 5' ID region is responsible for transport by dissecting 
most of the nucleotides and precisely pinpointing the U22 and basal stem is responsible for dendritic 
transport. It is still an open question how these RNAs are transported or localized into the real/natural in vivo
system (transgenic mice). For this purpose, we have tagged both the RNAs with MS2 aptamer to study the 
transport besides purification. Furthermore, for future studies at the electron microscope level we need to 
have antibodies available (e.g., MS2) to detect a protein bound to the BC RNAs using the immunogold 
labeling technique (Hoyer et al., 1979, de Harven et al., 1984). 
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In situ hybridization studies on coronal sections of MS2 tagged BC RNAs revealed, thus far, that the 
RNAs are localized in the cell body and are not transported up to the dendrites. Both MS2 tagged BC RNAs 
clearly showed expression in CA1, CA2 and CA3 pyramidal cells of hippocampus (Fig 3.18 & 3.19). We 
have not observed dendritic localization of both MS2 tagged BC RNAs. Expression pattern of both tagged 
BC RNAs was analogous to the BC1 RNA and BC200 RNA expression of wild type mice and BC200 
transgenic mouse model respectively, except the dendritic localization and low expression (Fig 3.18 & 3.19).
Our results from BC200 MS2 transgenic mice, showed that MS2 tag has been processed in BC200MS2 
transgenic mice, we have observed processing of about ?10% - 20% of the full-length RNA as judged by 
Northern blot analysis (Fig 3.7). BC200MS2 tagged RNA is not transported up to neuronal dendrites, it 
remains in the cell body, which was identified by using BC200 unique riboprobe (Fig 3.19). In case of 
BC1MS2 (MS2 at 3' end of BC1 RNA), BC1MS2 RNA was unable to detect in any of the transgenic mice. 
However, MS2 tag when placed internal to the BC1 RNA had shown a weak BC1MS2B RNA expression. In 
BC1MS2B transgenic mice, where processing of the MS2 tag can not be ruled out, even though, we were 
unable to detect the processed form of BC1MS2B RNA also showed similar localization (Fig 3.18) pattern as 
BC200MS2. This analogous expression pattern in both MS2 tagged BC RNAs, revealed that the tagged BC 
RNAs are unable to travel up to the dendrites. The reasons behind the tagged RNA that are unable to 
transport up to the dendrites are not clearly understood. However, our initial studies on the transgenic mice of 
MS2 tagged BC RNAs had promised to reveal the fates of these MS2 tagged BC RNAs dendritic transport, 
which was the previous shown in our laboratory, where 5' portion of BC1 RNA or full length BC1 RNA was 
unable to deliver the message, in natural in vivo systems (Khanam et al., 2007a). 
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Fig. 4.1 A model representing the in vivo fate of BC RNAs with MS2 tag transcripts in neurons of the 
corresponding transgenic mice (BC1MS2B+MS2TAP_BC1 RNA-/- and BC200MS2+MS2TAP). The blue 
with green color shaped structures represents BC1MS2B RNA and purple with green color shaped structures 
represent BC200MS2 RNA. Between the two MS2 stems a short spacer (dark green) was placed for proper 
folding with BC RNAs. MS2 placed internal to BC1 RNA showed no processing of MS2 tag from Northern, 
but the RNA remained restricted to the cell body (Fig 3.18). MS2 placed at 3' end of BC200 RNA showed 
~10 - 20% processing as judged by Northern blot analysis (Fig 3.7) the full length unprocessed BC200MS2 
RNA also remained restricted to the cell body (Fig 3.19).
4.4 Reconstruction of Rodent phylogeny-evidence of SINEs
To date SINE insertion analysis is the most reliable strategy to resolve the phylogenetic tree 
reconstructions, provided several independent markers support the monophyly of each phylogenetic group 
statistically (Waddell et al., 2001). Using SINE insertion analysis generated an ambiguity-free tree 
reconstruction of primate phylogeny (Schmitz et al., 2001, Schmitz et al., 2005). The distribution of rodent 
SINE families and subfamilies (Gogolevskaya et al., 2005, Martignetti and Brosius, 1993b, Serdobova and 
Kramerov, 1998) has contributed to our understanding of rodent phylogeny. However, no significant 
phylogenetic information was available based on the analysis of SINE insertions. Recently (Farwick et al., 
2006) conducted an exhaustive, automated CPAL search to generate phylogenetic informative SINE 
markers in rodents, uncovered 31 SINE elements from 16 genomic loci in 22 rodent species, covering 
representatives of all major rodent clades. The CPAL search requires a well annotated genome, like mouse 
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and an extensive sequence information from a distinct reference species, like human. From alternative 
strategies including search against Dipodomys, Ctenohystrica and Squirrel-realted clades for finding more 
SINE presence/absence patterns, we uncovered diverse phylogentically informative markers. From the 17 
genomic loci from three search stratagies, we found 21 markers from 40 rodent species covering all three 
rodent clades.
Retroposed SINEs offer the most reliable marker system for extrapolating the evolutionary history of 
any phylogenetic tree reconstruction. Their integration in the genome is random and the probability of same 
element integration independently at orthologous positions in different species (orthologous) is very low. We 
have observed this situation in two of our previously published markers (locus 8 and 14), nevertheless both 
elements are from different sources, and are homoplastic (Farwick et al., 2006), and will not cause erroneous 
interpretation of relationships. Previous reports mostly based on nuclear (IRBP) and mitochondrial genes 
(12S rRNA) (DeBry and Sagel, 2001, Murphy et al., 2001) have their own limitations. The presence of 
similar molecules in different species do not represent common ancestry as compared to SINEs at 
orthologous position. 
4.4.1 SINEs in Mouse-related clade 
The mouse-related clade has been divided into three suborders Myomorpha (Myodonta), 
Anomaluromorpha, and Castoriomorpha (Castoridae + Geomyoidae) (Adkins et al., 2003, Huchon et al., 
2002, Murphy et al., 2001). Farwick et al 2006 showed retroposed SINE markers to support the grouping of 
Myodonta and monophyly of this lineage. From our study a B3A SINE revealed the monophyly of 
Myodonta, comprises Muroidea and Dipodidae. Several SINEs (Markers 19, 20, 21, 22, 23, 24) supporting 
the grouping of Geomyoidae and its monophyly, comprise Dipodomys and Heteromys species. Thus far, we 
had not found yet any SINE, which group Castorimorpha. 
4.4.2 SINEs in Ctenohystrica  
There are several phylogenetic relationships within the Ctenohystrica comprising Hystricognathi and 
Ctenodactylidae. The monophyly of Hystricognathi is supported by morphological, paleontological and 
recent molecular data (Farwick et al., 2006, Huchon et al., 2007). Two SINE markers (26a and 27a) PB1 and 
B1F respectively support monophyly of Hystricognathi. Two additional SINEs B1 and ID4 (29 and 30) group 
Caviomorpha. 
4.4.3 SINEs in Squirrel-related clade 
Squirrel-related clade was supported by mitochondrial DNA data (Montgelard et al., 2002) clustering 
Sciuridae + Aplodontidae. From alternative SINE search strategy against Squirrel-related clade, we 
uncovered a new SINE element named ID-Str (Marker 33, See Fig 3.8), which group Sciuridae and 
91
Discussion 
?
Aplodontidae. In addition, we found a B1F SINE (Marker 34, See Fig 3.8), which group Sciuridae, 
Aplodontidae and Gliridae. 
4.4.4 Rodent Monophyly - SINE evidence 
 Morphological classifications showed the order Rodentia a monophyletic group, even though this has 
been challenged by different molecular studies (Graur et al., 1991). Nevertheless the hypothesis of rodent 
paraphyly was disproven immediately (Cao et al., 1994, Martignetti and Brosius, 1993b). Present study 
revealed five ID4 SINEs (Markers 18, 28, 31, 32, 35) supporting the morphological studies i.e. monophyly of 
rodents.
 Table 3 and 4 summarizes the SINE presence/absence information retrieved from CPAL and other 
alternative search strategies respectively. The monophyly of rodents supported by ID4 element (Marker 18, 
28, 31, 32, and 35) is present in all analyzed rodents clades. The monophyly of rodents has previously 
supported by the presence of BC1 RNA in all rodents (Martignetti and Brosius, 1993b). Previous results 
support the monophyly of Mouse-related and Ctenohystrica (markers 13a and 13d) (Farwick et al., 2006). 
Present results revealed the support of hystricognathi (markers 26 and 27) also support the monophyly of 
Squirrel-related clade (marker 34). From this study, we have solved another intriguing problem that is 
grouping of Sciuridae (Squirrel-related clade) which has never been shown previously via retroposon 
evidence. Unfortunately, we have not found any SINE element so far, which resolve the relationship between 
the three major clades – Mouse-related clade; Ctenohystrica; and Squirrel-related clade. 
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Summary and Outlook 
Summary and Outlook 
The MS2-tagged BC1 and BC200 RNA/RNP transgenic mouse models will be very important tools 
to study tagged RNA dendritic transport (dendritic delivery), as well as the composition and function of RNP 
particles, initially via their purification. The homozygous transgenic mouse models 
(BC1MS2B+MS2TAP_BC1 RNA-/- and BC200MS2+MS2TAP) will provide the basis to purify neuronal BC 
RNPs. Then, proteomics (mass spectrometry) can be used to exhaustively characterize the molecular 
compositions of these complexes. In analogy to PABP and its involvement in translation (Kondrashov et al., 
2005, Muddashetty et al., 2002, Wang et al., 2005, Wang et al., 2002), possible known functions of the newly 
uncovered proteins bound to the BC RNAs will aid us in making further progress towards understanding the 
functional significance of BC RNPs.  
The second role of MS2-tagged BC RNAs is to observe the tagged RNPs in dendritic transport using 
antibodies against tagged proteins (e.g., the BC1MS2 RNA and BC200MS2 RNA in combination with 
MS2TAP fusion proteins with the aid of immunoelectron microscopy). In this work, I have established two 
important transgenic mouse lines, which will be vital for carrying out studies on BC RNP composition. This 
approach could also be extended to the purification of any RNA/RNP via tagging. Mice generated with an 
MS2 domain tagged to any RNA could be crossed with our mouse line expressing the TAP tag fusion 
protein, and thus make it possible to characterize any RNP assembled in vivo.
The present analysis of rodent orthologous SINE data contributes to the solution of rodent 
phylogeny. SINE insertions are highly stable and provide a molecular fossil record over the course of 
evolution. Even though previous work showed that SINE insertions and the automated computational 
strategy (CPAL) provide a reliable source of markers to reconstruct the rodent phylogenetic tree, the most 
debated branches within the Squirrel-related clade and within the superfamily Geomyoidea were not yet 
successfully addressed with these analyses. Here we developed alternative screening strategies to resolve the 
highly debated Squirrel-related clade, and also confirmed the monophyly of rodents from SINE insertion 
analyses. The unresolved interrelationships among the three major clades require further investigation. Our 
approach shows that its application is capable of resolving the remaining questions in the phylogenetic 
relationships among rodents, the mammalian order with the most species (about 2277 species with 30-33 
families). 
95
References 
     References 
ABE, R., YAMAMOTO, K. & SAKAMOTO, H. (1996) Target specificity of neuronal RNA-binding protein, 
Mel-N1: direct binding to the 3' untranslated region of its own mRNA. Nucleic Acids Res, 24, 2011-
6. 
ADKINS, R. M., GELKE, E. L., ROWE, D. & HONEYCUTT, R. L. (2001) Molecular phylogeny and 
divergence time estimates for major rodent groups: evidence from multiple genes. Mol Biol Evol, 18,
777-91. 
ADKINS, R. M., WALTON, A. H. & HONEYCUTT, R. L. (2003) Higher-level systematics of rodents and 
divergence time estimates based on two congruent nuclear genes. Mol Phylogenet Evol, 26, 409-20. 
BACHLER, M., SCHROEDER, R. & VON AHSEN, U. (1999) StreptoTag: a novel method for the isolation 
of RNA-binding proteins. RNA, 5, 1509-16. 
BARREAU, C., PAILLARD, L. & OSBORNE, H. B. (2005) AU-rich elements and associated factors: are 
there unifying principles? Nucleic Acids Res, 33, 7138-50. 
BASILE, V., VICENTE, A., MARTIGNETTI, J. A., SKRYABIN, B. V., BROSIUS, J. & KENNEDY, J. L. 
(1998) Assignment of the human BC200 RNA gene (BCYRN1) to chromosome 2p16 by radiation 
hybrid mapping. Cytogenet Cell Genet, 82, 271-2. 
BERTRAND, E., CHARTRAND, P., SCHAEFER, M., SHENOY, S. M., SINGER, R. H. & LONG, R. M. 
(1998) Localization of ASH1 mRNA particles in living yeast. Mol Cell, 2, 437-45. 
BLICHENBERG, A., SCHWANKE, B., REHBEIN, M., GARNER, C. C., RICHTER, D. & KINDLER, S. 
(1999) Identification of a cis-acting dendritic targeting element in MAP2 mRNAs. J Neurosci, 19,
8818-29. 
BLOMMEL, P. G. & FOX, B. G. (2007) A combined approach to improving large-scale production of 
tobacco etch virus protease. Protein Expr Purif, 55, 53-68. 
BOLOGNANI, F., MERHEGE, M. A., TWISS, J. & PERRONE-BIZZOZERO, N. I. (2004) Dendritic 
localization of the RNA-binding protein HuD in hippocampal neurons: association with polysomes 
and upregulation during contextual learning. Neurosci Lett, 371, 152-7. 
BORODULINA, O. R. & KRAMEROV, D. A. (2001) Short interspersed elements (SINEs) from 
insectivores. Two classes of mammalian SINEs distinguished by A-rich tail structure. Mamm 
Genome, 12, 779-86. 
BOVIA, F. & STRUB, K. (1996) The signal recognition particle and related small cytoplasmic 
ribonucleoprotein particles. J Cell Sci, 109 ( Pt 11), 2601-8. 
BOVIA, F., WOLFF, N., RYSER, S. & STRUB, K. (1997) The SRP9/14 subunit of the human signal 
recognition particle binds to a variety of Alu-like RNAs and with higher affinity than its mouse 
homolog. Nucleic Acids Res, 25, 318-26. 
BROSIUS, J. (1999) RNAs from all categories generate retrosequences that may be exapted as novel genes 
or regulatory elements. Gene, 238, 115-34. 
BROSIUS, J. & TIEDGE, H. (1995) Reverse transcriptase: mediator of genomic plasticity. Virus Genes, 11,
163-79. 
BUI, N. & STRUB, K. (1999) New insights into signal recognition and elongation arrest activities of the 
signal recognition particle. Biol Chem, 380, 135-45. 
CAO, X., YEO, G., MUOTRI, A. R., KUWABARA, T. & GAGE, F. H. (2006) Noncoding RNAs in the 
Mammalian Central Nervous System. Annu Rev Neurosci.
CAO, Y., ADACHI, J., YANO, T. & HASEGAWA, M. (1994) Phylogenetic place of guinea pigs: no support 
of the rodent-polyphyly hypothesis from maximum-likelihood analyses of multiple protein 
sequences. Mol Biol Evol, 11, 593-604. 
CHAGNOVICH, D., FAYOS, B. E. & COHN, S. L. (1996) Differential activity of ELAV-like RNA-binding 
proteins in human neuroblastoma. J Biol Chem, 271, 33587-91. 
CHAO, J. A., PATSKOVSKY, Y., ALMO, S. C. & SINGER, R. H. (2008) Structural basis for the 
coevolution of a viral RNA-protein complex. Nat Struct Mol Biol, 15, 103-5. 
CHEN, W., BOCKER, W., BROSIUS, J. & TIEDGE, H. (1997a) Expression of neural BC200 RNA in 
human tumours. J Pathol, 183, 345-51. 
96
References 
?
CHEN, W., HEIERHORST, J., BROSIUS, J. & TIEDGE, H. (1997b) Expression of neural BC1 RNA: 
induction in murine tumours. Eur J Cancer, 33, 288-92. 
CHENG, J. G., TIEDGE, H. & BROSIUS, J. (1996) Identification and characterization of BC1 RNP 
particles. DNA Cell Biol, 15, 549-59. 
CHENG, J. G., TIEDGE, H. & BROSIUS, J. (1997) Expression of dendritic BC200 RNA, component of a 
11.4S ribonucleoprotein particle, is conserved in humans and simians. Neurosci Lett, 224, 206-10. 
CHICUREL, M. E., TERRIAN, D. M. & POTTER, H. (1993) mRNA at the synapse: analysis of a 
synaptosomal preparation enriched in hippocampal dendritic spines. J Neurosci, 13, 4054-63. 
CHURAKOV, G. A. & NOVIKOV, S. N. (2000) Heterogeneity and differential expression of MUP proteins 
as a genetic basis of the physiological activity of androgen-dependent pheromones. Dokl Biol Sci,
375, 549-52. 
CUADRADO, A., NAVARRO-YUBERO, C., FURNEAUX, H., KINTER, J., SONDEREGGER, P. & 
MUNOZ, A. (2002) HuD binds to three AU-rich sequences in the 3'-UTR of neuroserpin mRNA and 
promotes the accumulation of neuroserpin mRNA and protein. Nucleic Acids Res, 30, 2202-11. 
D'ERCHIA, A. M., GISSI, C., PESOLE, G., SACCONE, C. & ARNASON, U. (1996) The guinea-pig is not 
a rodent. Nature, 381, 597-600. 
DANIELS, G. R. & DEININGER, P. L. (1985) Repeat sequence families derived from mammalian tRNA 
genes. Nature, 317, 819-22. 
DAVIS, B. P. & MACDONALD, R. J. (1988) Limited transcription of rat elastase I transgene repeats in 
transgenic mice. Genes Dev, 2, 13-22. 
DE HARVEN, E., LEUNG, R. & CHRISTENSEN, H. (1984) A novel approach for scanning electron 
microscopy of colloidal gold-labeled cell surfaces. J Cell Biol, 99, 53-7. 
DEBRY, R. W. (2003) Identifying conflicting signal in a multigene analysis reveals a highly resolved tree: 
the phylogeny of Rodentia (Mammalia). Syst Biol, 52, 604-17. 
DEBRY, R. W. & SAGEL, R. M. (2001) Phylogeny of rodentia (Mammalia) inferred from the nuclear-
encoded gene IRBP. Mol Phylogenet Evol, 19, 290-301. 
DECHIARA, T. M. & BROSIUS, J. (1987) Neural BC1 RNA: cDNA clones reveal nonrepetitive sequence 
content. Proc Natl Acad Sci U S A, 84, 2624-8. 
DEININGER, P. L., BATZER, M. A., HUTCHISON, C. A., 3RD & EDGELL, M. H. (1992) Master genes in 
mammalian repetitive DNA amplification. Trends Genet, 8, 307-11. 
DREYFUSS, G., CHOI, Y. D. & ADAM, S. A. (1984) Characterization of heterogeneous nuclear RNA-
protein complexes in vivo with monoclonal antibodies. Mol Cell Biol, 4, 1104-14. 
DUMPELMANN, E., MITTENDORF, H. & BENECKE, B. J. (2003) Efficient transcription of the EBER2 
gene depends on the structural integrity of the RNA. RNA, 9, 432-42. 
FARWICK, A., JORDAN, U., FUELLEN, G., HUCHON, D., CATZEFLIS, F., BROSIUS, J. & SCHMITZ, 
J. (2006) Automated scanning for phylogenetically informative transposed elements in rodents. Syst
Biol, 55, 936-48. 
GARNER, C. C., TUCKER, R. P. & MATUS, A. (1988) Selective localization of messenger RNA for 
cytoskeletal protein MAP2 in dendrites. Nature, 336, 674-7. 
GARRICK, D., FIERING, S., MARTIN, D. I. & WHITELAW, E. (1998) Repeat-induced gene silencing in 
mammals. Nat Genet, 18, 56-9. 
GIBBS, R. A., WEINSTOCK, G. M., METZKER, M. L., MUZNY, D. M., SODERGREN, E. J., SCHERER, 
S., SCOTT, G., STEFFEN, D., WORLEY, K. C., BURCH, P. E., OKWUONU, G., HINES, S., 
LEWIS, L., DERAMO, C., DELGADO, O., DUGAN-ROCHA, S., MINER, G., MORGAN, M., 
HAWES, A., GILL, R., CELERA, HOLT, R. A., ADAMS, M. D., AMANATIDES, P. G., BADEN-
TILLSON, H., BARNSTEAD, M., CHIN, S., EVANS, C. A., FERRIERA, S., FOSLER, C., 
GLODEK, A., GU, Z., JENNINGS, D., KRAFT, C. L., NGUYEN, T., PFANNKOCH, C. M., 
SITTER, C., SUTTON, G. G., VENTER, J. C., WOODAGE, T., SMITH, D., LEE, H. M., 
GUSTAFSON, E., CAHILL, P., KANA, A., DOUCETTE-STAMM, L., WEINSTOCK, K., 
FECHTEL, K., WEISS, R. B., DUNN, D. M., GREEN, E. D., BLAKESLEY, R. W., BOUFFARD, 
G. G., DE JONG, P. J., OSOEGAWA, K., ZHU, B., MARRA, M., SCHEIN, J., BOSDET, I., 
FJELL, C., JONES, S., KRZYWINSKI, M., MATHEWSON, C., SIDDIQUI, A., WYE, N., 
MCPHERSON, J., ZHAO, S., FRASER, C. M., SHETTY, J., SHATSMAN, S., GEER, K., CHEN, 
97
References 
?
Y., ABRAMZON, S., NIERMAN, W. C., HAVLAK, P. H., CHEN, R., DURBIN, K. J., EGAN, A., 
REN, Y., SONG, X. Z., LI, B., LIU, Y., QIN, X., CAWLEY, S., COONEY, A. J., D'SOUZA, L. M., 
MARTIN, K., WU, J. Q., GONZALEZ-GARAY, M. L., JACKSON, A. R., KALAFUS, K. J., 
MCLEOD, M. P., MILOSAVLJEVIC, A., VIRK, D., VOLKOV, A., WHEELER, D. A., ZHANG, 
Z., BAILEY, J. A., EICHLER, E. E., TUZUN, E., et al. (2004) Genome sequence of the Brown 
Norway rat yields insights into mammalian evolution. Nature, 428, 493-521. 
GOGOLEVSKAYA, I. K., KOVAL, A. P. & KRAMEROV, D. A. (2005) Evolutionary history of 4.5SH 
RNA. Mol Biol Evol, 22, 1546-54. 
GOGOLEVSKY, K. P., VASSETZKY, N. S. & KRAMEROV, D. A. (2008) Bov-B-mobilized SINEs in 
vertebrate genomes. Gene, 407, 75-85. 
GOODIER, J. L. & MARAIA, R. J. (1998) Terminator-specific recycling of a B1-Alu transcription complex 
by RNA polymerase III is mediated by the RNA terminus-binding protein La. J Biol Chem, 273,
26110-6. 
GRAUR, D., HIDE, W. A. & LI, W. H. (1991) Is the guinea-pig a rodent? Nature, 351, 649-52. 
HARTENBERGER, J.-L. (1998) The Cenozoic radiation of mammals : some comments on the shape and 
tempo of a major evolutionary event, Milano, Società italiana di scienze naturali : Museo civico di 
storia naturale di Milano. 
HARTMUTH, K., VORNLOCHER, H. P. & LUHRMANN, R. (2004) Tobramycin affinity tag purification 
of spliceosomes. Methods Mol Biol, 257, 47-64. 
HASLER, J. & STRUB, K. (2006) Alu RNP and Alu RNA regulate translation initiation in vitro. Nucleic 
Acids Res, 34, 2374-85. 
HINMAN, M. N. & LOU, H. (2008) Diverse molecular functions of Hu proteins. Cell Mol Life Sci, 65, 3168-
81. 
HOCHULI, E. (1990) Purification of recombinant proteins with metal chelate adsorbent. Genet Eng (N Y),
12, 87-98. 
HOGAN, B., COSTANTINI, F. & LACY, E. (1986) Manipulating the mouse embryo : a laboratory manual, 
Cold Spring Harbor, N.Y., Cold Spring Harbor Laboratory. 
HOGG, J. R. & COLLINS, K. (2007) RNA-based affinity purification reveals 7SK RNPs with distinct 
composition and regulation. RNA, 13, 868-80. 
HORN, W. T., CONVERY, M. A., STONEHOUSE, N. J., ADAMS, C. J., LILJAS, L., PHILLIPS, S. E. & 
STOCKLEY, P. G. (2004) The crystal structure of a high affinity RNA stem-loop complexed with 
the bacteriophage MS2 capsid: further challenges in the modeling of ligand-RNA interactions. RNA,
10, 1776-82. 
HOYER, L. C., LEE, J. C. & BUCANA, C. (1979) Scanning immunoelectron microscopy for the 
identification and mapping of two or more antigens on cell surfaces. Scan Electron Microsc, 629-36. 
HUCHON, D., CHEVRET, P., JORDAN, U., KILPATRICK, C. W., RANWEZ, V., JENKINS, P. D., 
BROSIUS, J. & SCHMITZ, J. (2007) Multiple molecular evidences for a living mammalian fossil. 
Proc Natl Acad Sci U S A, 104, 7495-9. 
HUCHON, D., MADSEN, O., SIBBALD, M. J., AMENT, K., STANHOPE, M. J., CATZEFLIS, F., DE 
JONG, W. W. & DOUZERY, E. J. (2002) Rodent phylogeny and a timescale for the evolution of 
Glires: evidence from an extensive taxon sampling using three nuclear genes. Mol Biol Evol, 19,
1053-65. 
IACOANGELI, A., LIN, Y., MORLEY, E. J., MUSLIMOV, I. A., BIANCHI, R., REILLY, J., WEEDON, 
J., DIALLO, R., BOCKER, W. & TIEDGE, H. (2004) BC200 RNA in invasive and preinvasive 
breast cancer. Carcinogenesis, 25, 2125-33. 
IACOANGELI, A., ROZHDESTVENSKY, T. S., DOLZHANSKAYA, N., TOURNIER, B., SCHUTT, J., 
BROSIUS, J., DENMAN, R. B., KHANDJIAN, E. W., KINDLER, S. & TIEDGE, H. (2008a) On 
BC1 RNA and the fragile X mental retardation protein. Proc Natl Acad Sci U S A, 105, 734-9. 
IACOANGELI, A., ROZHDESTVENSKY, T. S., DOLZHANSKAYA, N., TOURNIER, B., SCHUTT, J., 
BROSIUS, J., DENMAN, R. B., KHANDJIAN, E. W., KINDLER, S. & TIEDGE, H. (2008b) Reply 
to Bagni: On BC1 RNA and the fragile X mental retardation protein. Proc Natl Acad Sci U S A, 105,
E29. 
98
References 
?
JOHANSSON, H. E., DERTINGER, D., LECUYER, K. A., BEHLEN, L. S., GREEF, C. H. & 
UHLENBECK, O. C. (1998) A thermodynamic analysis of the sequence-specific binding of RNA by 
bacteriophage MS2 coat protein. Proc Natl Acad Sci U S A, 95, 9244-9. 
KAGANMAN, I. (2008) Another handle for RNA. Nature Methods, 5, 126-126. 
KHANAM, T., MUDDASHETTY, R. S., KAHVEJIAN, A., SONENBERG, N. & BROSIUS, J. (2006) 
Poly(A)-binding protein binds to A-rich sequences via RNA-binding domains 1+2 and 3+4. RNA 
Biol, 3, 170-7. 
KHANAM, T., RAABE, C. A., KIEFMANN, M., HANDEL, S., SKRYABIN, B. V. & BROSIUS, J. 
(2007a) Can ID repetitive elements serve as cis-acting dendritic targeting elements? An in vivo 
study. PLoS ONE, 2, e961. 
KHANAM, T., ROZHDESTVENSKY, T. S., BUNDMAN, M., GALIVETI, C. R., HANDEL, S., 
SUKONINA, V., JORDAN, U., BROSIUS, J. & SKRYABIN, B. V. (2007b) Two primate-specific 
small non-protein-coding RNAs in transgenic mice: neuronal expression, subcellular localization and 
binding partners. Nucleic Acids Res, 35, 529-39. 
KIM, J., MARTIGNETTI, J. A., SHEN, M. R., BROSIUS, J. & DEININGER, P. (1994) Rodent BC1 RNA 
gene as a master gene for ID element amplification. Proc Natl Acad Sci U S A, 91, 3607-11. 
KLEIMAN, R., BANKER, G. & STEWARD, O. (1990) Differential subcellular localization of particular 
mRNAs in hippocampal neurons in culture. Neuron, 5, 821-30. 
KO, B. & GUNDERSON, S. I. (2002) Identification of new poly(A) polymerase-inhibitory proteins capable 
of regulating pre-mRNA polyadenylation. J Mol Biol, 318, 1189-206. 
KONDRASHOV, A. V., KIEFMANN, M., EBNET, K., KHANAM, T., MUDDASHETTY, R. S. & 
BROSIUS, J. (2005) Inhibitory effect of naked neural BC1 RNA or BC200 RNA on eukaryotic in 
vitro translation systems is reversed by poly(A)-binding protein (PABP). J Mol Biol, 353, 88-103. 
KOZAK, M. (1987) An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic 
Acids Res, 15, 8125-48. 
KRAMEROV, D. A. (1999) [The evidence of close phylogenetic relationship between Gliridae and Sciuridae 
families based on the study of short retroposon B1-dID]. Dokl Akad Nauk, 364, 277-80. 
KRAMEROV, D. A. & VASSETZKY, N. S. (2001) Structure and origin of a novel dimeric retroposon B1-
diD. J Mol Evol, 52, 137-43. 
KRAMEROV, D. A. & VASSETZKY, N. S. (2005) Short retroposons in eukaryotic genomes. Int Rev Cytol,
247, 165-221. 
KRAYEV, A. S., MARKUSHEVA, T. V., KRAMEROV, D. A., RYSKOV, A. P., SKRYABIN, K. G., 
BAYEV, A. A. & GEORGIEV, G. P. (1982) Ubiquitous transposon-like repeats B1 and B2 of the 
mouse genome: B2 sequencing. Nucleic Acids Res, 10, 7461-75. 
KREMERSKOTHEN, J., NETTERMANN, M., OP DE BEKKE, A., BACHMANN, M. & BROSIUS, J. 
(1998a) Identification of human autoantigen La/SS-B as BC1/BC200 RNA-binding protein. DNA 
Cell Biol, 17, 751-9. 
KREMERSKOTHEN, J., ZOPF, D., WALTER, P., CHENG, J. G., NETTERMANN, M., NIEWERTH, U., 
MARAIA, R. J. & BROSIUS, J. (1998b) Heterodimer SRP9/14 is an integral part of the neural 
BC200 RNP in primate brain. Neurosci Lett, 245, 123-6. 
KRIEGS, J. O., CHURAKOV, G., JURKA, J., BROSIUS, J. & SCHMITZ, J. (2007) Evolutionary history of 
7SL RNA-derived SINEs in Supraprimates. Trends Genet, 23, 158-61. 
KRIEGS, J. O., CHURAKOV, G., KIEFMANN, M., JORDAN, U., BROSIUS, J. & SCHMITZ, J. (2006) 
Retroposed elements as archives for the evolutionary history of placental mammals. PLoS Biol, 4,
e91.
KURYSHEV, V. Y., SKRYABIN, B. V., KREMERSKOTHEN, J., JURKA, J. & BROSIUS, J. (2001) Birth 
of a gene: locus of neuronal BC200 snmRNA in three prosimians and human BC200 pseudogenes as 
archives of change in the Anthropoidea lineage. J Mol Biol, 309, 1049-66. 
LAIRD, P. W., ZIJDERVELD, A., LINDERS, K., RUDNICKI, M. A., JAENISCH, R. & BERNS, A. (1991) 
Simplified mammalian DNA isolation procedure. Nucleic Acids Res, 19, 4293. 
LANDER, E. S., LINTON, L. M., BIRREN, B., NUSBAUM, C., ZODY, M. C., BALDWIN, J., DEVON, 
K., DEWAR, K., DOYLE, M., FITZHUGH, W., FUNKE, R., GAGE, D., HARRIS, K., HEAFORD, 
A., HOWLAND, J., KANN, L., LEHOCZKY, J., LEVINE, R., MCEWAN, P., MCKERNAN, K., 
99
References 
?
MELDRIM, J., MESIROV, J. P., MIRANDA, C., MORRIS, W., NAYLOR, J., RAYMOND, C., 
ROSETTI, M., SANTOS, R., SHERIDAN, A., SOUGNEZ, C., STANGE-THOMANN, N., 
STOJANOVIC, N., SUBRAMANIAN, A., WYMAN, D., ROGERS, J., SULSTON, J., 
AINSCOUGH, R., BECK, S., BENTLEY, D., BURTON, J., CLEE, C., CARTER, N., COULSON, 
A., DEADMAN, R., DELOUKAS, P., DUNHAM, A., DUNHAM, I., DURBIN, R., FRENCH, L., 
GRAFHAM, D., GREGORY, S., HUBBARD, T., HUMPHRAY, S., HUNT, A., JONES, M., 
LLOYD, C., MCMURRAY, A., MATTHEWS, L., MERCER, S., MILNE, S., MULLIKIN, J. C., 
MUNGALL, A., PLUMB, R., ROSS, M., SHOWNKEEN, R., SIMS, S., WATERSTON, R. H., 
WILSON, R. K., HILLIER, L. W., MCPHERSON, J. D., MARRA, M. A., MARDIS, E. R., 
FULTON, L. A., CHINWALLA, A. T., PEPIN, K. H., GISH, W. R., CHISSOE, S. L., WENDL, M. 
C., DELEHAUNTY, K. D., MINER, T. L., DELEHAUNTY, A., KRAMER, J. B., COOK, L. L., 
FULTON, R. S., JOHNSON, D. L., MINX, P. J., CLIFTON, S. W., HAWKINS, T., BRANSCOMB, 
E., PREDKI, P., RICHARDSON, P., WENNING, S., SLEZAK, T., DOGGETT, N., CHENG, J. F., 
OLSEN, A., LUCAS, S., ELKIN, C., UBERBACHER, E., FRAZIER, M., et al. (2001) Initial 
sequencing and analysis of the human genome. Nature, 409, 860-921. 
LEE, I. Y., WESTAWAY, D., SMIT, A. F., WANG, K., SETO, J., CHEN, L., ACHARYA, C., ANKENER, 
M., BASKIN, D., COOPER, C., YAO, H., PRUSINER, S. B. & HOOD, L. E. (1998) Complete 
genomic sequence and analysis of the prion protein gene region from three mammalian species. 
Genome Res, 8, 1022-37. 
LEVINE, T. D., GAO, F., KING, P. H., ANDREWS, L. G. & KEENE, J. D. (1993) Hel-N1: an autoimmune 
RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor 
mRNAs. Mol Cell Biol, 13, 3494-504. 
LIM, F. & PEABODY, D. S. (2002) RNA recognition site of PP7 coat protein. Nucleic Acids Res, 30, 4138-
44. 
LIN, Y., BROSIUS, J. & TIEDGE, H. (2001) Neuronal BC1 RNA: co-expression with growth-associated 
protein-43 messenger RNA. Neuroscience, 103, 465-79. 
LUDWIG, A., ROZHDESTVENSKY, T. S., KURYSHEV, V. Y., SCHMITZ, J. & BROSIUS, J. (2005) An 
unusual primate locus that attracted two independent Alu insertions and facilitates their transcription. 
J Mol Biol, 350, 200-14. 
LYFORD, G. L., YAMAGATA, K., KAUFMANN, W. E., BARNES, C. A., SANDERS, L. K., 
COPELAND, N. G., GILBERT, D. J., JENKINS, N. A., LANAHAN, A. A. & WORLEY, P. F. 
(1995) Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated 
protein that is enriched in neuronal dendrites. Neuron, 14, 433-45. 
MANIATIS, T., FRITSCH, E. F. & SAMBROOK, J. (1982) Molecular cloning : a laboratory manual, Cold
Spring Harbor, N.Y., Cold Spring Harbor Laboratory. 
MARTIGNETTI, J. A. & BROSIUS, J. (1993a) BC200 RNA: a neural RNA polymerase III product encoded 
by a monomeric Alu element. Proc Natl Acad Sci U S A, 90, 11563-7. 
MARTIGNETTI, J. A. & BROSIUS, J. (1993b) Neural BC1 RNA as an evolutionary marker: guinea pig 
remains a rodent. Proc Natl Acad Sci U S A, 90, 9698-702. 
MARTIGNETTI, J. A. & BROSIUS, J. (1995) BC1 RNA: transcriptional analysis of a neural cell-specific 
RNA polymerase III transcript. Mol Cell Biol, 15, 1642-50. 
MCKINNON, R. D., DANIELSON, P., BROW, M. A., BLOOM, F. E. & SUTCLIFFE, J. G. (1987) 
Expression of small cytoplasmic transcripts of the rat identifier element in vivo and in cultured cells. 
Mol Cell Biol, 7, 2148-54. 
MIYASHIRO, K., DICHTER, M. & EBERWINE, J. (1994) On the nature and differential distribution of 
mRNAs in hippocampal neurites: implications for neuronal functioning. Proc Natl Acad Sci U S A,
91, 10800-4. 
MOBARAK, C. D., ANDERSON, K. D., MORIN, M., BECKEL-MITCHENER, A., ROGERS, S. L., 
FURNEAUX, H., KING, P. & PERRONE-BIZZOZERO, N. I. (2000) The RNA-binding protein 
HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite 
outgrowth in PC12 cells. Mol Biol Cell, 11, 3191-203. 
100
References 
?
MONTGELARD, C., BENTZ, S., TIRARD, C., VERNEAU, O. & CATZEFLIS, F. M. (2002) Molecular 
systematics of sciurognathi (rodentia): the mitochondrial cytochrome b and 12S rRNA genes support 
the Anomaluroidea (Pedetidae and Anomaluridae). Mol Phylogenet Evol, 22, 220-33. 
MONTGELARD, C., FORTY, E., ARNAL, V. & MATTHEE, C. A. (2008) Suprafamilial relationships 
among Rodentia and the phylogenetic effect of removing fast-evolving nucleotides in mitochondrial, 
exon and intron fragments. BMC Evol Biol, 8, 321. 
MUDDASHETTY, R., KHANAM, T., KONDRASHOV, A., BUNDMAN, M., IACOANGELI, A., 
KREMERSKOTHEN, J., DUNING, K., BARNEKOW, A., HUTTENHOFER, A., TIEDGE, H. & 
BROSIUS, J. (2002) Poly(A)-binding protein is associated with neuronal BC1 and BC200 
ribonucleoprotein particles. J Mol Biol, 321, 433-45. 
MULLIN, C., DUNING, K., BARNEKOW, A., RICHTER, D., KREMERSKOTHEN, J. & MOHR, E. 
(2004) Interaction of rat poly(A)-binding protein with poly(A)- and non-poly(A) sequences is 
preferentially mediated by RNA recognition motifs 3+4. FEBS Lett, 576, 437-41. 
MURPHY, W. J., EIZIRIK, E., JOHNSON, W. E., ZHANG, Y. P., RYDER, O. A. & O'BRIEN, S. J. (2001) 
Molecular phylogenetics and the origins of placental mammals. Nature, 409, 614-8. 
MUS, E., HOF, P. R. & TIEDGE, H. (2007) Dendritic BC200 RNA in aging and in Alzheimer's disease. 
Proc Natl Acad Sci U S A, 104, 10679-84. 
MUSLIMOV, I. A., IACOANGELI, A., BROSIUS, J. & TIEDGE, H. (2006) Spatial codes in dendritic BC1 
RNA. J Cell Biol, 175, 427-39. 
MUSLIMOV, I. A., SANTI, E., HOMEL, P., PERINI, S., HIGGINS, D. & TIEDGE, H. (1997) RNA 
transport in dendrites: a cis-acting targeting element is contained within neuronal BC1 RNA. J
Neurosci, 17, 4722-33. 
MUSLIMOV, I. A., TITMUS, M., KOENIG, E. & TIEDGE, H. (2002) Transport of Neuronal BC1 RNA in 
Mauthner Axons. J Neurosci, 22, 4293-301. 
NAPOLI, I., MERCALDO, V., BOYL, P. P., ELEUTERI, B., ZALFA, F., DE RUBEIS, S., DI MARINO, 
D., MOHR, E., MASSIMI, M., FALCONI, M., WITKE, W., COSTA-MATTIOLI, M., 
SONENBERG, N., ACHSEL, T. & BAGNI, C. (2008) The fragile X syndrome protein represses 
activity-dependent translation through CYFIP1, a new 4E-BP. Cell, 134, 1042-54. 
OHSHIMA, K. & OKADA, N. (1994) Generality of the tRNA origin of short interspersed repetitive 
elements (SINEs). Characterization of three different tRNA-derived retroposons in the octopus. J
Mol Biol, 243, 25-37. 
OHSHIMA, K. & OKADA, N. (2005) SINEs and LINEs: symbionts of eukaryotic genomes with a common 
tail. Cytogenet Genome Res, 110, 475-90. 
OKADA, N. (1991) SINEs. Curr Opin Genet Dev, 1, 498-504. 
OKANO, H. J. & DARNELL, R. B. (1997) A hierarchy of Hu RNA binding proteins in developing and adult 
neurons. J Neurosci, 17, 3024-37. 
PEABODY, D. S. (1990) Translational repression by bacteriophage MS2 coat protein expressed from a 
plasmid. A system for genetic analysis of a protein-RNA interaction. J Biol Chem, 265, 5684-9. 
QUENTIN, Y. (1992) Origin of the Alu family: a family of Alu-like monomers gave birth to the left and the 
right arms of the Alu elements. Nucleic Acids Res, 20, 3397-401. 
RAO, A. & STEWARD, O. (1993) Evaluation of RNAs present in synaptodendrosomes: dendritic, glial, and 
neuronal cell body contribution. J Neurochem, 61, 835-44. 
REYES, A., GISSI, C., PESOLE, G., CATZEFLIS, F. M. & SACCONE, C. (2000) Where do rodents fit? 
Evidence from the complete mitochondrial genome of Sciurus vulgaris. Mol Biol Evol, 17, 979-83. 
REYES, A., PESOLE, G. & SACCONE, C. (1998) Complete mitochondrial DNA sequence of the fat 
dormouse, Glis glis: further evidence of rodent paraphyly. Mol Biol Evol, 15, 499-505. 
RIGAUT, G., SHEVCHENKO, A., RUTZ, B., WILM, M., MANN, M. & SERAPHIN, B. (1999) A generic 
protein purification method for protein complex characterization and proteome exploration. Nat
Biotechnol, 17, 1030-2. 
ROGOZIN, I. B., MAYOROV, V. I., LAVRENTIEVA, M. V., MILANESI, L. & ADKISON, L. R. (2000) 
Prediction and phylogenetic analysis of mammalian short interspersed elements (SINEs). Brief 
Bioinform, 1, 260-74. 
101
References 
?
ROZHDESTVENSKY, T. S., KOPYLOV, A. M., BROSIUS, J. & HUTTENHOFER, A. (2001) Neuronal 
BC1 RNA structure: evolutionary conversion of a tRNA(Ala) domain into an extended stem-loop 
structure. RNA, 7, 722-30. 
SALEM, A. H., RAY, D. A., XING, J., CALLINAN, P. A., MYERS, J. S., HEDGES, D. J., GARBER, R. 
K., WITHERSPOON, D. J., JORDE, L. B. & BATZER, M. A. (2003) Alu elements and hominid 
phylogenetics. Proc Natl Acad Sci U S A, 100, 12787-91. 
SCHMITZ, J., OHME, M. & ZISCHLER, H. (2001) SINE insertions in cladistic analyses and the 
phylogenetic affiliations of Tarsius bancanus to other primates. Genetics, 157, 777-84. 
SCHMITZ, J., ROOS, C. & ZISCHLER, H. (2005) Primate phylogeny: molecular evidence from 
retroposons. Cytogenet Genome Res, 108, 26-37. 
SERDOBOVA, I. M. & KRAMEROV, D. A. (1993) [Use of the short retroposon B2 in the study of 
phylogenetic relationship in rodents]. Genetika, 29, 1969-81. 
SERDOBOVA, I. M. & KRAMEROV, D. A. (1998) Short retroposons of the B2 superfamily: evolution and 
application for the study of rodent phylogeny. J Mol Evol, 46, 202-14. 
SHEDLOCK, A. M. & OKADA, N. (2000) SINE insertions: powerful tools for molecular systematics. 
Bioessays, 22, 148-60. 
SHEDLOCK, A. M., TAKAHASHI, K. & OKADA, N. (2004) SINEs of speciation: tracking lineages with 
retroposons. Trends Ecol Evol, 19, 545-53. 
SHEN, M. R., BROSIUS, J. & DEININGER, P. L. (1997) BC1 RNA, the transcript from a master gene for 
ID element amplification, is able to prime its own reverse transcription. Nucleic Acids Res, 25, 1641-
8. 
SINGER, M. F. (1982) SINEs and LINEs: highly repeated short and long interspersed sequences in 
mammalian genomes. Cell, 28, 433-4. 
SINGER, M. F. (1990) SINE and LINE nomenclature. Trends Genet, 6, 204. 
SKRYABIN, B. V., KREMERSKOTHEN, J., VASSILACOPOULOU, D., DISOTELL, T. R., 
KAPITONOV, V. V., JURKA, J. & BROSIUS, J. (1998) The BC200 RNA gene and its neural 
expression are conserved in Anthropoidea (Primates). J Mol Evol, 47, 677-85. 
SKRYABIN, B. V., SUKONINA, V., JORDAN, U., LEWEJOHANN, L., SACHSER, N., MUSLIMOV, I., 
TIEDGE, H. & BROSIUS, J. (2003) Neuronal untranslated BC1 RNA: targeted gene elimination in 
mice. Mol Cell Biol, 23, 6435-41. 
SRISAWAT, C. & ENGELKE, D. R. (2001) Streptavidin aptamers: affinity tags for the study of RNAs and 
ribonucleoproteins. RNA, 7, 632-41. 
SRISAWAT, C., GOLDSTEIN, I. J. & ENGELKE, D. R. (2001) Sephadex-binding RNA ligands: rapid 
affinity purification of RNA from complex RNA mixtures. Nucleic Acids Res, 29, E4. 
TARS, K., FRIDBORG, K., BUNDULE, M. & LILJAS, L. (2000) The three-dimensional structure of 
bacteriophage PP7 from Pseudomonas aeruginosa at 3.7-A resolution. Virology, 272, 331-7. 
TAYLOR, B. A., NAVIN, A., SKRYABIN, B. V. & BROSIUS, J. (1997) Localization of the mouse gene 
(Bc1) encoding neural BC1 RNA near the fibroblast growth factor 3 locus (Fgf3) on distal 
chromosome 7. Genomics, 44, 153-4. 
THOMPSON, J. D., GIBSON, T. J., PLEWNIAK, F., JEANMOUGIN, F. & HIGGINS, D. G. (1997) The 
CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by 
quality analysis tools. Nucleic Acids Res, 25, 4876-82. 
TIEDGE, H. & BROSIUS, J. (1996) Translational machinery in dendrites of hippocampal neurons in culture. 
J Neurosci, 16, 7171-81. 
TIEDGE, H., CHEN, W. & BROSIUS, J. (1993) Primary structure, neural-specific expression, and dendritic 
location of human BC200 RNA. J Neurosci, 13, 2382-90. 
TIEDGE, H., FREMEAU, R. T., JR., WEINSTOCK, P. H., ARANCIO, O. & BROSIUS, J. (1991) Dendritic 
location of neural BC1 RNA. Proc Natl Acad Sci U S A, 88, 2093-7. 
ULLU, E., MURPHY, S. & MELLI, M. (1982) Human 7SL RNA consists of a 140 nucleotide middle-
repetitive sequence inserted in an alu sequence. Cell, 29, 195-202. 
ULLU, E. & TSCHUDI, C. (1984) Alu sequences are processed 7SL RNA genes. Nature, 312, 171-2. 
102
References 
?
VAN DE LAGEMAAT, L. N., GAGNIER, L., MEDSTRAND, P. & MAGER, D. L. (2005) Genomic 
deletions and precise removal of transposable elements mediated by short identical DNA segments in 
primates. Genome Res, 15, 1243-9. 
VAN DEN WORM, S. H., STONEHOUSE, N. J., VALEGARD, K., MURRAY, J. B., WALTON, C., 
FRIDBORG, K., STOCKLEY, P. G. & LILJAS, L. (1998) Crystal structures of MS2 coat protein 
mutants in complex with wild-type RNA operator fragments. Nucleic Acids Res, 26, 1345-51. 
VASSETZKY, N. S., TEN, O. A. & KRAMEROV, D. A. (2003) B1 and related SINEs in mammalian 
genomes. Gene, 319, 149-60. 
VENTER, J. C., ADAMS, M. D., MYERS, E. W., LI, P. W., MURAL, R. J., SUTTON, G. G., SMITH, H. 
O., YANDELL, M., EVANS, C. A., HOLT, R. A., GOCAYNE, J. D., AMANATIDES, P., 
BALLEW, R. M., HUSON, D. H., WORTMAN, J. R., ZHANG, Q., KODIRA, C. D., ZHENG, X. 
H., CHEN, L., SKUPSKI, M., SUBRAMANIAN, G., THOMAS, P. D., ZHANG, J., GABOR 
MIKLOS, G. L., NELSON, C., BRODER, S., CLARK, A. G., NADEAU, J., MCKUSICK, V. A., 
ZINDER, N., LEVINE, A. J., ROBERTS, R. J., SIMON, M., SLAYMAN, C., HUNKAPILLER, M., 
BOLANOS, R., DELCHER, A., DEW, I., FASULO, D., FLANIGAN, M., FLOREA, L., 
HALPERN, A., HANNENHALLI, S., KRAVITZ, S., LEVY, S., MOBARRY, C., REINERT, K., 
REMINGTON, K., ABU-THREIDEH, J., BEASLEY, E., BIDDICK, K., BONAZZI, V., 
BRANDON, R., CARGILL, M., CHANDRAMOULISWARAN, I., CHARLAB, R., 
CHATURVEDI, K., DENG, Z., DI FRANCESCO, V., DUNN, P., EILBECK, K., EVANGELISTA, 
C., GABRIELIAN, A. E., GAN, W., GE, W., GONG, F., GU, Z., GUAN, P., HEIMAN, T. J., 
HIGGINS, M. E., JI, R. R., KE, Z., KETCHUM, K. A., LAI, Z., LEI, Y., LI, Z., LI, J., LIANG, Y., 
LIN, X., LU, F., MERKULOV, G. V., MILSHINA, N., MOORE, H. M., NAIK, A. K., NARAYAN, 
V. A., NEELAM, B., NUSSKERN, D., RUSCH, D. B., SALZBERG, S., SHAO, W., SHUE, B., 
SUN, J., WANG, Z., WANG, A., WANG, X., WANG, J., WEI, M., WIDES, R., XIAO, C., YAN, 
C., et al. (2001) The sequence of the human genome. Science, 291, 1304-51. 
WADDELL, P. J., KISHINO, H. & OTA, R. (2001) A phylogenetic foundation for comparative mammalian 
genomics. Genome Inform, 12, 141-54. 
WANG, H., IACOANGELI, A., LIN, D., WILLIAMS, K., DENMAN, R. B., HELLEN, C. U. & TIEDGE, 
H. (2005) Dendritic BC1 RNA in translational control mechanisms. J Cell Biol, 171, 811-21. 
WANG, H., IACOANGELI, A., POPP, S., MUSLIMOV, I. A., IMATAKA, H., SONENBERG, N., 
LOMAKIN, I. B. & TIEDGE, H. (2002) Dendritic BC1 RNA: functional role in regulation of 
translation initiation. J Neurosci, 22, 10232-41. 
WATERSTON, R. H., LINDBLAD-TOH, K., BIRNEY, E., ROGERS, J., ABRIL, J. F., AGARWAL, P., 
AGARWALA, R., AINSCOUGH, R., ALEXANDERSSON, M., AN, P., ANTONARAKIS, S. E., 
ATTWOOD, J., BAERTSCH, R., BAILEY, J., BARLOW, K., BECK, S., BERRY, E., BIRREN, B., 
BLOOM, T., BORK, P., BOTCHERBY, M., BRAY, N., BRENT, M. R., BROWN, D. G., BROWN, 
S. D., BULT, C., BURTON, J., BUTLER, J., CAMPBELL, R. D., CARNINCI, P., CAWLEY, S., 
CHIAROMONTE, F., CHINWALLA, A. T., CHURCH, D. M., CLAMP, M., CLEE, C., COLLINS, 
F. S., COOK, L. L., COPLEY, R. R., COULSON, A., COURONNE, O., CUFF, J., CURWEN, V., 
CUTTS, T., DALY, M., DAVID, R., DAVIES, J., DELEHAUNTY, K. D., DERI, J., 
DERMITZAKIS, E. T., DEWEY, C., DICKENS, N. J., DIEKHANS, M., DODGE, S., DUBCHAK, 
I., DUNN, D. M., EDDY, S. R., ELNITSKI, L., EMES, R. D., ESWARA, P., EYRAS, E., 
FELSENFELD, A., FEWELL, G. A., FLICEK, P., FOLEY, K., FRANKEL, W. N., FULTON, L. A., 
FULTON, R. S., FUREY, T. S., GAGE, D., GIBBS, R. A., GLUSMAN, G., GNERRE, S., 
GOLDMAN, N., GOODSTADT, L., GRAFHAM, D., GRAVES, T. A., GREEN, E. D., GREGORY, 
S., GUIGO, R., GUYER, M., HARDISON, R. C., HAUSSLER, D., HAYASHIZAKI, Y., HILLIER, 
L. W., HINRICHS, A., HLAVINA, W., HOLZER, T., HSU, F., HUA, A., HUBBARD, T., HUNT, 
A., JACKSON, I., JAFFE, D. B., JOHNSON, L. S., JONES, M., JONES, T. A., JOY, A., KAMAL, 
M., KARLSSON, E. K., et al. (2002) Initial sequencing and comparative analysis of the mouse 
genome. Nature, 420, 520-62. 
WATSON, J. B. & SUTCLIFFE, J. G. (1987) Primate brain-specific cytoplasmic transcript of the Alu repeat 
family. Mol Cell Biol, 7, 3324-7. 
103
References 
?
WEILER, K. S. & WAKIMOTO, B. T. (1995) Heterochromatin and gene expression in Drosophila. Annu
Rev Genet, 29, 577-605. 
WEST, N., ROY-ENGEL, A. M., IMATAKA, H., SONENBERG, N. & DEININGER, P. (2002) Shared 
protein components of SINE RNPs. J Mol Biol, 321, 423-32. 
WILLIAMS, A., HARKER, N., KTISTAKI, E., VEIGA-FERNANDES, H., RODERICK, K., TOLAINI, M., 
NORTON, T., WILLIAMS, K. & KIOUSSIS, D. (2008) Position effect variegation and imprinting 
of transgenes in lymphocytes. Nucleic Acids Res, 36, 2320-9. 
ZALFA, F., GIORGI, M., PRIMERANO, B., MORO, A., DI PENTA, A., REIS, S., OOSTRA, B. & 
BAGNI, C. (2003) The fragile X syndrome protein FMRP associates with BC1 RNA and regulates 
the translation of specific mRNAs at synapses. Cell, 112, 317-27. 
ZUKER, M. (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids 
Res, 31, 3406-15. 
104
 
 
 
 
 
 
 
 
 
Appendix 
Appendix
? ?
Figure 1 pBC1MS2 plasmid map.
For generating BC1MS2 transgenic mice, the rat BC1 RNA gene was used. The two MS2 RNA motifs 
[green] were introduced at the very 3' end of the BC1 RNA coding region [blue] proximal to the RNA 
polymerase III terminator (UUU). The A-box element and B'-box element in the BC1 RNA coding region are 
indicated [turquoise]. In the upstream region two putative octamer-binding sequences (OCTA) and a TATA-
box are shown. MS2 mutagenesis was carried out by PCR based amplification (see text, Materials and 
Methods, section 1.1). PCR amplified rat BC1MS2 (MS2 stems at the very 3' end of BC1 RNA) fragment 
was cloned in pCRTOPOII vector (Invitrogen). BC1MS2 transgenic mice were generated using the 1.5 kb 
SacI - BamHI fragment released from the vector. 
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Figure 2 pBC200MS2 plasmid map.
For generating BC200MS2 transgenic mice, the human BC200 RNA locus was used. The two MS2 RNA 
motifs [green] were introduced at the very 3' end of the BC200 RNA coding region [purple] proximal to 
RNA polymerase III terminator (UUU). The BC200 RNA locus contains control regions such as a TATA-
box. MS2 mutagenesis was carried out by PCR based amplification (see text, Materials and Methods, section 
1.1). PCR amplified human BC200MS2 fragment was cloned in pCRTOPOII vector (Invitrogen). 
BC200MS2 transgenic mice were generated by using the 3.9 kb EcoRI - EcoRI fragment released from the 
pBC200MS2 vector. 
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Figure 3 pNEMS2TAP plasmid map.
For generating MS2TAP protein expressing mice, the MS2TAP fragment was cloned into the pNECKu 
vector (Blichenberg et al., 1999). The vector features the chicken ?-actin promoter [yellow] and the 5' UTR 
[gray] interrupted by a ~1 kb intron [striped area] of the chicken ?-actin gene. The MS2TAP fusion protein 
consists of the MS2 coat protein [green] fused to the CBP tag [purple] and protein A tag [magenta] 
separated by a TEV protease cleavage site [red]. HA and FLAG peptide sequences [orange] were fused to 
the N-terminus of MS2TAP fusion protein. The MS2TAP fusion is followed by a polyadenylation signal 
from a fragment from SV40 virus [turquoise].The fragment encoding the MS2 coat protein was obtained 
from plasmid pG14-MS2-GFP (Bertrand et al., 1998); the fragment encoding the TAP protein from pTAP 
(Rigaut et al., 1999). (see text for PCR amplification details, Materials and Methods, section 1.2 ). 
MS2TAP transgenic mice were generated by using the ~4.6 kb PvuI - NruI fragment released from 
pNEMS2TAP.
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Figure 4 p3revTAP plasmid map.
Both the RNA expressing cassette (BC1MS2 RNA – MS2 at the very 3' end of BC1 RNA) and the protein 
expressing cassette (MS2TAP fusion protein) were cloned into a single vector. The plasmid features 
BC1MS2 RNA (blue and green) fragment and the chicken ?-actin promoter [yellow] including the 5' UTR 
[gray] interrupted by a ~1 kb intron [striped area]. The MS2TAP fusion protein features the MS2 coat protein 
[green] fused to the TAP module with the CBP tag [purple] and protein A tag [magenta] separated by a TEV 
protease cleavage site [red] followed by a polyadenylation signal from a fragment from SV40 virus 
containing poly(A) additional signal [turquoise]. HA and FLAG peptide sequences [orange] were fused to the 
N-terminus of MS2TAP fusion protein. The BC1MS2 fragment (SacI - ApaI) contained 423 bp upstream of 
the BC1MS2 RNA gene and about 200 bp downstream of the RNA polymerase III terminator of the RNA 
gene was obtained from pBC1MS2 (Appendix, Fig 1) and cloned into pBluescript II KS+. The MS2TAP 
fragment was isolated by PvuI - NruI digestion from pNEMS2TAP plasmid (Appendix, Fig 3) and subcloned 
into pBluescript II KS+, which harbored BC1MS2 (with the MS2 domains located at the very 3'end of BC1 
RNA). The plasmid with MS2TAP inserted in the opposite orientation with respect to BC1MS2 [head to 
head] was designated the plasmid as 3 revTAP. The insert carrying the RNA and protein coding genes (inner 
circle) were released with SfiI and AscI to generate the 3 revTAP transgenic mice. 
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Figure 5 p11dirTAP plasmid map.
Same as Appendix, Fig. 4, except that the cassette with MS2TAP inserted in the opposite orientation with 
respect to BC1MS2 [head to tail]. The vector was designated as 11 dirTAP. The insert carrying the RNA and 
protein coding genes (inner circle) were released with SfiI and AscI to generate the 11 dirTAP transgenic 
mice. 
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Figure 6 pBC1MS2A plasmid map.
In this construct, the two MS2 RNA motifs [green] were placed closer to the ID domain internal within the 
BC1 RNA coding region [blue] followed by A22 and the BC1 RNA unique region. The RNA polymerase III 
transcription termination signal from wild type locus was placed downstream to the MS2 RNA motifs. The 
A-box element and B'-box element in the BC1 RNA coding region are indicated [turquoise]. In the upstream 
region two putative octamer-binding sequences (OCTA) and a TATA-box are shown. MS2 mutagenesis was 
carried out by PCR based amplification (see text, Mareials and Methods, section 1.4). PCR amplified rat 
BC1MS2A fragment was cloned in pDrive cloning vector (Qiagen, Hilden). BC1MS2A transgenic mice were 
generated by inserting the 1.5 kb EcoRI fragment released from vector. 
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Figure 7 pBC1MS2B plasmid map.
In this construct, the two MS2 RNA motifs [green] were placed closer to the 3' unique domain within the 
BC1 RNA coding region [blue] downstream of the A22 sequence. The RNA polymerase III transcription 
termination signal from wild type locus was placed downstream to the MS2 RNA motifs. The A-box element 
and B'-box element in the BC1 RNA coding region are indicated [turquoise]. In the upstream region two 
putative octamer-binding sequences (OCTA) and a TATA-box are shown. MS2 mutagenesis was carried out 
by PCR based amplification (see text, Mareials and Methods, section 1.4). PCR amplified rat BC1MS2B 
fragment was cloned in pDrive cloning vector (Qiagen, Hilden). BC1MS2B transgenic mice were generated 
by inserting the 1.5 kb EcoRI fragment released from vector. 
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Fig 8 Pedigree of 3 revTAP, 11 dirTAP, BC200MS2, BC200MS2+MS2TAP and BC1MS2A transgenic 
mice. 3 revTAP and 11 dirTAP transgenic mice were generated by injecting fragment harbor RNA and 
protein coding genes (Appendix, Fig 4 and 5). Offsprings of the 3 revTAP and 11 dirTAP was analysed by 
Northern blot (BC1MS2 RNA – not detected, 3 revTAP mice # 21, 45 and 11 dirTAP mice # 19 and 25, see 
Fig 3.5) and Western blot (MS2TAP fusion protein detected, 11 dirTAP mouse # 21). BC200MS2 transgene 
was generated by injecting BC200MS2 gene fragment (Appendix, Fig 2). Founders of BC200MS2 RNA 
expressing transgene was crossed with 11 dirTAP transgene (expresses MS2TAP fusion protein). The 
resulted transgenic mice (BC200MS2+MS2TAP mice # 11, 13 and 21, see Fig 3.5) showed BC200MS2 
RNA expression. BC1MS2A transgenic mice were generated by injecting BC1MS2A gene (Appendix, Fig
6). Offsprings were analyzed by Northern blot and were unable to detect BC1MS2A RNA expression 
(BC1MS2A mice # 10 and 12, see 3.11). 
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Fig 9 Pedigree of BC1MS2B, BC1MS2B_in BC1 RNA-/- BC1MS2B+MS2TAP_ in BC1 RNA-/-
transgenic mice. Transgenic mice used in this study was obtained from different breedings, for analyzing 
Norhern blot, Western blot and Southern blot are shown in the pedigree. BC1MS2B transgenic mice was 
generated by injecting the DNA fragment (BC1MS2B, Appendix, Fig 7). The resulted mouse founders 
(BC1MS2B mice, Fig 8A # 3, 6, 11) were crossed among each transgenic mouse. The resulted offspring was 
used for Northern blot analysis (BC1MS2B mice # 14, 16, 25, see Fig 3.11). Among the offspring of three 
founder mice, one mouse (BC1MS2B mouse #16, see Fig 3.11) showed relatively high levels of BC1MS2B 
RNA expression. Therefore expanded that transgenic mouse line. MS2TAP transgenic mice were generated 
by injecting DNA (Appendix, Fig 5).The siblings from the BC1MS2B mouse #16 (BC1MS2B mouse #18) 
was crossed with MS2TAP transgenic mice, observed further improvement in BC1MS2B RNA expression 
(BC1MS2B + MS2TAP, mouse # 18, see Fig 3.11). The resulted transgenic mouse (BC1MS2B + MS2TAP) 
was bred with BC1 RNA-/- and observed three types of BC1MS2B transgne integration into the mouse 
genome (see Fig 3.12). Among the three types of integration low copy number transgenic mouse 
(BC1MS2B+MS2TAP mice, Fig 8C # 54 and 67, see Fig 3.12), BC1MS2B RNA expression was observed. 
Therefore expanded and further crossed with BC1 RNA-/- transgenic mice to attain homozygosity 
(BC1MS2B+MS2TAP_in.BC1 RNA-/-, mice # 5 and 10, see Fig 3.13). The resulted transgenic mice was bred 
for 3-4 generations to obtain homozygous for both the transgenes [BC1MS2BTg/Tg and MS2TAPTg/Tg genes], 
(BC1MS2BTg/Tg and MS2TAPTg/Tg _in.BC1 RNA-/-, mice # 5, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 
20, 21).  
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